EurekaMag PDF full texts Chapter 51,438
References:
Snarski, E.; Torosian, T.; Paluszewska, M.; Urbanowska, E.; Milczarczyk, A.; Jedynasty, K.; Franek, E.; Jedrzejczak, W.ła.W. 2009: Alleviation of exogenous insulin requirement in type 1 diabetes mellitus after immunoablation and transplantation of autologous hematopoietic stem cells. Polskie Archiwum Medycyny Wewnetrznej 119(6): 422-426
Ma, L.; Li, Y.; Yu, C.; Wang, Y.; Li, X.; Li, N.; Chen, Q.; Bu, N. 2012: Alleviation of exogenous oligochitosan on wheat seedlings growth under salt stress. Protoplasma 249(2): 393-399
Razeghi Jahromi, S.; Arrefhosseini, S.R.; Ghaemi, A.; Alizadeh, A.; Moradi Tabriz, H.; Togha, M. 2014: Alleviation of experimental allergic encephalomyelitis in C57BL/6 mice by soy daidzein. Iranian Journal of Allergy Asthma and Immunology 13(4): 256-264
Luttik, M.A.H.; Vuralhan, Z.; Suir, E.; Braus, G.H.; Pronk, J.T.; Daran, J.M. 2008: Alleviation of feedback inhibition in Saccharomyces cerevisiae aromatic amino acid biosynthesis: quantification of metabolic impact. Metabolic Engineering 10(3-4): 141-153
Wang, C.; Wu, H.; He, F.; Jing, X.; Liang, Q.; Heng, G.; Wang, L.; Gao, G.; Zhang, H. 2012: Alleviation of ferric chloride-induced seizures and retarded behaviour in epileptic rats by cortical electrical stimulation treatment. Journal of International Medical Research 40(1): 266-281
Ahemad, M.; Khan, M.S. 2012: Alleviation of fungicide-induced phytotoxicity in greengram [Vigna radiata (L.) Wilczek] using fungicide-tolerant and plant growth promoting Pseudomonas strain. Saudi Journal of Biological Sciences 19(4): 451-459
Rakov, D.V. 2007: Alleviation of gamma-radiation damage by water with reduced deuterium and 18O content. Aviakosmicheskaia i Ekologicheskaia Meditsina 41(3): 36-39
Tohamy, A.A.; Abdel Azeem, A.A.; Shafaa, M.W.; Mahmoud, W.S. 2012: Alleviation of genotoxic effects of cyclophosphamide using encapsulation into liposomes in the absence or presence of vitamin C. General Physiology and Biophysics 31(1): 85-91
Bhattacharya, P.; Pandey, A.K.; Paul, S.; Patnaik, R. 2014: Alleviation of glutamate mediated neuronal insult by piroxicam in rodent model of focal cerebral ischemia: a possible mechanism of GABA agonism. Journal of Physiology and Biochemistry 70(4): 901-913
Dou, W.; Mukherjee, S.; Li, H.; Venkatesh, M.; Wang, H.; Kortagere, S.; Peleg, A.; Chilimuri, S.S.; Wang, Z.-T.; Feng, Y.; Fearon, E.R.; Mani, S. 2012: Alleviation of gut inflammation by Cdx2/Pxr pathway in a mouse model of chemical colitis. Plos one 7(7): E36075
Choi, J.-W.; Kim, M.-J.; Lee, J.-Y. 2008: Alleviation of heat strain by cooling different body areas during red pepper harvest work at WBGT 33 degrees C. Industrial Health 46(6): 620-628
Lee, T-Yan.; Chang, H-Hong.; Lo, W-Chai.; Lin, H-Chieh. 2010: Alleviation of hepatic oxidative stress by Chinese herbal medicine Yin-Chen-Hao-Tang in obese mice with steatosis. International Journal of Molecular Medicine 25(6): 837-844
Xiong, W.; Yang, Z.; Zhai, H.; Wang, G.; Xu, X.; Ma, W.; Tang, R. 2013: Alleviation of high light-induced photoinhibition in cyanobacteria by artificially conferred biosilica shells. Chemical Communications 49(68): 7525-7527
Ii, H.; Yokoyama, N.; Yoshida, S.; Tsutsumi, K.; Hatakeyama, S.; Sato, T.; Ishihara, K.; Akiba, S. 2009: Alleviation of high-fat diet-induced fatty liver damage in group IVA phospholipase A2-knockout mice. Plos one 4(12): E8089
Padala, P.R.; Rapuri, S.B.; Padala, K.P. 2007: Alleviation of hot flashes with increase in venlafaxine dose. Primary Care Companion to the Journal of Clinical Psychiatry 9(1): 70-71
Shyu, J.-F.; Wang, H.-S.; Shyr, Y.-M.; Wang, S.-E.; Chen, C.-H.; Tan, J.-S.; Lin, M.-F.; Hsieh, P.-S.; Sytwu, H.-K.; Chen, T.-H. 2011: Alleviation of hyperglycemia in diabetic rats by intraportal injection of insulin-producing cells generated from surgically resected human pancreatic tissue. Journal of Endocrinology 208(3): 233-244
Zhao, Q.; Xu, C.-l.; Xiong, H.-y.; Huang, W.; Zhang, M.; Wang, Y.; Wang, S.-y.; Wang, W. 2013: Alleviation of hyperglycemia induced vascular endothelial injury by exenatide might be related to the reduction of nitrooxidative stress. Biomed Research International 2013: 843657
Bashaw, M.C.; Aharoni, A.; Hesselink, L. 1992: Alleviation of image distortion due to striations in a photorefractive medium by using a phase-conjugated reference wave. Optics Letters 17(16): 1149-1151
Kanak, M.A.; Takita, M.; Itoh, T.; SoRelle, J.A.; Murali, S.; Kunnathodi, F.; Shahbazov, R.; Lawrence, M.C.; Levy, M.F.; Naziruddin, B. 2014: Alleviation of instant blood-mediated inflammatory reaction in autologous conditions through treatment of human islets with NF-κB inhibitors. Transplantation 98(5): 578-584
Mizrahi, M.; Shabat, Y.; Ben Ya'acov, A.; Lalazar, G.; Adar, T.; Wong, V.; Muller, B.; Rawlin, G.; Ilan, Y. 2012: Alleviation of insulin resistance and liver damage by oral administration of Imm124-E is mediated by increased Tregs and associated with increased serum GLP-1 and adiponectin: results of a phase I/Ii clinical trial in NASH. Journal of Inflammation Research 5: 141-150
Li, G.; Huang, G. 2014: Alleviation of ion suppression effect in sonic spray ionization with induced alternating current voltage. Journal of Mass Spectrometry: Jms 49(7): 639-645
Jagetia, G.C.; Reddy, T.K. 2011: Alleviation of iron induced oxidative stress by the grape fruit flavanone naringin in vitro. Chemico-Biological Interactions 190(2-3): 121-128
Irisawa, Y.; Adachi, N.; Liu, K.; Arai, T.; Nagaro, T. 2008: Alleviation of ischemia-induced brain edema by activation of the central histaminergic system in rats. Journal of Pharmacological Sciences 108(1): 112-123
Wan, C.-D.; Wang, C.-Y.; Liu, T.; Cheng, R.; Wang, H.-B. 2008: Alleviation of ischemia/reperfusion injury in ob/ob mice by inhibiting UCP-2 expression in fatty liver. World Journal of Gastroenterology 14(4): 590-594
Nemat Alla, M.M.; Hassan, N.M. 2014: Alleviation of isoproturon toxicity to wheat by exogenous application of glutathione. Pesticide Biochemistry and Physiology 112: 56-62
Uyeturk, U.; Terzi, E.Hakan.; Kemahli, E.; Gucuk, A.; Tosun, M.; Çetinkaya, A. 2013: Alleviation of kidney damage induced by unilateral ureter obstruction in rats by Rhodiola rosea. Journal of Endourology 27(10): 1272-1276
Tangpong, J.; Satarug, S. 2010: Alleviation of lead poisoning in the brain with aqueous leaf extract of the Thunbergia laurifolia (Linn.). Toxicology Letters 198(1): 83-88
Tian, T.; Ali, B.; Qin, Y.; Malik, Z.; Gill, R.A.; Ali, S.; Zhou, W. 2014: Alleviation of lead toxicity by 5-aminolevulinic acid is related to elevated growth, photosynthesis, and suppressed ultrastructural damages in oilseed rape. Biomed Research International 2014: 530642
Nagda, G.; Bhatt, D.K. 2011: Alleviation of lindane induced toxicity in testis of Swiss mice (Mus musculus) by combined treatment with vitamin C, vitamin e and alpha-lipoic acid. Indian Journal of Experimental Biology 49(3): 191-199
Wu, C.-J.; Chen, L.-C.; Huang, W.-C.; Chuang, C.-L.; Kuo, M.-L. 2013: Alleviation of lung inflammatory responses by adeno-associated virus 2/9 vector carrying CC10 in OVA-sensitized mice. Human Gene Therapy 24(1): 48-57
Pandis, N.; Polychronopoulou, A.; Eliades, T. 2009: Alleviation of mandibular anterior crowding with copper-nickel-titanium vs nickel-titanium wires: a double-blind randomized control trial. American Journal of Orthodontics and Dentofacial Orthopedics: Official Publication of the American Association of Orthodontists its Constituent Societies and the American Board of Orthodontics 136(2): 152.E1-7;discussion: 152-153
Jarouliya, U.; Zacharia, J.Anish.; Kumar, P.; Bisen, P.S.; Prasad, G.B.K.S. 2012: Alleviation of metabolic abnormalities induced by excessive fructose administration in Wistar rats by Spirulina maxima. Indian Journal of Medical Research 135: 422-428
Lin, C.-W.; Wu, C.-H.; Sun, H.-C.; Chang, S.-H. 2014: Alleviation of metal and BTEX inhibition on BTEX degradation using PVA-immobilized degrader: kinetic model of BTEX degradation. Bioprocess and Biosystems Engineering 37(6): 1085-1093
Dalal, A.; Kumar, A.; Yadav, D.; Gudla, T.; Viehhauser, A.; Dietz, K-Josef.; Kirti, P.Bharadwaja. 2014: Alleviation of methyl viologen-mediated oxidative stress by Brassica juncea annexin-3 in transgenic Arabidopsis. Plant science: an international journal of experimental plant biology 219-220: 9-18
Ojserkis, R.; McKay, D.; Badour, C.L.; Feldner, M.T.; Arocho, J.; Dutton, C. 2014: Alleviation of moral disgust, shame, and guilt in posttraumatic stress reactions: an evaluation of comprehensive distancing. Behavior Modification 38(6): 801-836
Papaioannou, M.; Sapalidis, K.; Kotoula, V. 2008: Alleviation of myelodysplastic syndrome-associated skin rush after treatment with decitabine. European Journal of Haematology 81(6): 489-490
Zapata, A.; Pontis, S.; Schepers, R.J.; Wang, R.; Oh, E.; Stein, A.; Bäckman, C.M.; Worley, P.; Enguita, M.; Abad, M.A.; Trullas, R.; Shippenberg, T.S. 2012: Alleviation of neuropathic pain hypersensitivity by inhibiting neuronal pentraxin 1 in the rostral ventromedial medulla. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 32(36): 12431-12436
Wang, Y.; Neumann, H. 2010: Alleviation of neurotoxicity by microglial human Siglec-11. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 30(9): 3482-3488
Derrey, S.ép.; Lefaucheur, R.; Chastan, N.; Gérardin, E.; Hannequin, D.; Desbordes, M.; Maltête, D. 2010: Alleviation of off-period dystonia in Parkinson disease by a microlesion following subthalamic implantation. Journal of Neurosurgery 112(6): 1263-1266
Marcińska, I.; Czyczyło-Mysza, I.; Skrzypek, E.; Grzesiak, M.T.; Janowiak, F.; Filek, M.; Dziurka, M.ł; Dziurka, K.; Waligórski, P.; Juzoń, K.; Cyganek, K.; Grzesiak, S.ła. 2013: Alleviation of osmotic stress effects by exogenous application of salicylic or abscisic acid on wheat seedlings. International Journal of Molecular Sciences 14(7): 13171-13193
Chen, W-Ping.; Bao, J-Peng.; Hu, P-Fei.; Feng, J.; Wu, L-Dong. 2010: Alleviation of osteoarthritis by Trichostatin A, a histone deacetylase inhibitor, in experimental osteoarthritis. Molecular Biology Reports 37(8): 3967-3972
Choi, S.I.; Heo, T.R.; Min, B.-H.; Cui, J.H.; Choi, B.H.; Park, S.R. 2007: Alleviation of osteoarthritis by calycosin-7-O-beta-D-glucopyranoside (CG) isolated from Astragali radix (AR) in rabbit osteoarthritis (OA) model. Osteoarthritis and Cartilage 15(9): 1086-1092
Shen, Y.; Li, Y-Qi.; Li, S-Ping.; Ma, L.; Ding, L-Ju.; Ji, H. 2010: Alleviation of ovariectomy-induced osteoporosis in rats by Panax notoginseng saponins. Journal of Natural Medicines 64(3): 336-345
Rasheed, M.Hassanal.; Beevi, S.Sultan.; Rajaraman, R.; Bose, S.J.C. 2007: Alleviation of oxidative and nitrosative stress following curative resection in patient with oral cavity cancer. Journal of Surgical Oncology 96(3): 194-199
Bachnoff, N.; Trus, M.; Atlas, D. 2011: Alleviation of oxidative stress by potent and selective thioredoxin-mimetic peptides. Free Radical Biology and Medicine 50(10): 1355-1367
Van Bruchem-van de Scheur, G.A.G.; van der Arend, A.J.G.; Abu-Saad, H.H.; van Wijmen, F.C.B.; Spreeuwenberg, C.; ter Meulen, R.H.J. 2008: Alleviation of pain and symptoms with a life-shortening intention. Nursing Ethics 15(5): 682-695
Sidana, S.S. 2009: Alleviation of pain associated with immunization injections. Indian Pediatrics 46(8): 735; Discussion: 735-736
Akasaka, H.; Imaizumi, K.; Sakane, E.; Tsunemine, H.; Ito, K.; Kodaka, T.; Matsumoto, M.; Matsuoka, M.; Takahashi, T. 2012: Alleviation of palmoplantar pustulosis associated with adult T cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation. Japanese Journal of Clinical Hematology 53(8): 779-784
Furuya, H.; Nakao, H.; Yamada, I.; Ruan, Y.F.; Yap, Y.K.; Yoshimura, M.; Mori, Y.; Sasaki, T. 2000: Alleviation of photoinduced damage in GdxY1-xCa4O(BO3)3 at elevated crystal temperature for noncritically phase-matched 355-nm generation. Optics Letters 25(21): 1588-1590
Zhang, H.; Sun, Q.; Liu, T.; Ma, L.; Zhen, P.; Wang, K.; Lu, L.; Liu, X.; Zhang, X.; Song, D.; Zuo, X.; Liu, H.; Wang, W. 2014: Alleviation of plasma homocysteine level by phytoestrogen α-zearalanol might be related to the reduction of cystathionine β-synthase nitration. Biomed Research International 2014: 143192
Bao, X.-H.; Xu, J.; Chen, Y.; Yang, C.-L.; Ye, S.-D. 2014: Alleviation of podocyte injury: the possible pathway implicated in anti-inflammation of alpha-lipoic acid in type 2 diabetics. Aging Clinical and Experimental Research 26(5): 483-489
Li, J.; Sun, H.; Jin, L.; Cao, W.; Zhang, J.; Guo, C.-Y.; Ding, K.; Luo, C.; Ye, W.-C.; Jiang, R.-W. 2013: Alleviation of podophyllotoxin toxicity using coexisting flavonoids from Dysosma versipellis. Plos one 8(8): E72099
El-Sakka, A.I. 2011: Alleviation of post-radical prostatectomy cavernosal fibrosis: future directions and potential utility for PDE5 inhibitors. Expert Opinion on Investigational Drugs 20(10): 1305-1309
Radclyffe, L. 1947: Alleviation of prickly heat. British Medical Journal 2(4537): 1012
Narayanan, N.; Chou, C.P. 2009: Alleviation of proteolytic sensitivity to enhance recombinant lipase production in Escherichia coli. Applied and Environmental Microbiology 75(16): 5424-5427
Yiu, K.-H.; Lee, K.L.-F.; Lau, C.-P.; Siu, C.-W.; Miu, K.-M.; Lam, B.; Lam, J.; Ip, M.S.M.; Tse, H.-F. 2008: Alleviation of pulmonary hypertension by cardiac resynchronization therapy is associated with improvement in central sleep apnea. Pacing and Clinical Electrophysiology: Pace 31(12): 1522-1527
Dutta, S.; Gupta, M.L. 2014: Alleviation of radiation-induced genomic damage in human peripheral blood lymphocytes by active principles of Podophyllum hexandrum: an in vitro study using chromosomal and CBMN assay. Mutagenesis 29(2): 139-147
El-Mokadem, M.Y.; Taha, T.A.; Samak, M.A.; Yassen, A.M. 2012: Alleviation of reproductive toxicity of gossypol using selenium supplementation in rams. Journal of Animal Science 90(9): 3274-3285
Chang, Y.-C.; Chow, Y.-H.; Sun, H.-L.; Liu, Y.-F.; Lee, Y.-T.; Lue, K.-H.; Ko, J.-L. 2014: Alleviation of respiratory syncytial virus replication and inflammation by fungal immunomodulatory protein FIP-fve from Flammulina velutipes. Antiviral Research 110: 124-131
Cook, R.C.; Blinman, T.A. 2014: Alleviation of retching and feeding intolerance after fundoplication. Nutrition in Clinical Practice: Official Publication of the American Society for Parenteral and Enteral Nutrition 29(3): 386-396
Lee, S.-W.; Kim, J.-H.; Park, M.-C.; Park, Y.-B.; Chae, W.J.; Morio, T.; Lee, D.-H.; Yang, S.-H.; Lee, S.-K.; Lee, S.-K.; Lee, S.-K. 2012: Alleviation of rheumatoid arthritis by cell-transducible methotrexate upon transcutaneous delivery. Biomaterials 33(5): 1563-1572
Daei, G.; Ardekani, M.R.; Rejali, F.; Teimuri, S.; Miransari, M. 2009: Alleviation of salinity stress on wheat yield, yield components, and nutrient uptake using arbuscular mycorrhizal fungi under field conditions. Journal of Plant Physiology 166(6): 617-625
Kim, K.; Jang, Y.-J.; Lee, S.-M.; Oh, B.-T.; Chae, J.-C.; Lee, K.-J. 2014: Alleviation of salt stress by enterobacter sp. EJ01 in tomato and Arabidopsis is accompanied by up-regulation of conserved salinity responsive factors in plants. Molecules and Cells 37(2): 109-117
Erdal, S. 2012: Alleviation of salt stress in wheat seedlings by mammalian sex hormones. Journal of the Science of Food and Agriculture 92(7): 1411-1416
Chang, C.; Wang, B.; Shi, L.; Li, Y.; Duo, L.; Zhang, W. 2010: Alleviation of salt stress-induced inhibition of seed germination in cucumber (Cucumis sativus L.) by ethylene and glutamate. Journal of Plant Physiology 167(14): 1152-1156
Khan, M.I.R.; Asgher, M.; Khan, N.A. 2014: Alleviation of salt-induced photosynthesis and growth inhibition by salicylic acid involves glycinebetaine and ethylene in mungbean (Vigna radiata L.). Plant Physiology and Biochemistry: Ppb 80: 67-74
Yamada, J. 2009: Alleviation of seasonal allergic symptoms with superfine beta-1,3-glucan: a randomized study. Nippon Ganka Gakkai Zasshi 113(11): 1082-1087
Hölttä-Vuori, M.; Salo, V.T.; Ohsaki, Y.; Suster, M.L.; Ikonen, E. 2013: Alleviation of seipinopathy-related ER stress by triglyceride storage. Human Molecular Genetics 22(6): 1157-1166
Li, D.; Ci, X.; Li, Y.; Liu, C.; Wen, Z.; Jie, J.; Peng, L. 2014: Alleviation of severe inflammatory responses in LPS-exposed mice by Schisantherin A. Respiratory Physiology and Neurobiology 202: 24-31
Oksenberg, A. 2010: Alleviation of severe restless legs syndrome (RLS) symptoms by cigarette smoking. Journal of Clinical Sleep Medicine: Jcsm: Official Publication of the American Academy of Sleep Medicine 6(5): 489-490
Oukarroum, A.; Gaudreault, M.-H.él.èn.; Pirastru, L.; Popovic, R. 2013: Alleviation of silver toxicity by calcium chloride (CaCl2) in Lemna gibba L. Plant Physiology and Biochemistry: Ppb 71: 235-239
Umrigar, C.J.; Toulouse, J.; Filippi, C.; Sorella, S.; Hennig, R.G. 2007: Alleviation of the Fermion-sign problem by optimization of many-body wave functions. Physical Review Letters 98(11): 110201
Xin, Y-Fei.; Wan, L-Li.; Peng, J-Liang.; Guo, C. 2011: Alleviation of the acute doxorubicin-induced cardiotoxicity by Lycium barbarum polysaccharides through the suppression of oxidative stress. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association 49(1): 259-264
Sakr, M.T.; El-Metwally, M.A. 2009: Alleviation of the harmful effects of soil salt stress on growth, yield and endogenous antioxidant content of wheat plant by application of antioxidants. Pakistan Journal of Biological Sciences: Pjbs 12(8): 624-630
Yap, Y.K.; Deki, K.; Kitatochi, N.; Mori, Y.; Sasaki, T. 1998: Alleviation of thermally induced phase mismatch in CsLiB6O10 crystal by means of temperature-profile compensation. Optics Letters 23(13): 1016-1018
Viswanatha, G.L.; Shylaja, H.; Mohan, C.G. 2013: Alleviation of transient global ischemia/reperfusion-induced brain injury in rats with 1,2,3,4,6-penta-O-galloyl-β-d-glucopyranose isolated from Mangifera indica. European Journal of Pharmacology 720(1-3): 286-293
Jindal, R.; Chong, T.W.; Valerio, I.L.; Gimbel, M.L.; De La Cruz, C. 2010: Alleviation of venous congestion in muscle-sparing free TRAM flaps with a temporary angiocatheter. Plastic and Reconstructive Surgery 126(1): 29e-31e
Zain, N.A.M.; Ismail, M.R.; Mahmood, M.; Puteh, A.; Ibrahim, M.H. 2014: Alleviation of water stress effects on MR220 rice by application of periodical water stress and potassium fertilization. Molecules 19(2): 1795-1819
Chung, C.; You, Y.; Yoon, H.-G.; Kim, K.; Lee, Y.-H.; Lee, J.; Chung, J.W.; Chung, H.; Yang, S.; Jun, W. 2013: Alleviation of weight-gain in mice by an ethanolic extract from Rubus coreanus under conditions of a high-fat diet and exercise. Bioscience Biotechnology and Biochemistry 77(10): 2148-2150
Lee, L.-A.; Wang, P.-C.; Chen, N.-H.; Fang, T.-J.; Huang, H.-C.; Lo, C.-C.; Li, H.-Y. 2007: Alleviation of wound pain after surgeries for obstructive sleep apnea. Laryngoscope 117(9): 1689-1694
Campbell, B.C.; Duffey, S.S. 1981: Alleviation of α-tomatine-induced toxicity to the parasitoid,Hyposoter exiguae, by phytosterols in the diet of the host,Heliothis zea. Journal of Chemical Ecology 7(6): 927-946
Nagai, T.; Kataoka, E.; Aoki, Y.; Hokari, R.; Kiyohara, H.; Yamada, H. 2014: Alleviative Effects of a Kampo (a Japanese Herbal) Medicine "Maoto (Ma-Huang-Tang)" on the Early Phase of Influenza Virus Infection and Its Possible Mode of Action. Evidence-Based Complementary and Alternative Medicine: Ecam 2014: 187036
Hamano, Y. 2012: Alleviative effects of α-lipoic acid supplementation on acute heat stress-induced thermal panting and the level of plasma nonesterified fatty acids in hypothyroid broiler chickens. British Poultry Science 53(1): 125-133
Watson, H.Howe. 2014: Allevyn Life app. Nursing Standard: 1987) 29(9): 31
Wanner, M.; Martin-Diener, E.; Bauer, G.F.; Stamm, H.; Martin, B.W. 2011: Allez Hop, a nationwide programme for the promotion of physical activity in Switzerland: what is the evidence for a population impact after one decade of implementation?. British Journal of Sports Medicine 45(15): 1202-1207
Lillie, F.R. 1906: Allgemeine Biologie. Science 23(585): 428-429
Yang, Z.; Jin, H.; Kim, J.H. 2018: Attenuation profile matching: An accurate and scan parameter-robust measurement method for small airway dimensions in low-dose CT scans. Medical Physics 2018
Chang, A.J.; Kline, M.M.; Currie, Y.; Perez, M.O.; Hartiala, J.; Wijesuriya, H.; Buchanan, T.A.; Watanabe, R.M.; Allayee, H. 2008: Allgrove syndrome in a Mexican American family is caused by an ancestral mutation derived from North Africa. Clinical Genetics 73(4): 385-387
Gong, C-xiu.; Wen, Y-ran.; Zhao, X-li.; Su, C.; Cao, B-yan.; Zhang, X. 2007: Allgrove syndrome in the mainland of China: clinical report and mutation analysis. Zhonghua Er Ke Za Zhi 45(6): 422-425
Aghajanzadeh, M.; Safarpoor, F.; Hydayati, M.Hassan.; Kohssari, M.Reza.; Mashhour, M.Yosafi.; Soleymani, A.Shahran. 2006: Allgrove syndrome: reports of cases and literature review. Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association 12(1): 34-35
Yasawy, M.I. 2009: Allgrove'S syndrome: case report and literature review. Journal of Family and Community Medicine 16(1): 37-40
Torjesen, I. 2013: Alliance Boots accused of avoiding over £1bn in UK tax. Bmj 347: F6236
Mariner, T.'a.K. 2011: Alliance Health+ Trust. Journal of Primary Health Care 3(4): 327-328
McEver, M. 2008: Alliance addresses HOD. Journal of the Medical Association of Georgia 97(1): 4-5 9
Carlet, J.; Rambaud, C.; Pulcini, C.él. 2012: Alliance against BMR: save antibiotics!. La Revue du Praticien 62(7): 974-975
Carlet, J.; Rambaud, C.; Pulcini, C.; Aaron, L.; Acar, J.; Adéoti, M.; Alberti, C.; Alfandari, S.; Andremont, A.; Angouluant, F.ço.; Annane, D.; Antoniotti, G.; Aquino, J.-P.; De Saxcé, A.-M.A.; Arnera-Carlet, A.; Arnould, P.; Astagneau, P.; Attali, C.; Auber, F.éd.; Aubert, J.-P.; Autret-Leca, E.; Azoulay, E.; Ballereau, F.ço.; Bapt, G.ér.; Bardon, G.ér.; Bedos, J.-P.; Belivacqua, S.; Bensalem, F.; André, N.B.; Berche, P.; Bergheau, F.; Berrut, G.; Berthelot, P.; Beuhourry-Sassus, F.; Bingen, E.; Birgé, J.; Biscardi, S.; Bongrand, M.-C.; Bourdillon, F.ço.; Bousquet-Melou, A.; Brami, J.; Bretagne, S.; Brun-Buisson, C.; Bruneel, F.; Bur, Y.; Buscail, S.; Cabon, C.; Cambau, E.; Caranco, P.; Carlet, C.; Carlet, F.; Carlet, J.; Caron, 2012: Alliance against MDRO: safeguarding antibiotics. Annales Francaises d'Anesthesie et de Reanimation 31(9): 704-708
Kuehn, B.M. 2013: Alliance aims for standardized, shareable genomic data. JAMA 310(3): 248-249
Moszynski, P. 2008: Alliance aims to help health workers in poor countries challenge corruption, excessive pricing, and waste of drugs. Bmj 336(7654): 1155
Owen, J.; Antle, B.; Barbee, A. 2013: Alliance and group cohesion in relationship education. Family Process 52(3): 465-476
Shirk, S.R.; Gudmundsen, G.; Kaplinski, H.Crisp.; McMakin, D.L. 2008: Alliance and outcome in cognitive-behavioral therapy for adolescent depression. Journal of Clinical Child and Adolescent Psychology: the Official Journal for the Society of Clinical Child and Adolescent Psychology American Psychological Association Division 53 37(3): 631-639
Hoffart, A.; Øktedalen, T.; Langkaas, T.F.; Wampold, B.E. 2013: Alliance and outcome in varying imagery procedures for PTSD: a study of within-person processes. Journal of Counseling Psychology 60(4): 471-482
Cohen, J.J.; Cruess, S.; Davidson, C. 2007: Alliance between society and medicine: the public's stake in medical professionalism. JAMA 298(6): 670-673
Preheim, G.; Bader-Kail, K.; Miller, M.E.; Kelly, J.F.B.; Lynch, R.S. 2009: Alliance for Clinical Education (ACE): setting community standards through collaboration. Journal of Nursing Education 48(3): 141-149
Westra, B.; Murphy, J. 2011: Alliance for Nursing Informatics pledge to support the Consumer eHealth Program. Computers Informatics Nursing: Cin 29(11): 619-620
Sensmeier, J. 2010: Alliance for Nursing Informatics statement to the Robert Wood Johnson Foundation Initiative on the Future of nursing: Acute Care, Focusing on the Area of Technology, October 19, 2009. Computers Informatics Nursing: Cin 28(1): 63-67
Ohri-Vachaspati, P.; Turner, L.; Chaloupka, F.J. 2012: Alliance for a Healthier Generation's competitive beverage and food guidelines: do elementary school administrators know about them and do they report implementing them?. Journal of School Health 82(10): 469-477
Wang, X.; Ghaddar, S.; Brown, C.; Pagán, J.é A.; Balboa, M. 2012: Alliance for a Healthy Border: factors related to weight reduction and glycemic success. Population Health Management 15(2): 90-100
Neloms, G.; Schantz, S. 2014: Alliance for a healthier generation: resources and practices to support the school nurse role in building a healthier school environment. Nasn School Nurse 29(3): 130-133
Smith, U.; Sipido, K.; Dive, C.; Nicod, L. 2011: Alliance for biomedical research in Europe. Embo Molecular Medicine 3(9): 505-506
Reddy, S.T.; Chao, J.; Carter, J.L.; Drucker, R.; Katz, N.T.; Nesbit, R.; Roman, B.; Wallenstein, J.; Beck, G.L. 2014: Alliance for clinical education perspective paper: recommendations for redesigning the "final year" of medical school. Teaching and Learning in Medicine 26(4): 420-427
Singh, J. 2011: Alliance for human research protection. Journal of Pharmacology and Pharmacotherapeutics 2(3): 212-213
Anderson, C.; Sensmeier, J. 2009: Alliance for nursing informatics provides key elements for "meaningful use" dialogue. Computers Informatics Nursing: Cin 27(4): 266-267
Miles, P.V.; Miller, M.; Payne, D.M.; Perelman, R.; Saffer, M.; Zimmerman, E. 2009: Alliance for pediatric quality: creating a community of practice to improve health care for America's children. Pediatrics 123 Suppl. 2: S64-S66
Byrne, K. 2012: Alliance groups across U.S. face similar challenges. Journal of the Medical Association of Georgia 101(1): 8
Friedlander, M.L.; Escudero, V.ín.; Heatherington, L.; Diamond, G.M. 2011: Alliance in couple and family therapy. PsychoTherapy 48(1): 25-33
Horvath, A.O.; Del Re, A.C.; Flückiger, C.; Symonds, D. 2011: Alliance in individual psychotherapy. PsychoTherapy 48(1): 9-16
Beckner, V.; Vella, L.; Howard, I.; Mohr, D.C. 2007: Alliance in two telephone-administered treatments: relationship with depression and health outcomes. Journal of Consulting and Clinical Psychology 75(3): 508-512
Dulebohn, H. 2014: Alliance involved in TMA grassroots network. Tennessee Medicine: Journal of the Tennessee Medical Association 107(1): 43
Anonymous 1987: Alliance launches health manifesto. British Medical Journal 294(6577): 984
Dulebohn, H. 2014: Alliance leads in numbers. Tennessee Medicine: Journal of the Tennessee Medical Association 107(2): 44
Bauer, T.; Nelson, H. 2012: Alliance leads thoracic surgery trials for lung cancer in 2012. Bulletin of the American College of Surgeons 97(4): 41-43
Hayes, E.; McCahon, C.; Panahi, M.R.; Hamre, T.; Pohlman, K. 2008: Alliance not compliance: coaching strategies to improve type 2 diabetes outcomes. Journal of the American Academy of Nurse Practitioners 20(3): 155-162
McKeel, D.W.; Williams, H.; Anderson, J.; Michel, J.; Barrie, T.; Barker, K.; Schwartz, R.; Merritt, M. 2009: Alliance of Nuclear Worker Advocacy Groups. Health physics 96(2): 187-8; author reply 189
Bai, A.H.; Cheng, A.S. 2013: Alliance of epigenetic forces for the activation of oncogenic Wnt/β-catenin signaling. Journal of Gastroenterology and Hepatology 28(3): 383-385
Yadav, N.S.; Saxena, V.; Reddy, R.; Deshpande, N.; Deshpande, A.; Kovvuru, S.Kumar. 2012: Alliance of oral hygiene practices and abrasion among urban and rural residents of Central India. journal of contemporary dental practice 13(1): 55-60
De Groot, A.; Dulermo, R.ém.; Ortet, P.; Blanchard, L.; Guérin, P.; Fernandez, B.; Vacherie, B.; Dossat, C.; Jolivet, E.; Siguier, P.; Chandler, M.; Barakat, M.; Dedieu, A.; Barbe, V.ér.; Heulin, T.; Sommer, S.; Achouak, W.; Armengaud, J. 2009: Alliance of proteomics and genomics to unravel the specificities of Sahara bacterium Deinococcus deserti. Plos Genetics 5(3): E1000434
Maliski, S.L.; Husain, M.; Connor, S.E.; Litwin, M.S. 2012: Alliance of support for low-income Latino men with prostate cancer: God, doctor, and self. Journal of Religion and Health 51(3): 752-762
Kramer, U.; de Roten, Y.; Beretta, Véronique.; Michel, L.; Despland, J-Nicolas. 2009: Alliance patterns over the course of short-term dynamic psychotherapy: the shape of productive relationships. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 19(6): 699-706
Escudero, V.ín.; Boogmans, E.; Loots, G.; Friedlander, M.L. 2012: Alliance rupture and repair in conjoint family therapy: an exploratory study. PsychoTherapy 49(1): 26-37
Cash, S.K.; Hardy, G.E.; Kellett, S.; Parry, G. 2014: Alliance ruptures and resolution during cognitive behaviour therapy with patients with borderline personality disorder. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 24(2): 132-145
Aspland, H.; Llewelyn, S.; Hardy, G.E.; Barkham, M.; Stiles, W. 2008: Alliance ruptures and rupture resolution in cognitive-behavior therapy: a preliminary task analysis. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 18(6): 699-710
Safran, J.D.; Kraus, J. 2014: Alliance ruptures, impasses, and enactments: a relational perspective. PsychoTherapy 51(3): 381-387
Burns, K. 2013: Alliance seeks to offer insight into pet nutrition. Journal of the American Veterinary Medical Association 242(10): 1327
Clark, N.M.; Quinn, M.; Dodge, J.A.; Nelson, B.W. 2014: Alliance system and policy change: necessary ingredients for improvement in diabetes care and reduction of disparities. Health Promotion Practice 15(2 Suppl): 11s-22s
Kalish, M.; Zarbin, A. 2010: Alliance to MedChi update. Maryland Medicine: Mm: a Publication of Medchi the Maryland State Medical Society 11(4): 27
Lindgren, A.; Barber, J.P.; Sandahl, C. 2008: Alliance to the group-as-a-whole as a predictor of outcome in psychodynamic group therapy. International Journal of Group PsychoTherapy 58(2): 163-184
Brabson, G.M. 2010: Alliance works to help the health of Tennessee. Tennessee Medicine: Journal of the Tennessee Medical Association 103(9): 50
Kasper, B. 2013: Alliance year in review. Tennessee Medicine: Journal of the Tennessee Medical Association 106(5): 44
Perry, J.Christopher.; Bond, M.; Presniak, M.D. 2013: Alliance, reactions to treatment, and counter-transference in the process of recovery from suicidal phenomena in long-term dynamic psychotherapy. PsychoTherapy Research: Journal of the Society for PsychoTherapy Research 23(5): 592-605
Eubanks-Carter, C.; Muran, J.C.; Safran, J.D. 2015: Alliance-focused training. PsychoTherapy 52(2): 169-173
Liening, D. 2011: Alliance: getting involved for medicine's sake. Tennessee Medicine: Journal of the Tennessee Medical Association 104(1): 50
Hegerl, U.; Rummel-Kluge, C.; Värnik, A.; Arensman, E.; Koburger, N. 2013: Alliances against depression - A community based approach to target depression and to prevent suicidal behaviour. Neuroscience and Biobehavioral Reviews 37(10 Pt 1): 2404-2409
Kläui, H. 2010: Alliances against depression--the role of the general practitioner. Therapeutische Umschau. Revue Therapeutique 67(11): 597-599
Sampson, D.A. 2009: Alliances of cooperation: negotiating new Hampshire nurse practitioners' prescribing practice. Nursing History Review: Official Journal of the American Association for the History of Nursing 17: 153-178
Li, X.-H.; Li, C.-Y.; Lu, J.-M.; Tian, R.-B.; Wei, J. 2012: Allicin ameliorates cognitive deficits ageing-induced learning and memory deficits through enhancing of Nrf2 antioxidant signaling pathways. Neuroscience Letters 514(1): 46-50
Waag, T.; Gelhaus, C.; Rath, J.; Stich, A.; Leippe, M.; Schirmeister, T. 2010: Allicin and derivates are cysteine protease inhibitors with antiparasitic activity. Bioorganic and Medicinal Chemistry Letters 20(18): 5541-5543
Manaster, Y.; Shenkman, B.; Rosenberg, N.; Savion, N. 2009: Allicin and disulfiram enhance platelet integrin alphaIIbbeta3-fibrinogen binding. Thrombosis Research 124(4): 477-482
Gu, X.; Wu, H.; Fu, P. 2013: Allicin attenuates inflammation and suppresses HLA-B27 protein expression in ankylosing spondylitis mice. Biomed Research International 2013: 171573
Li, X.-H.; Li, C.-Y.; Xiang, Z.-G.; Zhong, F.; Chen, Z.-Y.; Lu, J.-M. 2010: Allicin can reduce neuronal death and ameliorate the spatial memory impairment in Alzheimer's disease models. Neurosciences 15(4): 237-243
Gruhlke, M.C.H.; Portz, D.; Stitz, M.; Anwar, A.; Schneider, T.; Jacob, C.; Schlaich, N.L.; Slusarenko, A.J. 2010: Allicin disrupts the cell's electrochemical potential and induces apoptosis in yeast. Free Radical Biology and Medicine 49(12): 1916-1924
Suddek, G.M. 2014: Allicin enhances chemotherapeutic response and ameliorates tamoxifen-induced liver injury in experimental animals. Pharmaceutical Biology 52(8): 1009-1014
Gao, Y.; Liu, Y.; Cao, W.; Deng, Z.; Liu, H.; Xu, L.; Chen, X. 2009: Allicin enhances cytotoxicity of CPT-11 to colon cancer LoVo cell in vitro. Zhongguo Zhong Yao Za Zhi 34(23): 3092-3095
Feng, Y.; Zhu, X.; Wang, Q.; Jiang, Y.; Shang, H.; Cui, L.; Cao, Y. 2012: Allicin enhances host pro-inflammatory immune responses and protects against acute murine malaria infection. Malaria Journal 11: 268
An, M.; Shen, H.; Cao, Y.; Zhang, J.; Cai, Y.; Wang, R.; Jiang, Y. 2009: Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans. International Journal of Antimicrobial Agents 33(3): 258-263
Arzanlou, M.; Bohlooli, S.; Jannati, E.; Mirzanejad-Asl, H. 2011: Allicin from garlic neutralizes the hemolytic activity of intra- and extra-cellular pneumolysin O in vitro. Toxicon: Official Journal of the International Society on Toxinology 57(4): 540-545
Osman, M.; Adnan, A.; Salmah Bakar, N.; Alashkham, F. 2012: Allicin has significant effect on autoimmune anti-islet cell antibodies in type 1 diabetic rats. Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 63(4): 248-254
Chu, Y.-L.; Ho, C.-T.; Chung, J.-G.; Raghu, R.; Lo, Y.-C.; Sheen, L.-Y. 2013: Allicin induces anti-human liver cancer cells through the p53 gene modulating apoptosis and autophagy. Journal of Agricultural and Food Chemistry 61(41): 9839-9848
Zhang, W.; Ha, M.; Gong, Y.; Xu, Y.; Dong, N.; Yuan, Y. 2010: Allicin induces apoptosis in gastric cancer cells through activation of both extrinsic and intrinsic pathways. Oncology Reports 24(6): 1585-1592
Chu, Y.-L.; Ho, C.-T.; Chung, J.-G.; Rajasekaran, R.; Sheen, L.-Y. 2012: Allicin induces p53-mediated autophagy in Hep G2 human liver cancer cells. Journal of Agricultural and Food Chemistry 60(34): 8363-8371
Cha, J.H.; Choi, Y.J.; Cha, S.H.; Choi, C.H.; Cho, W.H. 2012: Allicin inhibits cell growth and induces apoptosis in U87MG human glioblastoma cells through an ERK-dependent pathway. Oncology Reports 28(1): 41-48
Wu, C.-C.; Chu, Y.-L.; Sheen, L.-Y. 2012: Allicin modulates the antioxidation and detoxification capabilities of primary rat hepatocytes. Journal of Traditional and Complementary Medicine 2(4): 323-330
Chen, S.; Tang, Y.; Qian, Y.; Chen, R.; Zhang, L.; Wo, L.; Chai, H. 2014: Allicin prevents H₂O₂-induced apoptosis of HUVECs by inhibiting an oxidative stress pathway. Bmc Complementary and Alternative Medicine 14: 321
Liu, C.; Cao, F.; Tang, Q.-Z.; Yan, L.; Dong, Y.-G.; Zhu, L.-H.; Wang, L.; Bian, Z.-Y.; Li, H. 2010: Allicin protects against cardiac hypertrophy and fibrosis via attenuating reactive oxygen species-dependent signaling pathways. Journal of Nutritional Biochemistry 21(12): 1238-1250
Liu, Y.; Qi, H.; Wang, Y.; Wu, M.; Cao, Y.; Huang, W.; Li, L.; Ji, Z.; Sun, H. 2012: Allicin protects against myocardial apoptosis and fibrosis in streptozotocin-induced diabetic rats. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 19(8-9): 693-698
Chan, J.Y.-Y.; Tsui, H.-T.; Chung, I.Y.-M.; Chan, R.Y.-K.; Kwan, Y.-W.; Chan, S.-W. 2014: Allicin protects rat cardiomyoblasts (H9c2 cells) from hydrogen peroxide-induced oxidative injury through inhibiting the generation of intracellular reactive oxygen species. International Journal of Food Sciences and Nutrition 65(7): 868-873
Zhou, Y.-f.; Li, W.-t.; Han, H.-c.; Gao, D.-k.; He, X.-s.; Li, L.; Song, J.-n.; Fei, Z. 2014: Allicin protects rat cortical neurons against mechanical trauma injury by regulating nitric oxide synthase pathways. Brain Research Bulletin 100: 14-21
Bat-Chen, W.; Golan, T.; Peri, I.; Ludmer, Z.; Schwartz, B. 2010: Allicin purified from fresh garlic cloves induces apoptosis in colon cancer cells via Nrf2. Nutrition and Cancer 62(7): 947-957
Leng, B-Feng.; Qiu, J-Zhang.; Dai, X-Han.; Dong, J.; Wang, J-Feng.; Luo, M-Jing.; Li, H-En.; Niu, X-Di.; Zhang, Y.; Ai, Y-Xing.; Deng, X-Ming. 2011: Allicin reduces the production of α-toxin by Staphylococcus aureus. Molecules 16(9): 7958-7968
Horev-Azaria, L.; Eliav, S.; Izigov, N.; Pri-Chen, S.; Mirelman, D.; Miron, T.; Rabinkov, A.; Wilchek, M.; Jacob-Hirsch, J.; Amariglio, N.; Savion, N. 2009: Allicin up-regulates cellular glutathione level in vascular endothelial cells. European Journal of Nutrition 48(2): 67-74
Yu, L.; Guo, N.; Meng, R.; Liu, B.; Tang, X.; Jin, J.; Cui, Y.; Deng, X. 2010: Allicin-induced global gene expression profile of Saccharomyces cerevisiae. Applied Microbiology and Biotechnology 88(1): 219-229
Borlinghaus, J.; Albrecht, F.; Gruhlke, M.C.H.; Nwachukwu, I.D.; Slusarenko, A.J. 2014: Allicin: chemistry and biological properties. Molecules 19(8): 12591-12618
Yamamoto, Y.; Yamaguchi, A.; Bono, H.; Takagi, T. 2011: Allie: a database and a search service of abbreviations and long forms. Database: the Journal of Biological Databases and Curation 2011: Bar013
Nevin, J. 1922: Making a Hospital the Civic Health Center. American Journal of Public Health 12(10): 841-842
Tobbell, D.A. 2008: Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970. Bulletin of the history of medicine 82(4): 878-912
Muhney, K.A.; Campbell, P.R. 2010: Allied dental and dental educators' perceptions of and reporting practices on academic dishonesty. Journal of Dental Education 74(11): 1214-1219
Waldman, H.Barry.; Perlman, S.P. 2008: Allied dental personnel: will there be enough?. New York State Dental Journal 74(6): 28-30
Lizarondo, L.; Kumar, S.; Hyde, L.; Skidmore, D. 2010: Allied health assistants and what they do: A systematic review of the literature. Journal of Multidisciplinary Healthcare 3: 143-153
Nijkrake, M.J.; Keus, S.H.J.; Oostendorp, R.A.B.; Overeem, S.; Mulleners, W.; Bloem, B.R.; Munneke, M. 2009: Allied health care in Parkinson's disease: referral, consultation, and professional expertise. Movement Disorders: Official Journal of the Movement Disorder Society 24(2): 282-286
Nijkrake, M.J.; Keus, S.H.J.; Kalf, J.G.; Sturkenboom, I.H.W.M.; Munneke, M.; Kappelle, A.C.; Bloem, B.R. 2007: Allied health care interventions and complementary therapies in Parkinson's disease. Parkinsonism and Related Disorders 13 Suppl. 3: S488-S494
Feros, D.L.; Byrne, M.K.; Deane, F.P.; Lambert, G.; Meadows, G.; Favilla, A.; Gray, J. 2010: Allied health clinicians' beliefs and attitudes about medication adherence in depressive disorders. Journal of Evaluation in Clinical Practice 16(6): 1361-1363
Baldwin, A.; Wilson, L. 2008: Allied health disaster volunteering. Journal of Allied Health 37(4): 236-241
Smith, R.A.; Pilling, S. 2007: Allied health graduate program - supporting the transition from student to professional in an interdisciplinary program. Journal of Interprofessional Care 21(3): 265-276
Rajapakse, S. 2013: Allied health in-reach in the emergency department: does it reduce length of stay?. International Journal of Clinical Practice 67(8): 705-706
Rahim, H.; Shah, B.; Becker, E.A.; Crooks, A.; Caraballo, M.; Iacobellis, F.; Jariwala, J. 2012: Allied health profession students' attitudes toward the patient role in treatment decision-making. Journal of Allied Health 41(4): 149-153
Miller, T.W.; Gallicchio, V.S. 2007: Allied health professionals with 2020 vision. Journal of Allied Health 36(4): 236-240
Coombs, C.; Arnold, J.; Loan-Clarke, J.; Bosley, S.; Martin, C. 2010: Allied health professionals' intention to work for the National Health Service: a study of stayers, leavers and returners. Health Services Management Research 23(2): 47-53
Mac Kinnon, J.; Friedrich-Nel, H. 2010: Allied health program outcomes assessment in an international context: an example from South Africa. Journal of Allied Health 39(1): E7
Rogers, J.L.; Lautar, C.J.; Dunn, L.R. 2010: Allied health students' perceptions of effective clinical instruction. Health Care Manager 29(1): 63-67
Mase, D.J.; Mase, D.J. 2010: Allied health-today and tomorrow. 1973. Journal of Allied Health 39(4): 314-320
Self, T.L.; Coufal, K.; Parham, D.F. 2010: Allied healthcare providers' role in screening for autism spectrum disorders. Journal of Allied Health 39(3): 165-174
Horning, S. 2006: Allied in achieving the best-quality cancer care. Journal of Oncology Practice 2(3): 102
Barton, C.A.; Opolski, M.; Cleland, E.; Cotton, A.; Briggs, N.; Taylor, M.; Howell, C. 2008: Allied mental health referral. Trends in the Adelaide Hills Division of General Practice. Australian Family Physician 37(10): 888-891
Cooper, B.G.; Troosters, T.; Burge, G.; Field, D.; Hrafnkelsdottir, S.S.; Pitta, F.; Lloyd, J.K.; Steenbuggen, I. 2010: Allied respiratory professionals. European Respiratory Journal 36(4): 701-703
Cooper, B.R.; Monson, A.L. 2007: Allied restorative functions training in Minnesota: a case study. Journal of Dental Education 71(3): 373-377
Turnbull, C.; Grimmer-Somers, K.; Kumar, S.; May, E.; Law, D.; Ashworth, E. 2009: Allied, scientific and complementary health professionals: a new model for Australian allied health. Australian Health Review: a Publication of the Australian Hospital Association 33(1): 27-37
Hall, M.N.; Kruse, J. 2010: Allies in family medicine advocacy: the patient-centered primary care collaborative. Annals of Family Medicine 8(1): 89-90
Draughn, T.; Elkins, B.; Roy, R. 2002: Allies in the struggle. Journal of Lesbian Studies 6(3-4): 9-20
Javanmardian, M.; Saxena, S.B. 2013: Allies in value-based care. Trustee: the Journal for Hospital Governing Boards 66(5): 13-16; 1
Reis, Cássia.Barbosa.; Andrade, S.Maria.Oliveira.de.; Cunha, R.Venâncio.da. 2013: Allies of A. Aegypti: factors contributing to the occurrence of dengue according to social representations of professionals of family health teams. Ciencia and Saude Coletiva 18(2): 517-526
Maru, V. 2010: Allies unknown: Social accountability and legal empowerment. Health and Human Rights 12(1): 83-93
Prokopuk, N.; Son, K.-A. 2008: Alligator clips to molecular dimensions. Journal of Physics. Condensed Matter: An Institute of Physics Journal 20(37): 374116
Gold, J.A. 2013: Alligator hands. Annals of Internal Medicine 159(7): 498-499
Prinz, J.; Seidel, A. 2012: Alligator or squirrel: musically induced fear reveals threat in ambiguous figures. Perception 41(12): 1535-1539
Chen, I.H.; Yang, W.; Meyers, M.A. 2014: Alligator osteoderms: mechanical behavior and hierarchical structure. Materials Science and Engineering. C Materials for Biological Applications 35: 441-448
Holden, C. 1977: Alligator protections loosened. Science 195(4278): 561
George, A.; Lee, S.K.; Carrillo, E.H. 2012: Alligator wrestling: the ultimate wrestling match. Journal of Trauma and Acute Care Surgery 72(3): E113
Reese, A.M. 1918: Alligators as Food. Science 47(1226): 640-641
Salcido, R. 2008: Alligators and wound healing: the primordial soup. Advances in Skin and Wound Care 21(8): 352-353
Gardiner, J. 1886: Alligators in the Bahamas. Science 8(194): 369
Cohain, J.S. 2012: Alligators, hospital birth and other urban legends. Journal of Health Psychology 17(4): 467-470
Morozova, E.A.; Revtovich, S.V.; Anufrieva, N.V.; Kulikova, V.V.; Nikulin, A.D.; Demidkina, T.V. 2014: Alliin is a suicide substrate of Citrobacter freundii methionine γ-lyase: structural bases of inactivation of the enzyme. Acta Crystallographica. Section D Biological Crystallography 70(Part 11): 3034-3042
Nasim, S.A.; Dhir, B.; Kapoor, R.; Fatima, S.; Mahmooduzzafar; Mujib, A. 2011: Alliin obtained from leaf extract of garlic grown under in situ conditions possess higher therapeutic potency as analyzed in alloxan-induced diabetic rats. Pharmaceutical Biology 49(4): 416-421
Quintero-Fabián, S.; Ortuño-Sahagún, D.; Vázquez-Carrera, M.; López-Roa, Río.Ivette. 2013: Alliin, a garlic (Allium sativum) compound, prevents LPS-induced inflammation in 3T3-L1 adipocytes. Mediators of Inflammation 2013: 381815
Yutani, M.; Taniguchi, H.; Borjihan, H.; Ogita, A.; Fujita, K.-I.; Tanaka, T. 2011: Alliinase from Ensifer adhaerens and its use for Generation of Fungicidal Activity. Amb Express 1(1): 2
Haglany, M. 2012: Allina's pioneering move on population health. Healthcare Informatics: the Business Magazine for Information and Communication Systems 29(9): 38-40
Wilson, M.; Acolas, M.-L.; Bégout, M.-L.; Madsen, P.T.; Wahlberg, M. 2008: Allis shad (Alosa alosa) exhibit an intensity-graded behavioral response when exposed to ultrasound. Journal of the Acoustical Society of America 124(4): El243-El247
Cass, G.R.; McRae, G.J. 1982: Cost of air pollution control. Environmental Science and Technology 16(5): 262a-264a
Volk, T.J. 1993: Alliteration accidental?. Science 259(5093): 295
Xu, X.-H.; Sun, H.-Y.; Zhang, Y.-H.; Wu, W.; Chen, K.-H.; Liu, Y.; Deng, C.-Y.; Yu, X.-Y.; Jin, M.-W.; Li, G.-R. 2012: Allitridi inhibits multiple cardiac potassium channels expressed in HEK 293 cells. Plos one 7(12): E51550
Deng, C.-Y.; Rao, F.; Kuang, S.-J.; Wu, S.-L.; Shan, Z.-X.; Li, X.-H.; Zhou, Z.-L.; Lin, Q.-X.; Liu, X.-Y.; Yang, M.; Lin, S.-G.; Yu, X.-Y. 2011: Allitridi inhibits transient outward potassium currents in human atrial myocytes. Clinical and Experimental Pharmacology and Physiology 38(5): 323-327
Zhang, J.; Wang, H.; Xiang, Z.-D.; Shu, S.-N.; Fang, F. 2013: Allitridin inhibits human cytomegalovirus replication in vitro. Molecular Medicine Reports 7(4): 1343-1349
Li, G.; Cheng, G.; Wu, J.; Ma, S.; Zhang, A.; Han, W.; Sun, C. 2014: Allitridin reduces i Kr current by disrupting the trafficking of human ether-à-go-go-related gene channels. Cardiology 128(1): 1-8
Düsman, E.ân.; Luzza, M.; Savegnago, L.; Lauxen, D.; Vicentini, V.E.P.; Tonial, I.B.; Sauer, T.P. 2014: Allium cepa L. as a bioindicator to measure cytotoxicity of surface water of the Quatorze River, located in Francisco Beltrão, Paraná, Brazil. Environmental Monitoring and Assessment 186(3): 1793-1800
Rodríguez, Y.A.; Christofoletti, C.A.; Pedro, J.ín.; Bueno, O.C.; Malaspina, O.; Ferreira, R.A.C.; Fontanetti, C.S. 2015: Allium cepa and Tradescantia pallida bioassays to evaluate effects of the insecticide imidacloprid. Chemosphere 120: 438-442
Lerda, D.; Biagi Bistoni, M.; Pelliccioni, P.; Litterio, N. 2010: Allium cepa as a biomonitor of ochratoxin a toxicity and genotoxicity. Plant Biology 12(4): 685-688
Leme, D.M.; Marin-Morales, M.A. 2009: Allium cepa test in environmental monitoring: a review on its application. Mutation Research 682(1): 71-81
Merhi, F.; Auger, J.; Rendu, F.; Bauvois, B. 2008: Allium compounds, dipropyl and dimethyl thiosulfinates as antiproliferative and differentiating agents of human acute myeloid leukemia cell lines. Biologics: Targets and Therapy 2(4): 885-895
Kucerová, P.; Kubec, R.; Simek, P.; Václavík, L.ás.; Schraml, J. 2011: Allium discoloration: the precursor and formation of the red pigment in giant onion (Allium giganteum Regel) and some other subgenus Melanocrommyum species. Journal of Agricultural and Food Chemistry 59(5): 1821-1828
Sennikov, A.N.; Lazkov, G.A. 2013: Allium formosum Sennikov and Lazkov (Amaryllidaceae), a new species from Kyrgyzstan. Phytokeys 21: 29-36
Abdalla, F.H.; Bellé, L.P.; De Bona, K.S.; Bitencourt, P.E.R.; Pigatto, A.S.; Moretto, M.B. 2010: Allium sativum L. extract prevents methyl mercury-induced cytotoxicity in peripheral blood leukocytes (LS). Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 48(1): 417-421
Sendl, A. 1995: Allium sativum and Allium ursinum: Part 1 Chemistry, analysis, history, botany. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 1(4): 323-339
Majewski, M.ł 2014: Allium sativum: facts and myths regarding human health. Roczniki Panstwowego Zakladu Higieny 65(1): 1-8
Kusterer, J.; Fritsch, R.M.; Keusgen, M. 2011: Allium species from Central and Southwest Asia are rich sources of marasmin. Journal of Agricultural and Food Chemistry 59(15): 8289-8297
Leonardo, C.; Salvitti, M.; Franco, G.; De Nunzio, C.; Tuderti, G.; Misuraca, L.; Sabatini, I.; De Dominicis, C. 2013: Allium stent for treatment of ureteral stenosis. Minerva Urologica e Nefrologica 65(4): 277-283
Sabha, D.; Hiyasat, B.; Grötzinger, K.; Hennig, L.; Schlegel, F.; Mohr, F.-W.; Rauwald, H.W.; Dhein, S. 2012: Allium ursinum L.: bioassay-guided isolation and identification of a galactolipid and a phytosterol exerting antiaggregatory effects. Pharmacology 89(5-6): 260-269
Turati, F.; Pelucchi, C.; Guercio, V.; La Vecchia, C.; Galeone, C. 2015: Allium vegetable intake and gastric cancer: a case-control study and meta-analysis. Molecular Nutrition and Food Research 59(1): 171-179
Galeone, C.; Tavani, A.; Pelucchi, C.; Negri, E.; La Vecchia, C. 2009: Allium vegetable intake and risk of acute myocardial infarction in Italy. European Journal of Nutrition 48(2): 120-123
Zhu, B.; Zou, L.; Qi, L.; Zhong, R.; Miao, X. 2014: Allium vegetables and garlic supplements do not reduce risk of colorectal cancer, based on meta-analysis of prospective studies. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association 12(12): 1991-2001.E1-4; Quiz E121
Zhou, X.-F.; Ding, Z.-S.; Liu, N.-B. 2013: Allium vegetables and risk of prostate cancer: evidence from 132,192 subjects. Asian Pacific Journal of Cancer Prevention: Apjcp 14(7): 4131-4134
Galeone, C.; Pelucchi, C.; Dal Maso, L.; Negri, E.; Montella, M.; Zucchetto, A.; Talamini, R.; La Vecchia, C. 2009: Allium vegetables intake and endometrial cancer risk. Public Health Nutrition 12(9): 1576-1579
Khan, S.; Mehmood, R.; Kazmi, M.Hussain.; Malik, A. 2011: Alliumonoate: a new cyclopentane derivative from Allium victorialis. Journal of Asian Natural Products Research 13(12): 1165-1169
Flegel, W.A.; Denomme, G.A. 2012: Allo- and autoanti-D in weak D types and in partial D. Transfusion 52(9): 2067-9; author reply 2070
Young, R.C.; Goloman, G. 2013: Allo- and xeno-reassembly of human and rat myometrium from cells and scaffolds. Tissue Engineering. Part a 19(19-20): 2112-2119
Shirakura, R. 2007: Allo- and xeno-transplantation. Kyobu Geka. Japanese Journal of Thoracic Surgery 60(5): 373-378
Amir, A.L.; D'Orsogna, L.J.A.; Roelen, D.L.; van Loenen, M.M.; Hagedoorn, R.S.; de Boer, R.; van der Hoorn, M.A.W.G.; Kester, M.G.D.; Doxiadis, I.I.N.; Falkenburg, J.H.F.; Claas, F.H.J.; Heemskerk, M.H.M. 2010: Allo-HLA reactivity of virus-specific memory T cells is common. Blood 115(15): 3146-3157
Bianchi, A.T.; Van Der Kwast, T.H.; Benner, R. 1982: Allo-I- J antigens in suppression of DTH to H-2 subregion antigens. Immunology Today 3(5): 123-124
Tiwari, A.K.; Dara, R.C.; Arora, D.; Aggarwal, G.; Rawat, G.; Mitra, S.; Prashant, P.K.; Raina, V. 2014: Allo-antibody identification: a software approach!. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 51(2): 197-202
Nagashima, R.; Kawakami, F.; Takahashi, S.; Obata, F.; Kubo, M. 2014: Allo-antigen stimulated CD8+ T-cells suppress NF-κB and Ets-1 DNA binding activity, and inhibit phosphorylated NF-κB p65 nuclear localization in CD4+ T-cells. Viral Immunology 27(6): 305-315
Zhang, X.-h.; Fu, H.-x.; Xu, L.-p.; Liu, D.-h.; Chen, H.; Han, W.; Chen, Y.-h.; Wang, F.-r.; Wang, J.-z.; Wang, Y.; Zhao, T.; Liu, K.-y.; Huang, X.-j. 2012: Allo-hematopoietic stem cell transplantation is a potential treatment for a patient with a combined disorder of hereditary spherocytosis. Chinese Medical Journal 125(5): 947-950
Debiec, H.; Valayannopoulos, V.; Boyer, O.; Nöel, L.-H.él.èn.; Callard, P.; Sarda, H.él.èn.; de Lonlay, P.; Niaudet, P.; Ronco, P. 2014: Allo-immune membranous nephropathy and recombinant aryl sulfatase replacement therapy: a need for tolerance induction therapy. Journal of the American Society of Nephrology: Jasn 25(4): 675-680
Durovic, B.; Zenhaeusern, G.; Hoenger, G.; Gasser, O.; Schaub, S.; Hess, C. 2011: Allo-induced acute-phase response; IL-6 identifies a subset of individuals at risk for graft injury. Scandinavian Journal of Immunology 73(2): 156-158
Isakova, I.A.; Lanclos, C.; Bruhn, J.; Kuroda, M.J.; Baker, K.C.; Krishnappa, V.; Phinney, D.G. 2014: Allo-reactivity of mesenchymal stem cells in rhesus macaques is dose and haplotype dependent and limits durable cell engraftment in vivo. Plos one 9(1): E87238
Weng, X.; Lu, S.; Zhong, M.; Liang, Z.; Shen, G.; Chen, J.; Wu, X. 2009: Allo-restricted CTLs generated by coculturing of PBLs and autologous monocytes loaded with allogeneic peptide/HLA/IgG1-Fc fusion protein. Journal of Leukocyte Biology 85(3): 574-581
Grabov-Nardini, G.; Haik, J.; Regev, E.; Winkler, E. 2009: AlloDerm Sling for Correction of Synmastia After Immediate, Tissue Expander, Breast Reconstruction in Thin Women. Eplasty 9: E54
Glasberg, S.B.; Light, D. 2012: AlloDerm and Strattice in breast reconstruction: a comparison and techniques for optimizing outcomes. Plastic and Reconstructive Surgery 129(6): 1223-1233
Bowers, C.A.; Brimley, C.; Cole, C.; Gluf, W.; Schmidt, R.H. 2015: AlloDerm for duraplasty in Chiari malformation: superior outcomes. Acta Neurochirurgica 157(3): 507-511
Adams, B.N.; Musa, F.B.; Taylor, J.; Holcomb, K. 2014: AlloDerm graft mimicking uterine carcinosarcoma recurrence on PET/CT. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 34(1): 102-103
Kontos, A.P.; Qian, Z.; Urato, N.S.; Hassanein, A.; Proper, S.A. 2009: AlloDerm grafting for large wounds after Mohs micrographic surgery. Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery 35(4): 692-698
Zeng, X-Tao.; Tang, X-Jun.; Wang, X-Jun.; Li, M-Zhu.; Guo, Y.; Huang, W.; Niu, Y-Ming.; Leng, W-Dong. 2012: AlloDerm implants for prevention of Frey syndrome after parotidectomy: a systematic review and meta-analysis. Molecular Medicine Reports 5(4): 974-980
Newman, M.I.; Samson, M.C.; Berho, M. 2009: AlloDerm in breast reconstruction: 2 years later. Plastic and Reconstructive Surgery 123(6): 205e-206e
Newman, M.I.; Hanabergh, E.; Samson, M.C. 2010: AlloDerm performance in the setting of prosthetic breast surgery, infection, and irradiation. Plastic and Reconstructive Surgery 126(3): 1120
Kelly, D.A.; Plikatitis, C.; Blalock, D.; Argenta, L.C.; David, L.R. 2012: AlloDerm revision for failed pharyngoplasty. Journal of Craniofacial Surgery 23(3): 645-649
Becker, S.; Saint-Cyr, M.; Wong, C.; Dauwe, P.; Nagarkar, P.; Thornton, J.F.; Peng, Y. 2009: AlloDerm versus DermaMatrix in immediate expander-based breast reconstruction: a preliminary comparison of complication profiles and material compliance. Plastic and Reconstructive Surgery 123(1): 1-6
Wester, J.L.; Pittman, A.L.; Lindau, R.H.; Wax, M.K. 2014: AlloDerm with split-thickness skin graft for coverage of the forearm free flap donor site. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 150(1): 47-52
Nikou, M.M.; Ramezani, M.; Amoozegar, M.A.; Fazeli, S.A.S.; Schumann, P.; Spröer, C.; Sánchez-Porro, C.; Ventosa, A. 2014: Alloactinosynnema iranicum sp. nov., a rare actinomycete isolated from a hypersaline wetland, and emended description of the genus Alloactinosynnema. International Journal of Systematic and Evolutionary Microbiology 64(Part 4): 1173-1179
Barbon, C.M.; Davies, J.K.; Voskertchian, A.; Kelner, R.H.; Brennan, L.L.; Nadler, L.M.; Guinan, E.C. 2014: Alloanergization of human T cells results in expansion of alloantigen-specific CD8(+) CD28(-) suppressor cells. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 14(2): 305-318
Pham, B.-N.; Peyrard, T.; Juszczak, G.; Auxerre, C.; Godin, S.; Bonin, P.; Rouger, P.; Le Pennec, P.-Y. 2009: Alloanti-c (RH4) revealing that the (C)ce s haplotype encodes a partial c antigen. Transfusion 49(7): 1329-1334
Ong, J.; Walker, P.S.; Schmulbach, E.; Storry, J.R.; Vege, S.; Westhoff, C.; Lomas-Francis, C.; Reid, M.E. 2009: Alloanti-c in a c-positive, JAL-positive patient. Vox Sanguinis 96(3): 240-243
Peyrard, T.; Pham, B.-N.; Poupel, S.; Martin-Blanc, S.ép.; Auxerre, C.; Kappler-Gratias, S.; Bonin, P.; Rouger, P.; Le Pennec, P.-Y. 2009: Alloanti-c/ce in a c+ceAR/Ce patient suggests that the rare RHCE ceAR allele (ceAR) encodes a partial c antigen. Transfusion 49(11): 2406-2411
Ghevaert, C.; Rankin, A.; Huiskes, E.; Porcelijn, L.; Javela, K.; Kekomaki, R.; Bakchoul, T.; Santoso, S.; Nutland, S.; Smyth, D.J.; Smith, G.A.; McBride, S.; Watkins, N.A.; Ouwehand, W.H. 2009: Alloantibodies against low-frequency human platelet antigens do not account for a significant proportion of cases of fetomaternal alloimmune thrombocytopenia: evidence from 1054 cases. Transfusion 49(10): 2084-2089
Wada, H.; Souri, M.; Matsumoto, R.; Sugihara, T.; Ichinose, A. 2013: Alloantibodies against the B subunit of plasma factor XIIi developed in its congenital deficiency. Thrombosis and Haemostasis 109(4): 661-668
Allanki, S.D. 2011: Alloantibodies and drug-induced immune hemolytic anemia in liver transplantation. Case Reports in Transplantation 2011: 250674
Cinti, P.; Pretagostini, R.; Lai, Q.; Tamburro, M.L.; Rossi, M.; Poli, L.; Berloco, P. 2009: Alloantibodies and outcomes of deceased donor kidney allografts. Human Immunology 70(8): 651-654
Ho, E.K.; Vlad, G.; Colovai, A.I.; Vasilescu, E.R.; Schwartz, J.; Sondermeijer, H.; Burke, E.; Marboe, C.C.; Itescu, S.; Suciu-Foca, N.; Mancini, D. 2009: Alloantibodies in heart transplantation. Human Immunology 70(10): 825-829
Franchini, M.; Frattini, F.; Crestani, S.; Bonfanti, C. 2013: Alloantibodies in previously untreated hemophilia a patients: the role of environmental factors. Hematology 18(4): 183-190
Burns, A.M.; Chong, A.S. 2011: Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming. Journal of Immunology 186(1): 214-221
Stowell, S.R.; Henry, K.L.; Smith, N.H.; Hudson, K.E.; Halverson, G.R.; Park, J.C.; Bennett, A.M.; Girard-Pierce, K.R.; Arthur, C.M.; Bunting, S.T.; Zimring, J.C.; Hendrickson, J.E. 2013: Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine model. Blood 122(8): 1494-1504
Zakarija, A.; Harris, S.; Rademaker, A.W.; Brewer, J.; Krudysz-Amblo, J.; Butenas, S.; Mann, K.G.; Green, D. 2011: Alloantibodies to factor VIIi in haemophilia. Haemophilia: the Official Journal of the World Federation of Hemophilia 17(4): 636-640
Jeremiah, Z.A.; Oburu, J.E.; Erhabor, O.; Buseri, F.I. 2011: Alloantibodies to glycoprotein La/LLa (anti-HPA-5a and -5b) and IIb/IIIa (anti-HPA1a, -3a and -4a) in Nigerian parous women. British Journal of Biomedical Science 68(1): 34-37
Jeremiah, Z.Awortu.; Atiegoba, A.Ifeanyi.; Mgbere, O. 2011: Alloantibodies to human platelet glycoprotein antigens (HPA) and HLA class 1 in a cross section of Nigerian antenatal women. Human Antibodies 20(3-4): 71-75
Piemonti, L.; Everly, M.J.; Maffi, P.; Scavini, M.; Poli, F.; Nano, R.; Cardillo, M.; Melzi, R.; Mercalli, A.; Sordi, V.; Lampasona, V.; Espadas de Arias, A.; Scalamogna, M.; Bosi, E.; Bonifacio, E.; Secchi, A.; Terasaki, P.I. 2013: Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes. Diabetes 62(5): 1656-1664
Jane-Wit, D.; Manes, T.D.; Yi, T.; Qin, L.; Clark, P.; Kirkiles-Smith, N.C.; Abrahimi, P.; Devalliere, J.; Moeckel, G.; Kulkarni, S.; Tellides, G.; Pober, J.S. 2013: Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells. Circulation 128(23): 2504-2516
Kuo, H.-H.; Morrell, C.N.; Baldwin, W.M. 2012: Alloantibody induced platelet responses in transplants: potent mediators in small packages. Human Immunology 73(12): 1233-1238
Burns, J.M.; Cornell, L.D.; Perry, D.K.; Pollinger, H.S.; Gloor, J.M.; Kremers, W.K.; Gandhi, M.J.; Dean, P.G.; Stegall, M.D. 2008: Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 8(12): 2684-2694
Lutz, C.T.; Al-Attar, A.; May, J.R.; Jennings, C.D. 2014: Alloantibody to a Bw4 epitope in a Bw4+B*27: 05 patient. Transplantation 98(8): 853-856
Easterfield, A.J.; Delriviere, L.; Wallduck, M.S.; Sivaganesh, S.; Bradley, J.A.; Bolton, E.M. 2007: Alloantibody-associated chronic rejection of MHC class I-disparate heart grafts is modulated by intravenous soluble donor alloantigen. Transplant Immunology 18(2): 138-141
Asakura, S.; Hashimoto, D.; Takashima, S.; Sugiyama, H.; Maeda, Y.; Akashi, K.; Tanimoto, M.; Teshima, T. 2010: Alloantigen expression on non-hematopoietic cells reduces graft-versus-leukemia effects in mice. Journal of Clinical Investigation 120(7): 2370-2378
Hall, B.M.; Tran, G.; Hodgkinson, S.J. 2009: Alloantigen specific T regulatory cells in transplant tolerance. International Immunopharmacology 9(5): 570-574
Schütz, C.; Hoves, S.; Halbritter, D.; Zhang, H-Ge.; Mountz, J.D.; Fleck, M. 2011: Alloantigen specific deletion of primary human T cells by Fas ligand (CD95L)-transduced monocyte-derived killer-dendritic cells. Immunology 133(1): 115-122
Shearer, G.M.; Boasso, A. 2011: Alloantigen-based AIDS vaccine: revisiting a "rightfully" discarded promising strategy. F1000 Medicine Reports 3: 12
Koch, S.D.; Uss, E.; van Lier, R.é A.W.; ten Berge, I.J.M. 2008: Alloantigen-induced regulatory CD8+CD103+ T cells. Human Immunology 69(11): 737-744
Kuo, Y.-R.; Huang, C.-W.; Goto, S.; Wang, C.-T.; Hsu, L.-W.; Lin, Y.-C.; Yang, K.D.; Chen, C.-L.; Lee, W.P.A. 2009: Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation. Journal of Surgical Research 153(2): 317-325
Koenecke, C.; Czeloth, N.; Bubke, A.; Schmitz, S.; Kissenpfennig, A.; Malissen, B.; Huehn, J.; Ganser, A.; Förster, R.; Prinz, I. 2009: Alloantigen-specific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD. European Journal of Immunology 39(11): 3091-3096
Hori, T.; Kuribayashi, K.; Uemoto, S.; Saito, K.; Wang, L.; Torii, M.; Shibutani, S.; Taniguchi, K.; Yagi, S.; Iida, T.; Yamamoto, C.; Kato, T. 2008: Alloantigen-specific prolongation of allograft survival in recipient mice treated by alloantigen immunization following ultraviolet-B irradiation. Transplant Immunology 19(1): 45-54
Sagoo, P.; Ratnasothy, K.; Tsang, Y.; Barber, L.D.; Noble, A.; Lechler, R.I.; Lombardi, G. 2012: Alloantigen-specific regulatory T cells prevent experimental chronic graft-versus-host disease by simultaneous control of allo- and autoreactivity. European Journal of Immunology 42(12): 3322-3333
Morales, J.; Alba, A.; Espinoza, R.; Sepúlveda, C.; Contreras, L.; Buckel, E.; Noriega, L.; Fierro, J.A. 2011: Alloantigen-specific response is preserved and autoimmunity is maintained in an HIV-positive patient with immunoglobulin A nephropathy undergoing renal transplantation: a warning about long-term reduction in immunosuppression--a case report. Transplantation Proceedings 43(6): 2341-2343
Velásquez, S.Y.; Süsal, C.; Opelz, G.; García, L.F.; Alvarez, C.M. 2012: Alloantigen-stimulated induction and release of CD30 in patients with end-stage renal failure. Human Immunology 73(11): 1102-1108
Dehaen, W.; Mashentseva, A.A.; Seitembetov, T.S. 2011: Allobetulin and its derivatives: synthesis and biological activity. Molecules 16(3): 2443-2466
Abell-Davis, S.E.; Gadek, P.A.; Pearce, C.A.; Congdon, B.C. 2012: Allocasuarina tree hosts determine the spatial distribution of hypogeous fungal sporocarps in three tropical Australian sclerophyll forests. Mycologia 104(5): 1008-1019
Lee, D.W.; Lee, S.D. 2011: Allocatelliglobosispora scoriae gen. nov., sp. nov., isolated from volcanic ash. International Journal of Systematic and Evolutionary Microbiology 61(Part 2): 264-270
Lasry, A.; Sansom, S.L.; Hicks, K.A.; Uzunangelov, V. 2012: Allocating HIV prevention funds in the United States: recommendations from an optimization model. Plos one 7(6): E37545
Richter, A.; Hicks, K.A.; Earnshaw, S.R.; Honeycutt, A.A. 2008: Allocating HIV prevention resources: a tool for state and local decision making. Health Policy 87(3): 342-349
Brooks, K.; Laws, M.B.; Wilson, I. 2014: Allocating HIV treatment to the adherent: a qualitative study of patient perceptions of their HIV care in the Dominican Republic. Journal of Health Care for the Poor and Underserved 25(4): 1748-1762
Rainer, G. 2011: Allocating attention in rank-ordered groups. Neuron 70(1): 5-7
Hillner, B.E.; Smith, T.J. 2011: Allocating cancer-directed expenditures: tensions between prevention, early detection and treatment is unnecessary. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 188: 1-9
McDonald-Madden, E.; Chadès, I.; McCarthy, M.A.; Linkie, M.; Possingham, H.P. 2011: Allocating conservation resources between areas where persistence of a species is uncertain. Ecological Applications: a Publication of the Ecological Society of America 21(3): 844-858
Curtis, L.E.; Kallenbach, R.L.; Roberts, C.A. 2008: Allocating forage to fall-calving cow-calf pairs strip-grazing stockpiled tall fescue. Journal of Animal Science 86(3): 780-789
Lasry, A.; Carter, M.W.; Zaric, G.S. 2011: Allocating funds for HIV/AIDS: a descriptive study of KwaDukuza, South Africa. Health Policy and Planning 26(1): 33-42
Mitton, C.; Levy, A.; Gorsky, D.; MacNeil, C.; Dionne, F.; Marrie, T. 2013: Allocating limited resources in a time of fiscal constraints: a priority setting case study from Dalhousie University Faculty of Medicine. Academic Medicine: Journal of the Association of American Medical Colleges 88(7): 939-945
Neuberger, J. 1999: Allocating livers to substance and alcohol misusers. Addiction Biology 4(4): 385-390
Salo, M.; Helle, S.; Toivonen, T. 2011: Allocating logging rights in Peruvian Amazonia--does it matter to be local?. Plos one 6(5): E19704
Rubinson, L.; Christian, M.D. 2008: Allocating mechanical ventilators during mass respiratory failure: Kudos to New York State, but more work to be done. Disaster medicine and public health preparedness 2(1): 7-10
Wintle, B.A.; Runge, M.C.; Bekessy, S.A. 2010: Allocating monitoring effort in the face of unknown unknowns. Ecology Letters 13(11): 1325-1337
Hosseini, N.; Taaffe, K.M. 2015: Allocating operating room block time using historical caseload variability. Health Care Management Science 18(4): 419-430
Anantha, R.Venkatesh.; Paskar, D.; Vogt, K.; Crawford, S.; Parry, N.; Leslie, K. 2014: Allocating operating room resources to an acute care surgery service does not affect wait-times for elective cancer surgeries: a retrospective cohort study. World Journal of Emergency Surgery: Wjes 9(1): 21
McMaster, M.J. 2008: Allocating organs: an opportunity to make a difference on policy in the United States. Nephrology News and Issues 22(13): 10; 12
Eckert, J. 2007: Ulterior motives behind physician pricing transparency. Mgma Connexion 7(1): 15-16
Bezdek, R.H.; Taylor, W.B. 1981: Allocating petroleum products during oil supply disruptions. Science 212(4501): 1357-1363
Barboza, P.S.; Parker, K.L. 2008: Allocating protein to reproduction in arctic reindeer and caribou. Physiological and Biochemical Zoology: Pbz 81(6): 835-855
Xi, D.; Tamhane, A.C. 2015: Allocating recycled significance levels in group sequential procedures for multiple endpoints. Biometrical Journal. Biometrische Zeitschrift 57(1): 90-107
Hick, J.L.; DeVries, A.S.; Fink-Kocken, P.; Braun, J.E.; Marchetti, J. 2012: Allocating resources during a crisis: you can't always get what you want. Minnesota Medicine 95(4): 46-50
Kemppainen, A. 2009: Allocating resources during pandemic addressed in annual ethics lecture. Michigan Medicine 108(4): 13
Gróf, A. 2007: Allocating resources for cancer control--resolving multicriteria decision-making using the analytic hierarchy process. Magyar Onkologia 51(3): 197-208
Campbell, M.; Keesara, S.; Potts, M. 2009: Allocating resources for serving the poor: a core factor in development. Journal of Family Planning and Reproductive Health Care 35(3): 143-144
Stuart, G.W.; Erkel, E.A.; Shull, L.H. 2010: Allocating resources in a data-driven college of nursing. Nursing outlook 58(4): 200-206
McLean, M.R. 2013: Allocating resources--a wicked problem. Health Progress 94(6): 60-67
Yu, S.; Unger, A.J.A.; Parker, B.; Kim, T. 2012: Allocating risk capital for a brownfields redevelopment project under hydrogeological and financial uncertainty. Journal of Environmental Management 100: 96-108
Wirtz, V.J.; Santa-Ana-Tellez, Y.; Trout, C.H.; Kaplan, W.A. 2012: Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America. Health Policy and Planning 27(8): 638-648
Thambu, D. 2010: Allocating scarce life support in a public health emergency. Indian Journal of Medical Ethics 7(3): 183-184
Furnham, A.; Loganathan, N.; McClelland, A. 2010: Allocating scarce medical resources to the overweight. Journal of Clinical Ethics 21(4): 346-356
Strosberg, M.A. 2006: Allocating scarce resources in a pandemic: ethical and public policy dimensions. Virtual Mentor: Vm 8(4): 241-244
Amarasingham, R.; Patel, P.C.; Toto, K.; Nelson, L.L.; Swanson, T.S.; Moore, B.J.; Xie, B.; Zhang, S.; Alvarez, K.S.; Ma, Y.; Drazner, M.H.; Kollipara, U.; Halm, E.A. 2013: Allocating scarce resources in real-time to reduce heart failure readmissions: a prospective, controlled study. Bmj Quality and Safety 22(12): 998-1005
McCoy, D.; Kinyua, K. 2012: Allocating scarce resources strategically--an evaluation and discussion of the Global Fund's pattern of disbursements. Plos one 7(5): E34749
Anderson, M.L.; Finlay, B.L. 2014: Allocating structure to function: the strong links between neuroplasticity and natural selection. Frontiers in Human Neuroscience 7: 918
Robinson, A.; Burgman, M.A.; Cannon, R. 2011: Allocating surveillance resources to reduce ecological invasions: maximizing detections and information about the threat. Ecological Applications: a Publication of the Ecological Society of America 21(4): 1410-1417
Hamilton, D.P. 1991: Allocating the pain in energy science. Science 253(5027): 1482
Amos, L.; Kanellis, J.; Summers, S.; Saunder, A.; Suh, N.; Mulley, W. 2012: Allocating the unexpected kidney. Nephrology 17(6): 588-589
Forsyth, D.K.; Burt, C.D.B. 2008: Allocating time to future tasks: the effect of task segmentation on planning fallacy bias. Memory and Cognition 36(4): 791-798
Coleman, C.H. 2009: Allocating vaccines and antiviral medications during an influenza pandemic. Seton Hall Law Review 39(4): 1111-1123
Skorobogataia, E.V.; Kalmykova, N.V.; Blinova, M.I.; Pinaev, G.P. 2008: Allocation and identification of fibrocytes from human peripheral blood. Tsitologiia 50(2): 118-123
Glorie, K.; Haase-Kromwijk, B.; van de Klundert, J.; Wagelmans, A.; Weimar, W. 2014: Allocation and matching in kidney exchange programs. Transplant International: Official Journal of the European Society for Organ Transplantation 27(4): 333-343
Cipriani, A.; Nosè, M.; Barbui, C. 2008: Allocation concealment and blinding in clinical trials. Epidemiologia e Psichiatria Sociale 17(2): 115-116
Berger, V.W.; Do, A-Chi. 2010: Allocation concealment continues to be misunderstood. Journal of clinical epidemiology 63(4): 468-9; author reply 469-70
Arendts, G.; Howard, K.; Rose, J.M. 2011: Allocation decisions and patient preferences in emergency medicine. Emergency Medicine Journal: Emj 28(12): 1051-1054
Aguado, P.L.; Curt, M.D.; Pereira, H.; Fernández, J.ús. 2012: Allocation of 14C assimilated in late spring to tissue and biochemical stem components of cork oak (Quercus suber L.) over the seasons. Tree Physiology 32(3): 313-325
Yasuda, K.; Sato, Y.; Iimura, N.; Iwata, H. 2014: Allocation of Attentional Resources toward a Secondary Cognitive Task Leads to Compromised Ankle Proprioceptive Performance in Healthy Young Adults. Rehabilitation Research and Practice 2014: 170304
Anonymous 1938: Allocation of Deaths. American Journal of Public Health and the Nation's Health 28(1): 27
Anonymous 1931: Allocation of Dues. Bulletin of the New York Academy of Medicine 7(2): 157
Delanaye, P.; Rozet, E.; Maillard, N.; Mariat, C. 2010: Allocation of ECD kidneys based on donor GFR: the choice of the estimating equation matters. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 10(6): 1493-1494
Mikami, Y.; Saito, A.; Miwa, E.; Higuchi, K. 2011: Allocation of Fe and ferric chelate reductase activities in mesophyll cells of barley and sorghum under Fe-deficient conditions. Plant Physiology and Biochemistry: Ppb 49(5): 513-519
Hawkes, N. 2012: Allocation of NHS resources: are some patients more equal than others?. Bmj 344: E3362
Wilson, D.A.; Colditz, G.A. 1981: Allocation of Pre-Registration Posts -by Ballot. Medical Teacher 3(1): 33-34
Konrad, R.; Bezchlibnyk-Butler, K.; Wodoslawsky, M.Dubyk. 2009: Allocation of aid for health institutions in Ukraine: implications from a case study of Chornobyl (Chernobyl) area hospitals. International Journal of Health Services: Planning Administration Evaluation 39(4): 623-641
Jonikaitis, D.; Szinte, M.; Rolfs, M.; Cavanagh, P. 2013: Allocation of attention across saccades. Journal of Neurophysiology 109(5): 1425-1434
Hirai, M.; Saunders, D.R.; Troje, N.F. 2011: Allocation of attention to biological motion: local motion dominates global shape. Journal of Vision 11(3)
Tacikowski, P.; Nowicka, A. 2010: Allocation of attention to self-name and self-face: An ERP study. Biological Psychology 84(2): 318-324
Leppänen, J.M.; Niehaus, D.J.H.; Koen, L.; Schoeman, R.; Emsley, R. 2008: Allocation of attention to the eye and mouth region of faces in schizophrenia patients. Cognitive Neuropsychiatry 13(6): 505-519
Tobis, I.P.; Kihlstrom, J.F. 2010: Allocation of attentional resources in posthypnotic suggestion. International Journal of Clinical and Experimental Hypnosis 58(4): 367-382
Cella Pizarro, L.; Bisigato, A.J. 2010: Allocation of biomass and photoassimilates in juvenile plants of six Patagonian species in response to five water supply regimes. Annals of Botany 106(2): 297-307
Haddad, H.J.; Salameh, Z.; Sadig, W.; Aboushelib, M.; Jakstat, H.A. 2011: Allocation of color space for different age groups using three-dimensional shade guide systems. European Journal of Esthetic Dentistry: Official Journal of the European Academy of Esthetic Dentistry 6(1): 94-102
Zhang, Z.; Jia, M.; Wan, D. 2009: Allocation of control rights and cooperation efficiency in public-private partnerships: theory and evidence from the Chinese pharmaceutical industry. International Journal of Health Care Finance and Economics 9(2): 169-182
Bokhorst, A.G.; Dorrepaal, C.A. 2009: Allocation of corneas in europe. Developments in Ophthalmology 43: 87-96
Barbehenn, R.V.; Kochmanski, J.; Menachem, B.; Poirier, L.M. 2013: Allocation of cysteine for glutathione production in caterpillars with different antioxidant defense strategies: a comparison of Lymantria dispar and Malacosoma disstria. Archives of Insect Biochemistry and Physiology 84(2): 90-103
Monteiro, F.; Coria, S.A.; Boni, R.; Pereira, L.A. 2009: Allocation of deceased donor kidneys in São Paulo, Brazil: effect of human leukocyte antigen compatibility on graft survival. Transplantation Proceedings 41(1): 93-94
Johnson, L.-M.; Levine, D. 2013: Allocation of drugs in short supply. Virtual Mentor: Vm 15(8): 645-648
Calder, J.M. 1946: Allocation of duties in the Public Health Nursing Service. Journal. Royal Sanitary Institute 66: 472-477
Wortman, H.M. 1948: Allocation of duties to different types of nursing personnel. Southern Hospitals 16(1): 21
Wang, D.D.; Proctor, R.W.; Pick, D.F. 2009: Allocation of effort as a function of payoffs for individual tasks in a multitasking environment. Behavior Research Methods 41(3): 705-716
Naar-King, S.; Montepiedra, G.; Nichols, S.; Farley, J.; Garvie, P.A.; Kammerer, B.; Malee, K.; Sirois, P.A.; Storm, D.; McIntosh, K.; Kammerer, B.; Burchett, S.; Allison, S.; Tepper, V.; Hilyard, C.; Nachman, S.; Perillo, J.; Kelly, M.; Ferraro, D.; Foster, J.; Chen, J.; Conway, D.; Laguerre, R.; Yogev, R.; Chadwick, E.; Malee, K.; Wiznia, A.; Iacovella, Y.; Burey, M.; Auguste, R.; Wara, D.; Muskat, M.; Tilton, N.; Garvie, P.; Hopper, D.; Donohoe, M.; Carr, S.; Van Dyke, R.; Sirois, P.; Borne, C.; Bradford, S.; Jacobs, K.; Ranftle, A.; McEvoy, R.; Paul, S.; Barr, E.; Abzug, M.; Oleske, J.; Bettica, L.; Monti, L.; Johnson, J.; Paul, M.; Jackson, C.; Noroski, L.; Aldape, T.; Stechenberg, B.; Fisher, D.; McQuiston, S.; Toye, M.; Scott, G.; Mi 2009: Allocation of family responsibility for illness management in pediatric HIV. Journal of Pediatric Psychology 34(2): 187-194
Clark, F.L.G. 1945: Allocation of food within the family. Proceedings of the Nutrition Society 3: 12-20
Goodyear, J.; Adams, P.C. 2009: Allocation of gastroenterology training positions in Ontario: supply or demand?. Canadian Journal of Gastroenterology 23(2): 82-83
Chen, G.; Yang, Y.; Robinson, D. 2013: Allocation of gross primary production in forest ecosystems: allometric constraints and environmental responses. New Phytologist 200(4): 1176-1186
Crowe, M.Lind. 2010: Allocation of health care resources at the point of care. Journal of Legal Medicine 31(4): 455-465
Hassani, S.; Abolhallaje, M.; Inanlo, S.; Hosseini, H.; Pourmohammadi, K.; Bastani, P.; Ramezanian, M.; Marnani, A.B. 2013: Allocation of health resources according to the type and size of Iranian governmental hospitals. Iranian Journal of Public Health 42(Supple 1): 166-173
Gutwein, L.G.; Alvarez, J.F.; Gutwein, J.L.; Kays, D.W.; Islam, S. 2013: Allocation of healthcare dollars: analysis of nonneonatal circumcisions in Florida. American Surgeon 79(9): 865-869
Andrade, M.ôn.V.; Junoy, J.P.; Andrade, E.I.G.; Acurcio, F.d.A.; Sesso, R.; Queiroz, O.V.d.; Szuster, D.A.új.; Gomes, I.C.; Almeida, A.M.; Cherchiglia, M.L. 2010: Allocation of initial modality for renal replacement therapy in Brazil. Clinical Journal of the American Society of Nephrology: Cjasn 5(4): 637-644
Krupa, M.; Mazur, E.; Szczepańska, K.; Filimonow, K.; Maleszewski, M.; Suwińska, A. 2014: Allocation of inner cells to epiblast vs primitive endoderm in the mouse embryo is biased but not determined by the round of asymmetric divisions (8→16- and 16→32-cells). Developmental Biology 385(1): 136-148
Newstead, C. 2011: Allocation of kidney transplants in the UK. British Journal of Hospital Medicine 72(12): 698-701
Liao, E.; Jiang, Y.; Yan, X.-H.; Chen, Z.; Wang, J.; Zhang, L. 2013: Allocation of marine environmental carrying capacity in the Xiamen Bay. Marine Pollution Bulletin 75(1-2): 21-27
Sagan, L.A. 1973: Allocation of natural resources. Science 182(4119): 1296
Thornley, J.H.M.; Parsons, A.J. 2014: Allocation of new growth between shoot, root and mycorrhiza in relation to carbon, nitrogen and phosphate supply: teleonomy with maximum growth rate. Journal of Theoretical Biology 342: 1-14
Simon, J.; Gleadow, R.M.; Woodrow, I.E. 2010: Allocation of nitrogen to chemical defence and plant functional traits is constrained by soil N. Tree Physiology 30(9): 1111-1117
Lu, J.; Li, M.; Gao, L.; Pan, Y.; Xiang, Y.; Huang, J.; Jiang, X. 2018: Attenuation rules and germicidal efficacy of ozoneted water. Zhong Nan da Xue Xue Bao. Yi Xue Ban 43(2): 143-146
Busse, B.; Hahn, M.; Niecke, M.; Jobke, B.; Püschel, K.; Delling, G.; Katzer, A. 2008: Allocation of nonbirefringent wear debris: darkfield illumination associated with PIXE microanalysis reveals cobalt deposition in mineralized bone matrix adjacent to CoCr implants. Journal of Biomedical Materials Research. Part a 87(2): 536-545
Judd, E.T.; Hatle, J.D.; Drewry, M.D.; Wessels, F.J.; Hahn, D.A. 2010: Allocation of nutrients to somatic tissues in young ovariectomized grasshoppers. Integrative and Comparative Biology 50(5): 818-828
Kellner, R.L.; Dettner, K. 1995: Allocation of pederin during lifetime of Paederus rove beetles (Coleoptera: Staphylinidae): Evidence for polymorphism of hemolymph toxin. Journal of Chemical Ecology 21(11): 1719-1733
Li, L.; Li, B. 2008: Allocation of processing resources between right and left spatial attention. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2008: 4391-4394
Bernardi, A.; Jirillo, A.; Pegoraro, R.; Bonavina, M.G. 2007: Allocation of public sources in oncology: which role can ethics play?. Annals of Oncology: Official Journal of the European Society for Medical Oncology 18(7): 1129-1131
Göen, T.; Eckert, E.; Schäferhenrich, A.; Hartwig, A. 2012: Allocation of reliable analytical procedures for human biomonitoring published by the DFG Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area. International Journal of Hygiene and Environmental Health 215(2): 233-237
Vrochides, D.; Hassanain, M.; Metrakos, P.; Tchervenkov, J.; Chaudhury, P.; Chan, G.; Paraskevas, S. 2011: Allocation of renal grafts to older recipients does not result in loss of functioning graft-years. Hippokratia 15(2): 167-169
Kandula, P.; Anderson, T.A.; Vagefi, P.A. 2013: Allocation of resources for organ transplantation. Anesthesiology Clinics 31(4): 667-674
Solsona, J.F.; Díaz, Y.; Iglesias, M.L.; Gracia, M.P.; Pérez, A.; Vázquez, A. 2007: Allocation of resources in patients with bad prognosis: the need for debate. Medicina Intensiva 31(2): 62-67
Folmer, H.R. 1980: Allocation of resources using a simulation game. Medical Teacher 2(1): 10-17
Batt, R.E.; Yeh, J.; Bush, R.B. 2009: Allocation of scarce medical library resources as a form of implicit medical rationing. Journal of Minimally Invasive Gynecology 16(5): 660-661
Knebel, A.R.; Coleman, C.N.; Cliffer, K.D.; Murrain-Hill, P.; McNally, R.; Oancea, V.; Jacobs, J.; Buddemeier, B.; Hick, J.L.; Weinstock, D.M.; Hrdina, C.M.; Taylor, T.; Matzo, M.; Bader, J.L.; Livinski, A.A.; Parker, G.; Yeskey, K. 2011: Allocation of scarce resources after a nuclear detonation: setting the context. Disaster Medicine and Public Health Preparedness 5(Suppl 1): S20-S31
Timbie, J.W.; Ringel, J.S.; Fox, D.Steven.; Waxman, D.A.; Pillemer, F.; Carey, C.; Moore, M.; Karir, V.; Johnson, T.J.; Iyer, N.; Hu, J.; Shanman, R.; Larkin, J.Wozar.; Timmer, M.; Motala, A.; Perry, T.R.; Newberry, S.; Kellermann, A.L. 2012: Allocation of scarce resources during mass casualty events. Evidence report/technology assessment 2012(207): 1-305
Ibrahim, M.H.; Jaafar, H.Z.E.; Karimi, E.; Ghasemzadeh, A. 2014: Allocation of secondary metabolites, photosynthetic capacity, and antioxidant activity of Kacip Fatimah (Labisia pumila Benth) in response to CO2 and light intensity. Thescientificworldjournal 2014: 360290
Vogt, J.; De Houwer, J.; Koster, E.H.W.; Van Damme, S.; Crombez, G. 2008: Allocation of spatial attention to emotional stimuli depends upon arousal and not valence. Emotion 8(6): 880-885
Alp, E.; Melching, C.S. 2011: Allocation of supplementary aeration stations in the Chicago waterway system for dissolved oxygen improvement. Journal of Environmental Management 92(6): 1577-1583
Cendales, L.C.; Rahmel, A.; Pruett, T.L. 2012: Allocation of vascularized composite allografts: what is it?. Transplantation 93(11): 1086-1087
Applegate, H.G. 1981: Allocation of vehicular emissions of carbon monoxide in El Paso, Texas, and Ciudad Juarez, Chihuahua. Environmental Science and Technology 15(8): 963-966
Powell, T.; Christ, K.C.; Birkhead, G.S. 2008: Allocation of ventilators in a public health disaster. Disaster Medicine and Public Health Preparedness 2(1): 20-26
Mahon, S.M. 2013: Allocation of work activities in a comprehensive cancer genetics program. Clinical Journal of Oncology Nursing 17(4): 397-404
Matas, A.J. 2009: Allocation or rationing--word choice is crucial. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 9(1): 9-10
Roayaie, K.; Feng, S. 2007: Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 13(11 Suppl. 2): S36-S43
Gitto, S.; Lorenzini, S.; Biselli, M.; Conti, F.; Andreone, P.; Bernardi, M. 2009: Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 41(10): 700-706
Benckert, C.; Quante, M.; Jonas, S. 2010: Allocation problems in organ transplantation: practical medical experience. Zeitschrift für Evidenz Fortbildung und Qualitat Im Gesundheitswesen 104(5): 397-399
Gotsch, S.G.; Geiger, E.L.; Franco, A.C.; Goldstein, G.; Meinzer, F.C.; Hoffmann, W.A. 2010: Allocation to leaf area and sapwood area affects water relations of co-occurring savanna and forest trees. Oecologia 163(2): 291-301
Doughty, C.E.; Malhi, Y.; Araujo-Murakami, A.; Metcalfe, D.B.; Silva-Espejo, J.E.; Arroyo, L.; Heredia, J.P.; Pardo-Toledo, E.; Mendizabal, L.M.; Rojas-Landivar, V.D.; Vega-Martinez, M.; Flores-Valencia, M.; Sibler-Rivero, R.; Moreno-Vare, L.; Viscarra, L.Jessica.; Chuviru-Castro, T.; Osinaga-Becerra, M.; Ledezma, R. 2014: Allocation trade-offs dominate the response of tropical forest growth to seasonal and interannual drought. Ecology 95(8): 2192-2201
Gainsbury, S.; Clover, B.; Dowler, C. 2010: Allocations. SHAs to retain 2 per cent of PCT cash to pay for change. Health Service Journal 120(6237): 3
Dexter, F.; Wachtel, R.E.; Epstein, R.H.; McIntosh, C.; O'Neill, L. 2007: Allocative efficiency vs technical efficiency in operating room management. Anaesthesia 62(12): 1290-1; author reply 1291-2
Lithfous, S.ég.èn.; Dufour, A.é; Blanc, F.éd.ér.; Després, O. 2014: Allocentric but not egocentric orientation is impaired during normal aging: an ERP study. Neuropsychology 28(5): 761-771
Knight, R.; Hayman, R. 2014: Allocentric directional processing in the rodent and human retrosplenial cortex. Frontiers in Human Neuroscience 8: 135
Rorden, C.; Hjaltason, H.; Fillmore, P.; Fridriksson, J.; Kjartansson, O.; Magnusdottir, S.; Karnath, H.-O. 2012: Allocentric neglect strongly associated with egocentric neglect. Neuropsychologia 50(6): 1151-1157
Altmann, C.F.; Getzmann, S.; Lewald, Jörg. 2012: Allocentric or craniocentric representation of acoustic space: an electrotomography study using mismatch negativity. Plos one 7(7): E41872
Zilli, E.M.; Heilman, K.M. 2015: Allocentric spatial neglect with posterior cortical atrophy. Neurocase 21(2): 190-197
Landwehr, K.; Hecht, H.; Both, B. 2014: Allocentric time-to-contact and the devastating effect of perspective. Vision Research 105: 53-60
Chen, Y.; Monaco, S.; Byrne, P.; Yan, X.; Henriques, D.Y.P.; Crawford, J.Douglas. 2014: Allocentric versus egocentric representation of remembered reach targets in human cortex. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 34(37): 12515-12526
Preuss, N.; Harris, L.R.; Mast, F.W. 2013: Allocentric visual cues influence mental transformation of bodies. Journal of Vision 13(12): 14
Heath, M.; Neely, K.; Binsted, G. 2007: Allocentric visual cues influence online limb adjustments. Motor Control 11(1): 54-70
Thompson, A.A.; Glover, C.V.; Henriques, D.Y.P. 2012: Allocentrically implied target locations are updated in an eye-centred reference frame. Neuroscience Letters 514(2): 214-218
Skelton, T.S.; Tejpal, N.; Gong, Y.; Kubiak, J.Z.; Kloc, M.; Ghobrial, R.M. 2012: Allochimeric molecules and mechanisms in abrogation of cardiac allograft rejection. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 31(1): 73-84
Srinivas, T.N.R.; Anil Kumar, P.; Sucharitha, K.; Sasikala, C.; Ramana, C.V. 2009: Allochromatium phaeobacterium sp. nov. International Journal of Systematic and Evolutionary Microbiology 59(Part 4): 750-753
Cort, J.R.; Selan, U.; Schulte, A.; Grimm, F.; Kennedy, M.A.; Dahl, C. 2008: Allochromatium vinosum DsrC: solution-state NMR structure, redox properties, and interaction with DsrEFH, a protein essential for purple sulfur bacterial sulfur oxidation. Journal of Molecular Biology 382(3): 692-707
Hornok, S.án. 2009: Allochronic seasonal peak activities of Dermacentor and Haemaphysalis spp. under continental climate in Hungary. Veterinary Parasitology 163(4): 366-369
Schöfl, G.; Dill, A.; Heckel, D.G.; Groot, A.T. 2011: Allochronic separation versus mate choice: nonrandom patterns of mating between fall armyworm host strains. American Naturalist 177(4): 470-485
Tomaz-Soccol, V.; Castro, E.A.; Navarro, I.T.; de Farias, M.R.; de Souza, L.íl.M.; Carvalho, Y.ê; Bispo, S.é; Membrive, N.A.; Minozzo, J.ão.C.; Truppel, J.é; Bueno, W.; Luz, E. 2009: Allochthonous cases of canine visceral leishmaniasis in Paraná, Brazil: epidemiological implications. Revista Brasileira de Parasitologia Veterinaria 18(3): 46-51
Schwedt, T.J.; Larson-Prior, L.; Coalson, R.S.; Nolan, T.; Mar, S.; Ances, B.M.; Benzinger, T.; Schlaggar, B.L. 2014: Allodynia and descending pain modulation in migraine: a resting state functional connectivity analysis. Pain Medicine 15(1): 154-165
Jolivalt, C.G.; Lee, C.A.; Ramos, K.M.; Calcutt, N.A. 2008: Allodynia and hyperalgesia in diabetic rats are mediated by GABA and depletion of spinal potassium-chloride co-transporters. Pain 140(1): 48-57
Jensen, T.S.; Finnerup, N.B. 2014: Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. LANCET. Neurology 13(9): 924-935
Young, W.B. 2009: Allodynia as a complication of migraine: background and management. Current Treatment Options in Neurology 11(1): 3-9
Sasaki, M.; Abekura, M.; Morris, S.; Kataoka, Y.; Yoshimura, K.; Ninomiya, K.; Iwatsuki, K.; Yoshimine, T. 2009: Allodynia corresponding to the levels of cervical cord injury treated by surgical decompression: a report of 3 cases. Surgical Neurology 72(3): 281-5; Discussion 285
Ashkenazi, A. 2010: Allodynia in cluster headache. Current Pain and Headache Reports 14(2): 140-144
Tietjen, G.E.; Brandes, J.L.; Peterlin, B.Lee.; Eloff, A.; Dafer, R.M.; Stein, M.R.; Drexler, E.; Martin, V.T.; Hutchinson, S.; Aurora, S.K.; Recober, A.; Herial, N.A.; Utley, C.; White, L.; Khuder, S.A. 2009: Allodynia in migraine: association with comorbid pain conditions. Headache 49(9): 1333-1344
Misra, U.K.; Kalita, J.; Bhoi, S.K. 2013: Allodynia in migraine: clinical observation and role of prophylactic therapy. Clinical Journal of Pain 29(7): 577-582
Lovati, C.; D'Amico, D.; Bertora, P. 2009: Allodynia in migraine: frequent random association or unavoidable consequence?. Expert Review of Neurotherapeutics 9(3): 395-408
Louter, M.A.; Wardenaar, K.J.; Veen, G.; van Oosterhout, W.P.J.; Zitman, F.G.; Ferrari, M.D.; Terwindt, G.M. 2014: Allodynia is associated with a higher prevalence of depression in migraine patients. Cephalalgia: An International Journal of Headache 34(14): 1187-1192
Cady, R.K.; Freitag, F.G.; Mathew, N.T.; Elkind, A.H.; Mao, L.; Fisher, A.C.; Biondi, D.M.; Finlayson, G.; Greenberg, S.J.; Hulihan, J.F. 2009: Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention. Headache 49(3): 350-363
Buonocore, M.; Gatti, A.M.; Amato, G.; Aloisi, A.M.; Bonezzi, C. 2012: Allodynic skin in post-herpetic neuralgia: histological correlates. Journal of Cellular Physiology 227(3): 934-938
Hoza, P.; Pilný, J.; Kubeš, J. 2013: Allofit cementless acetabular component: five-year experience. Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca 80(2): 148-154
Zhang, Y.; Chee, A.; Shi, P.; Wang, R.; Moss, I.; Chen, E.-Y.; He, T.-C.; An, H.S. 2015: Allogeneic Articular Chondrocyte Transplantation Downregulates Interleukin 8 Gene Expression in the Degenerating Rabbit Intervertebral Disk in Vivo. American Journal of Physical Medicine and Rehabilitation 94(7): 530-538
Socié, G.ér. 2013: Allogeneic BM transplantation for the treatment of aplastic anemia: current results and expanding donor possibilities. HEMATOLOGY. American Society of Hematology. Education Program 2013: 82-86
Todo, S.; Fujiwara, F.; Ikushima, S.; Yoshihara, T.; Kataoka, Y.; Sakurai-Shimada, Y.; Sakata, K.; Kasubuchi, Y.; Morioka, Y.; Imashuku, S. 1990: Allogeneic Bone Marrow Transplantation for Familial Erythrophagocytic Lymphohistiocytosis, with High Dose VP16-Containing Conditioning Regimen. Leukemia and Lymphoma 1(5-6): 361-364
Har-Noy, M.; Zeira, M.; Weiss, L.; Fingerut, E.; Or, R.; Slavin, S. 2009: Allogeneic CD3/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia/lymphoma. Leukemia Research 33(4): 525-538
Hasegawa, H.; Yamashita, K.; Otubo, D.; Fujii, S.-I.; Kamigaki, T.; Kuroda, D.; Kakeji, Y. 2014: Allogeneic DCG promote lung NK cell activation and antitumor effect after invariant NKT cell activation. Anticancer Research 34(7): 3411-3417
Li, B.; Simmons, A.; Du, T.; Lin, C.; Moskalenko, M.; Gonzalez-Edick, M.; VanRoey, M.; Jooss, K. 2009: Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies. Clinical Immunology 133(2): 184-197
Falkenburg, W.J.J.; Melenhorst, J.Joseph.; van de Meent, M.; Kester, M.G.D.; Hombrink, P.; Heemskerk, M.H.M.; Hagedoorn, R.S.; Gostick, E.; Price, D.A.; Falkenburg, J.H.Frederik.; Barrett, A.John.; Jedema, I. 2011: Allogeneic HLA-A*02-restricted WT1-specific T cells from mismatched donors are highly reactive but show off-target promiscuity. Journal of Immunology 187(5): 2824-2833
Abboud, C. 2012: Allogeneic HSCT for ATL: a good start. Blood 120(8): 1541-1542
Kobayashi, A.; Hara, H.; Ohashi, M.; Nishimoto, T.; Yoshida, K.; Ohkohchi, N.; Yoshida, T.; Aoki, K. 2007: Allogeneic MHC gene transfer enhances an effective antitumor immunity in the early period of autologous hematopoietic stem cell transplantation. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 13(24): 7469-7479
Bregni, M.; Ciceri, F.; Peccatori, J. 2011: Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC). Journal of Cancer 2: 347-349
Sun, Y.; Tawara, I.; Zhao, M.; Qin, Z.S.; Toubai, T.; Mathewson, N.; Tamaki, H.; Nieves, E.; Chinnaiyan, A.M.; Reddy, P. 2013: Allogeneic T cell responses are regulated by a specific miRNA-mRNA network. Journal of Clinical Investigation 123(11): 4739-4754
Müller, A.M.S.; Linderman, J.A.; Florek, M.; Miklos, D.; Shizuru, J.A. 2010: Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation. Proceedings of the National Academy of Sciences of the United States of America 107(33): 14721-14726
Saudemont, A.; Madrigal, J.A. 2014: Allogeneic T cells: maestro in the co-ordination of the immune response after hematopoietic stem cell transplantation. Haematologica 99(2): 203-205
Adeegbe, D.; Levy, R.B.; Malek, T.R. 2010: Allogeneic T regulatory cell-mediated transplantation tolerance in adoptive therapy depends on dominant peripheral suppression and central tolerance. Blood 115(10): 1932-1940
Haque, T.; McAulay, K.A.; Kelly, D.; Crawford, D.H. 2010: Allogeneic T-cell therapy for Epstein-Barr virus-positive posttransplant lymphoproliferative disease: long-term follow-up. Transplantation 90(1): 93-94
Rigol, M.; Solanes, N.úr.; Roura, S.; Roqué, M.è; Novensà, L.; Dantas, A.P.; Martorell, J.; Sitges, M.; Ramírez, J.é; Bayés-Genís, A.; Heras, M. 2014: Allogeneic adipose stem cell therapy in acute myocardial infarction. European Journal of Clinical Investigation 44(1): 83-92
Ricco, S.; Renzi, S.; Del Bue, M.; Conti, V.; Merli, E.; Ramoni, R.; Lucarelli, E.; Gnudi, G.; Ferrari, M.; Grolli, S. 2013: Allogeneic adipose tissue-derived mesenchymal stem cells in combination with platelet rich plasma are safe and effective in the therapy of superficial digital flexor tendonitis in the horse. International Journal of Immunopathology and Pharmacology 26(1 Suppl): 61-68
Ren, M.-l.; Peng, W.; Yang, Z.-l.; Sun, X.-j.; Zhang, S.-c.; Wang, Z.-g.; Zhang, B. 2012: Allogeneic adipose-derived stem cells with low immunogenicity constructing tissue-engineered bone for repairing bone defects in pigs. Cell Transplantation 21(12): 2711-2721
Ishikane, S.; Yamahara, K.; Sada, M.; Harada, K.; Kodama, M.; Ishibashi-Ueda, H.; Hayakawa, K.; Mishima, K.; Iwasaki, K.; Fujiwara, M.; Kangawa, K.; Ikeda, T. 2010: Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats. Journal of Molecular and Cellular Cardiology 49(5): 753-761
Marcus, A.; Eshhar, Z. 2011: Allogeneic adoptive cell transfer therapy as a potent universal treatment for cancer. Oncotarget 2(7): 525-526
Etem, M.E.; Laird-Fryer, B.; Holub, M.P.; Hedl, J.J.; Symington, D.B.; Figueroa, D. 2010: Allogeneic adsorptions: a comparison of the traditional method with a modified PEG adsorption method. Immunohematology 26(3): 104-108
Kimura, M.; Toyoda, M.; Gojo, S.; Itakura, Y.; Kami, D.; Miyoshi, S.; Kyo, S.; Ono, M.; Umezawa, A. 2012: Allogeneic amniotic membrane-derived mesenchymal stromal cell transplantation in a porcine model of chronic myocardial ischemia. Journal of Stem Cells and Regenerative Medicine 8(3): 171-180
Planka, L.; Gal, P.; Kecova, H.; Klima, J.; Hlucilova, J.; Filova, E.; Amler, E.; Krupa, P.; Kren, L.; Srnec, R.; Urbanova, L.; Lorenzova, J.; Necas, A. 2008: Allogeneic and autogenous transplantations of MSCs in treatment of the physeal bone bridge in rabbits. Bmc Biotechnology 8: 70
Deeg, H.J. 1988: Allogeneic and autologous bone-marrow transplantation. Canadian Family Physician Medecin de Famille Canadien 34: 2489-2498
Kido, A.; Amano, I.; Honoki, K.; Tanaka, H.; Morii, T.; Fujii, H.; Yoshitani, K.; Tanaka, Y. 2010: Allogeneic and autologous stem cell transplantation in advanced small round cell sarcomas. Journal of Orthopaedic Science: Official Journal of the Japanese Orthopaedic Association 15(5): 690-695
Müller, T.; Schlahsa, L.; Zhang, H.J.; Skaik, Y.; Eiz-Vesper, B.; Immenschuh, S.; Blasczyk, R.; Figueiredo, C. 2014: Allogeneic and xenogeneic anti-tumor effect of callithrix jacchus natural killer cells is dependent on NKp30 and B7-H6 interaction. Journal of Biological Regulators and Homeostatic Agents 28(2): 183-193
Lin, C.-S.; Lin, G.; Lue, T.F. 2012: Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells and Development 21(15): 2770-2778
Da Costa, T.ís.B.; Sardinha, L.R.; Larocca, R.; Peron, J.P.S.; Rizzo, L.V. 2011: Allogeneic apoptotic thymocyte-stimulated dendritic cells expand functional regulatory T cells. Immunology 133(1): 123-132
Tolar, J.; Wagner, J.E. 2013: Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix. Lancet 382(9899): 1214-1223
Ehninger, G.; Bornhäuser, M. 2009: Allogeneic blood stem cell transplantation. European Journal of Cancer 45(Suppl 1): 412-413
Vamvakas, E.C. 2014: Allogeneic blood transfusion and cancer recurrence: 20 years later. Transfusion 54(9): 2149-2153
Pedersen, A.B.; Mehnert, F.; Overgaard, S.; Johnsen, S.P. 2009: Allogeneic blood transfusion and prognosis following total hip replacement: a population-based follow up study. Bmc Musculoskeletal Disorders 10: 167
Atay, E.F.; Güven, M.; Altıntaş, F.; Kadıoğlu, B.ış; Ceviz, E.; Ipek, S. 2010: Allogeneic blood transfusion decreases with postoperative autotransfusion in hip and knee arthroplasty. Acta Orthopaedica et Traumatologica Turcica 44(4): 306-312
Müller, S.A.; Mehrabi, A.; Rahbari, N.N.; Warschkow, R.; Elbers, H.; Leowardi, C.; Fonouni, H.; Tarantino, I.; Schemmer, P.; Schmied, B.M.; Büchler, M.W. 2014: Allogeneic blood transfusion does not affect outcome after curative resection for advanced cholangiocarcinoma. Annals of Surgical Oncology 21(1): 155-164
Basora, M.; Pereira, A.; Soriano, A.; Martínez-Pastor, J.C.; Sánchez-Etayo, G.; Tió, M.; Salazar, F. 2010: Allogeneic blood transfusion does not increase the risk of wound infection in total knee arthroplasty. Vox Sanguinis 98(2): 124-129
Lim, M.C.; Kim, J.-Y.; Kim, T.-H.; Park, S.; Kong, S.-Y.; Yoon, J.-H.; Kang, S.; Seo, S.-S.; Park, S.Y. 2008: Allogeneic blood transfusion given before radiotherapy is associated with the poor clinical outcome in patients with cervical cancer. Yonsei Medical Journal 49(6): 993-1003
Zdravkovic, D.; Bilanovic, D.; Randjelovic, T.; Granic, M.; Djukanovic, B.; Ivanovic, N.; Dikic, S.; Nikolic, D.; Zdravkovic, M.; Soldatovic, I. 2011: Allogeneic blood transfusion in patients in Dukes B stage of colorectal cancer. Medical Oncology 28(1): 170-174
Rashiq, S.; Jamieson-Lega, K.; Komarinski, C.; Nahirniak, S.; Zinyk, L.; Finegan, B. 2010: Allogeneic blood transfusion reduction by risk-based protocol in total joint arthroplasty. Canadian Journal of Anaesthesia 57(4): 343-349
Ranucci, M. 2007: Allogeneic blood transfusions and infections after cardiac surgery. American Heart Journal 153(5): E21; Author Reply E23
Friedman, R.; Homering, M.; Holberg, G.; Berkowitz, S.D. 2014: Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. Journal of Bone and Joint Surgery. American Volume 96(4): 272-278
Tang, H.-C.; Wang, Z.-H.; Xiang, M. 2008: Allogeneic bone graft for the treatment of children's bone cyst. Zhongguo Gu Shang 21(12): 928-929
Luo, J.Z.Q.; Xiong, F.; Al-Homsi, A.S.; Ricordi, C.; Luo, L. 2013: Allogeneic bone marrow cocultured with human islets significantly improves islet survival and function in vivo. Transplantation 95(6): 801-809
Fricke, S.; Rothe, K.; Hilger, N.; Ackermann, M.; Oelkrug, C.; Fricke, C.; Schönfelder, U.; Niederwieser, D.; Emmrich, F.; Sack, U. 2012: Allogeneic bone marrow grafts with high levels of CD4(+) CD25(+) FoxP3(+) T cells can lead to engraftment failure. Cytometry. Part A: the Journal of the International Society for Analytical Cytology 81(6): 476-488
Du, J.; Shan, Z.; Ma, P.; Wang, S.; Fan, Z. 2014: Allogeneic bone marrow mesenchymal stem cell transplantation for periodontal regeneration. Journal of Dental Research 93(2): 183-188
Wang, L.; Han, Q.; Chen, H.; Wang, K.; Shan, G.-l.; Kong, F.; Yang, Y.-j.; Li, Y.-z.; Zhang, X.; Dong, F.; Wang, Q.; Xu, D.; Hu, Z.-j.; Wang, S.-h.; Keating, A.; Bi, Y.-l.; Zhang, F.-c.; Zhao, R.C.-h. 2014: Allogeneic bone marrow mesenchymal stem cell transplantation in patients with UDCA-resistant primary biliary cirrhosis. Stem Cells and Development 23(20): 2482-2489
Otero, L.; Zurita, M.; Bonilla, C.; Aguayo, C.ón.; Rico, M.A.; Rodríguez, A.; Vaquero, J.ús. 2012: Allogeneic bone marrow stromal cell transplantation after cerebral hemorrhage achieves cell transdifferentiation and modulates endogenous neurogenesis. CytoTherapy 14(1): 34-44
Luo, L.; Badiavas, E.; Luo, J.Z.; Maizel, A. 2007: Allogeneic bone marrow supports human islet beta cell survival and function over six months. Biochemical and Biophysical Research Communications 361(4): 859-864
Cargo, C.A.; Yates, E.; Marley, C.; Piggott, S.; McMullin, M.F.; Jones, F.G.C. 2008: Allogeneic bone marrow transplant in Belfast--an outcome overview of the first 25 years. Ulster Medical Journal 77(3): 185-190
Yamada, Y.; Ito, K.; Watanabe, Y.; Nosaka, K.; Horikawa, K.; Hidaka, M.; Kawano, F.; Sasaki, Y.; Mitsuya, H.; Asou, N. 2008: Allogeneic bone marrow transplantation after L-asparaginase-induced pancreatitis in a patient with acute lymphoblastic leukemia. Leukemia Research 32(12): 1944-1946
Hoshino, A.; Shimizu, M.; Matsukura, H.; Sakaki-Nakatsubo, H.; Nomura, K.; Miyawaki, T.; Kanegane, H. 2014: Allogeneic bone marrow transplantation appears to ameliorate IgA nephropathy in a patient with X-linked thrombocytopenia. Journal of Clinical Immunology 34(1): 53-57
Ishiguro, K.; Hayashi, T.; Aoki, Y.; Maruyama, Y.; Ikeda, H.; Ishida, T.; Shinomura, Y. 2014: Allogeneic bone marrow transplantation in a patient with primary hepatic diffuse large B-cell lymphoma that relapsed after autologous stem cell transplantation. Nihon Shokakibyo Gakkai Zasshi 111(9): 1798-1804
Van Wijmeersch, B.; Sprangers, B.; Rutgeerts, O.; Lenaerts, C.; Landuyt, W.; Waer, M.; Billiau, A.D.; Dubois, B.én.éd. 2007: Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: evidence for a graft-versus-autoimmunity effect. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 13(6): 627-637
Eggenhofer, E.; Popp, F.C.; Renner, P.; Slowik, P.; Neuwinger, A.; Piso, P.; Geissler, E.K.; Schlitt, H.J.; Dahlke, M.H. 2008: Allogeneic bone marrow transplantation restores liver function in Fah-knockout mice. Experimental Hematology 36(11): 1507-1513
Markiewicz, M.ła.; Giebel, S.; Wyleioł, I.; Tomaszewska, R.; Miszczyk, L.; Gawlicka, G.; Wojnar, J.; Holowiecki, J. 2006: Allogeneic bone marrow transplantation with total body irradiation-based conditioning in acute lymphoblastic leukemia patient with Cochlear implant. Annals of Transplantation 11(2): 21-22; Discussion: 32-43
Auberger, J.; Clausen, J.; Kircher, B.; Kropshofer, G.; Lindner, B.; Nachbaur, D. 2011: Allogeneic bone marrow vs. peripheral blood stem cell transplantation: a long-term retrospective single-center analysis in 329 patients. European Journal of Haematology 87(6): 531-538
Jin, G.; Qiu, G.; Wu, D.; Hu, Y.; Qiao, P.; Fan, C.; Gao, F. 2013: Allogeneic bone marrow-derived mesenchymal stem cells attenuate hepatic ischemia-reperfusion injury by suppressing oxidative stress and inhibiting apoptosis in rats. International Journal of Molecular Medicine 31(6): 1395-1401
Waasdorp, J.; Reynolds, M.A. 2010: Allogeneic bone onlay grafts for alveolar ridge augmentation: a systematic review. International Journal of Oral and Maxillofacial Implants 25(3): 525-531
Wang, W.; Wang, Y.; Bi, W.; Yang, J.; Han, G.; Ia, J.; Xu, M.; Liu, G. 2014: Allogeneic bone transplantation for pelvic reconstruction of large skeletal defects after tumor resection. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 28(3): 331-334
Simaria, A.S.; Hassan, S.; Varadaraju, H.; Rowley, J.; Warren, K.; Vanek, P.; Farid, S.S. 2014: Allogeneic cell therapy bioprocess economics and optimization: single-use cell expansion technologies. Biotechnology and Bioengineering 111(1): 69-83
Hamaguchi, M.; Eto, M.; Kamiryo, Y.; Takeuchi, A.; Harano, M.; Tatsugami, K.; Teshima, T.; Harada, M.; Yoshikai, Y.; Naito, S. 2009: Allogeneic cell therapy from immunized donors with tumor antigen peptide enhances the antitumor effect after cyclophosphamide-using non-myeloablative allogeneic hematopoietic cell transplantation. Cancer Science 100(1): 138-143
Long, Y.; Sun, Q.; Wu, J.; Wang, Y.; Jiao, S. 2014: Allogeneic cell-based immunotherapy combined with chemotherapy and targeted therapy in advanced pancreatic cancer with metastases: A case report. Oncology Letters 7(5): 1594-1598
Gaziev, J.; Lucarelli, G. 2010: Allogeneic cellular gene therapy for hemoglobinopathies. Hematology/Oncology Clinics of North America 24(6): 1145-1163
Marcus, A.; Eshhar, Z. 2014: Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer. Expert Opinion on Biological Therapy 14(7): 947-954
Qiao, S.; Ren, H.; Shi, Y.; Liu, W. 2014: Allogeneic compact bone-derived mesenchymal stem cell transplantation increases survival of mice exposed to lethal total body irradiation: a potential immunological mechanism. Chinese Medical Journal 127(3): 475-482
Tang, Y.-m.; Song, H.; Yang, S.-l. 2007: Allogeneic cord blood hematopoietic stem cell transplantation in two cases of children with leukemia. Zhejiang da Xue Xue Bao. Yi Xue Ban 36(6): 626-628
Bianchi, M.; Landini, A.; Giannatonio, C.; Papacci, P.; d'Onofrio, G.; Zini, G. 2012: Allogeneic cord blood red cells for transfusion. Transfusion Medicine Reviews 26(1): 90
Labussiere, H.; Peffault de Latour, R.; Bay, J.-O. 2010: Allogeneic cord blood transplantation for adults: current results and future development. Bulletin du Cancer 97(1): 137-148
Diaz, M.A.; Gonzalez-Vicent, M.; Ramirez, M.; Sevilla, J.; Lassaletta, A.; Perez, A.; Madero, L. 2009: Allogeneic cord blood transplantation in children with hematological malignancies: a long-term follow-up single-center study. Pediatric Hematology and Oncology 26(4): 165-174
Shaikh, F.; Naithani, R.; Kirby-Allen, M.; Doyle, J. 2012: Allogeneic cord hematopoietic stem cell transplantation in an infant with primary myelofibrosis. Journal of Pediatric Hematology/Oncology 34(5): E199-E201
Yan, F.; Lu, Y.; Yin, J.; Jiang, F.; Huang, Z.-P. 2014: Allogeneic corneoscleral limbus tissue transplantation for treatment of the necrosis in porphyria eye disease. International Journal of Ophthalmology 7(4): 731-733
Xu, W.; Yang, S.; Li, B.; Yang, C.; Ye, S.; Tang, X.; Ye, Z. 2009: Allogeneic cortical bone cage support combining with autologous cancellous bone grafting for managing femoral head necrosis. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 23(5): 527-529
You, J.; Wang, C.-l.; Hao, X.-s. 2007: Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity. Zhonghua Yi Xue Za Zhi 87(39): 2785-2790
Dong, Q.-Y.; Chen, L.; Gao, G.-Q.; Wang, L.; Song, J.; Chen, B.; Xu, Y.-X.; Sun, L. 2008: Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 31(6): E328-E337
Pfistershammer, K.; Lawitschka, A.; Klauser, C.; Leitner, J.; Weigl, R.; Heemskerk, M.H.M.; Pickl, W.F.; Majdic, O.; Böhmig, G.A.; Fischer, G.F.; Greinix, H.T.; Steinberger, P. 2009: Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients. Blood 114(11): 2323-2332
Janikashvili, N.; LaCasse, C.J.; Larmonier, C.; Trad, M.; Herrell, A.; Bustamante, S.; Bonnotte, B.; Har-Noy, M.; Larmonier, N.; Katsanis, E. 2011: Allogeneic effector/memory Th-1 cells impair FoxP3+ regulatory T lymphocytes and synergize with chaperone-rich cell lysate vaccine to treat leukemia. Blood 117(5): 1555-1564
Murphy, M.P.; Wang, H.; Patel, A.N.; Kambhampati, S.; Angle, N.; Chan, K.; Marleau, A.M.; Pyszniak, A.; Carrier, E.; Ichim, T.E.; Riordan, N.H. 2008: Allogeneic endometrial regenerative cells: an "Off the shelf solution" for critical limb ischemia?. Journal of Translational Medicine 6: 45
Trentman, T.L.; Hoxworth, J.M.; Kusne, S.; Torloni, A.S.; Patel, N.P.; Rosenfeld, D.M. 2009: Allogeneic epidural blood patch in the setting of persistent spinal headache and disseminated coccidioidomycosis. Pain Physician 12(3): 639-643
Zhang, G.-Y.; Li, Q.-F.; Cai, J.-L.; Cao, Y.-L.; Fu, X.-B. 2013: Allogeneic fibroblasts and keratinocytes for venous leg ulcers. Lancet 381(9864): 372
Laheru, D.; Lutz, E.; Burke, J.; Biedrzycki, B.; Solt, S.; Onners, B.; Tartakovsky, I.; Nemunaitis, J.; Le, D.; Sugar, E.; Hege, K.; Jaffee, E. 2008: Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: a pilot study of safety, feasibility, and immune activation. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14(5): 1455-1463
Kircik, L.H.; Dickerson, J.E.; Kitten, C.; Weedon, K.A.; Slade, H.B. 2013: Allogeneic growth arrested keratinocytes and fibroblasts delivered in a fibrin spray accelerate healing in Mohs micrographic surgery wounds. Journal of Drugs in Dermatology: Jdd 12(5): 558-561
Shustov, A.R.; Gooley, T.A.; Sandmaier, B.M.; Shizuru, J.; Sorror, M.L.; Sahebi, F.; McSweeney, P.; Niederwieser, D.; Bruno, B.; Storb, R.; Maloney, D.G. 2010: Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas. British Journal of Haematology 150(2): 170-178
Samuelson, S.; Sandmaier, B.M.; Heslop, H.E.; Popat, U.; Carrum, G.; Champlin, R.E.; Storb, R.; Prchal, J.T.; Gooley, T.A.; Deeg, H.Joachim. 2011: Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60-78 years of age. British journal of haematology 153(1): 76-82
Masmas, T.N.; Kornblit, B.; Sengeløv, H.; Madsen, H.O.; Jakobsen, B.K.; Olesen, G.; Vindeløv, L.L. 2010: Allogeneic haematopoietic cell transplantation with nonmyeloablative conditioning in Denmark. Danish Medical Bulletin 57(5): A4146
Aoki, K.; Ishikawa, T.; Ishiyama, K.; Aoki, J.; Itonaga, H.; Fukuda, T.; Kakihana, K.; Uchida, N.; Ueda, Y.; Eto, T.; Mori, T.; Kondo, T.; Iwato, K.; Morishima, Y.; Tanaka, J.; Atsuta, Y.; Miyazaki, Y. 2015: Allogeneic haematopoietic cell transplantation with reduced-intensity conditioning for elderly patients with advanced myelodysplastic syndromes: a nationwide study. British Journal of Haematology 168(3): 463-466
Li, M.; Gao, C.; Li, H.; Wang, Z.; Cao, Y.; Huang, W.; Li, X.; Wang, S.; Yu, L.; Da, W. 2011: Allogeneic haematopoietic stem cell transplantation as a salvage strategy for relapsed or refractory nasal NK/T-cell lymphoma. Medical Oncology 28(3): 840-845
Goździk, J.; Pituch-Noworolska, A.; Skoczeń, S.; Czogała, W.; Wędrychowicz, A.; Baran, J.ła.; Krasowska-Kwiecień, A.; Wiecha, O.; Zembala, M. 2011: Allogeneic haematopoietic stem cell transplantation as therapy for chronic granulomatous disease--single centre experience. Journal of Clinical Immunology 31(3): 332-337
Kato, M.; Hasegawa, D.; Koh, K.; Kato, K.; Takita, J.; Inagaki, J.; Yabe, H.; Goto, H.; Adachi, S.; Hayakawa, A.; Takeshita, Y.; Sawada, A.; Atsuta, Y.; Kato, K. 2015: Allogeneic haematopoietic stem cell transplantation for infant acute lymphoblastic leukaemia with KMT2A (MLL) rearrangements: a retrospective study from the paediatric acute lymphoblastic leukaemia working group of the Japan Society for Haematopoietic Cell Transplantation. British journal of haematology 168(4): 564-570
Robin, M.; Tabrizi, R.; Mohty, M.; Furst, S.; Michallet, M.; Bay, J-Olivier.; Cahn, J-Yves.; De Coninck, E.; Dhedin, N.; Bernard, M.; Rio, B.; Buzyn, Aès.; Huynh, A.; Bilger, K.; Bordigoni, P.; Contentin, N.; Porcher, Rël.; Socié, Gérard.; Milpied, N. 2011: Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). British Journal of Haematology 152(3): 331-339
Terras, S.; Moritz, R.K.C.; Ditschkowski, M.; Beelen, D.W.; Altmeyer, P.; Stücker, M.; Kreuter, A. 2013: Allogeneic haematopoietic stem cell transplantation in a patient with cutaneous γ/δ-T-cell lymphoma. Acta Dermato-Venereologica 93(3): 360-361
Bart-Smith, E.; Mufti, G.J. 2014: Allogeneic haematopoietic stem cell transplantation in myelodysplastic syndromes. Current Opinion in Oncology 26(6): 642-649
Hütter, G.; Zaia, J.A. 2011: Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years. Clinical and Experimental Immunology 163(3): 284-295
Hwang, W.Y.K.; Ong, S.Y. 2009: Allogeneic haematopoietic stem cell transplantation without a matched sibling donor: current options and future potential. Annals of the Academy of Medicine Singapore 38(4): 340-346
Nair, V.; Sharma, A.; Das, S.; Sharma, S.; Grover, N.; Kaur, J. 2013: Allogeneic haematopoietic stem cell transplantation: the Army hospital experience. National Medical Journal of India 26(1): 6-11
Hough, R.; Cooper, N.; Veys, P. 2009: Allogeneic haemopoietic stem cell transplantation in children: what alternative donor should we choose when no matched sibling is available?. British Journal of Haematology 147(5): 593-613
Ren, X.-P.; Song, Y.; Ye, Y.-J.; Li, P.-W.; Han, K.-C.; Shen, Z.-L.; Shan, J.-G.; Luther, K.; Yang, B.-F. 2014: Allogeneic head and body reconstruction: mouse model. Cns Neuroscience and Therapeutics 20(12): 1056-1060
Brockbank, K.G.M.; Wright, G.J.; Yao, H.; Greene, E.D.; Chen, Z.Z.; Schenke-Layland, K. 2011: Allogeneic heart valve storage above the glass transition at -80°C. Annals of Thoracic Surgery 91(6): 1829-1835
Andolina, J.R.; Kletzel, M.; Tse, W.T.; Jacobsohn, D.A.; Duerst, R.E.; Schneiderman, J.; Helenowski, I.; Rademaker, A.; Chaudhury, S. 2011: Allogeneic hematopoetic stem cell transplantation in pediatric myelodysplastic syndromes: improved outcomes for de novo disease. Pediatric Transplantation 15(3): 334-343
Kanate, A.S.; Pasquini, M.C.; Hari, P.N.; Hamadani, M. 2014: Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions. World Journal of Stem Cells 6(2): 69-81
Nivison-Smith, I.; Dodds, A.J.; Doocey, R.; Ganly, P.; Gibson, J.; Ma, D.D.F.; Simpson, J.M.; Szer, J.; Bradstock, K.F. 2011: Allogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998-2006: factors associated with improved survival outcome. Leukemia and Lymphoma 52(9): 1727-1735
Zain, J.; Palmer, J.M.; Delioukina, M.; Thomas, S.; Tsai, N.-C.; Nademanee, A.; Popplewell, L.; Gaal, K.; Senitzer, D.; Kogut, N.; O'Donnell, M.; Forman, S.J. 2011: Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control. Leukemia and Lymphoma 52(8): 1463-1473
Kalaycio, M.E.; Kukreja, M.; Woolfrey, A.E.; Szer, J.; Cortes, J.; Maziarz, R.T.; Bolwell, B.J.; Buser, A.; Copelan, E.; Gale, R.P.; Gupta, V.; Maharaj, D.; Marks, D.I.; Pavletic, S.Z.; Horowitz, M.M.; Arora, M. 2010: Allogeneic hematopoietic cell transplant for prolymphocytic leukemia. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 16(4): 543-547
Delioukina, M.L.; Palmer, J.M.; Thomas, S.H.; Krishnan, A.; Stiller, T.; Forman, S.J. 2011: Allogeneic hematopoietic cell transplant with fludarabine-based reduced-intensity conditioning as treatment for advanced chronic lymphocytic leukemia. Leukemia and Lymphoma 52(4): 719-723
Burke, M.J.; Cao, Q.; Trotz, B.; Weigel, B.; Kumar, A.; Smith, A.; Verneris, M.R. 2009: Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). Pediatric Blood and Cancer 53(7): 1289-1294
Pagel, J.M.; Gooley, T.A.; Rajendran, J.; Fisher, D.R.; Wilson, W.A.; Sandmaier, B.M.; Matthews, D.C.; Deeg, H.J.; Gopal, A.K.; Martin, P.J.; Storb, R.F.; Press, O.W.; Appelbaum, F.R. 2009: Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome. Blood 114(27): 5444-5453
Storb, R.; Gyurkocza, B.; Storer, B.E.; Maloney, D.G.; Sorror, M.L.; Mielcarek, M.; Martin, P.J.; Sandmaier, B.M. 2013: Allogeneic hematopoietic cell transplantation following minimal intensity conditioning: predicting acute graft-versus-host disease and graft-versus-tumor effects. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 19(5): 792-798
Laport, G.G. 2008: Allogeneic hematopoietic cell transplantation for Hodgkin lymphoma: a concise review. Leukemia and Lymphoma 49(10): 1854-1859
Lee, J.-H.; Yoon, S.-S.; Jung, C.W.; Lee, J.-H.; Kim, D.-Y.; Lee, Y.-S.; Yun, S.C.; Kim, I.; Park, S.; Kim, B.K.; Kim, K.; Ahn, J.S.; Lee, K.-H. 2010: Allogeneic hematopoietic cell transplantation for acute leukemia in first relapse or second remission. Korean Journal of Hematology 45(2): 95-101
Khaled, S.K.; Thomas, S.H.; Forman, S.J. 2012: Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in adults. Current Opinion in Oncology 24(2): 182-190
Yanada, M. 2015: Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical perspective. International Journal of Hematology 101(3): 243-254
Paun, O.; Lazarus, H.M. 2012: Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first complete remission: have the indications changed?. Current Opinion in Hematology 19(2): 95-101
Yan, S.; Zhao, J.; Xie, D.; Huang, X.; Cheng, J.; Guo, Y.; Liu, C.; Ma, Z.; Yang, H.; Zhang, G. 2018: Attenuation, safety, and efficacy of a QX-like infectious bronchitis virus serotype vaccine. Vaccine 36(14): 1880-1886
Abou Mourad, Y.R.; Fernandez, H.F.; Kharfan-Dabaja, M.A. 2008: Allogeneic hematopoietic cell transplantation for adult Philadelphia-positive acute lymphoblastic leukemia in the era of tyrosine kinase inhibitors. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 14(9): 949-958
Pidala, J.; Djulbegovic, B.; Anasetti, C.; Kharfan-Dabaja, M.; Kumar, A. 2011: Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission. Cochrane Database of Systematic Reviews 10: Cd008818
Ram, R.; Gafter-Gvili, A.; Shpilberg, O.; Raanani, P. 2011: Allogeneic hematopoietic cell transplantation for adult patients with acute leukemia: the role of meta-analyses. Acta Haematologica 125(1-2): 39-46
Gupta, V.; Tallman, M.S.; Weisdorf, D.J. 2011: Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns. Blood 117(8): 2307-2318
Ballen, K.K.; Woolfrey, A.E.; Zhu, X.; Ahn, K.W.; Wirk, B.; Arora, M.; George, B.; Savani, B.N.; Bolwell, B.; Porter, D.L.; Copelan, E.; Hale, G.; Schouten, H.C.; Lewis, I.; Cahn, J.Y.; Halter, J.; Cortes, J.; Kalaycio, M.E.; Antin, J.; Aljurf, M.D.; Carabasi, M.H.; Hamadani, M.; McCarthy, P.; Pavletic, S.; Gupta, V.; Deeg, H.J.; Maziarz, R.T.; Horowitz, M.M.; Saber, W. 2012: Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 18(9): 1446-1454
Hamadani, M.; Saber, W.; Ahn, K.Woo.; Carreras, J.; Cairo, M.S.; Fenske, T.S.; Gale, R.Peter.; Gibson, J.; Hale, G.A.; Hari, P.N.; Hsu, J.W.; Inwards, D.J.; Kamble, R.T.; Klein, A.; Maharaj, D.; Marks, D.I.; Rizzieri, D.A.; Savani, B.N.; Schouten, H.C.; Waller, E.K.; Wirk, B.; Lazarus, H.M. 2013: Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 19(4): 625-631
Delgado, J.; Milligan, D.W.; Dreger, P. 2009: Allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: ready for prime time?. Blood 114(13): 2581-2588
Nivison-Smith, I.; Dodds, A.J.; Butler, J.; Bradstock, K.F.; Ma, D.D.F.; Simpson, J.M.; Szer, J. 2012: Allogeneic hematopoietic cell transplantation for chronic myelofibrosis in Australia and new Zealand: older recipients receiving myeloablative conditioning at increased mortality risk. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 18(2): 302-308
Eissa, H.; Gooley, T.A.; Sorror, M.L.; Nguyen, F.; Scott, B.L.; Doney, K.; Loeb, K.R.; Martin, P.J.; Pagel, J.M.; Radich, J.P.; Sandmaier, B.M.; Warren, E.H.; Storb, R.; Appelbaum, F.R.; Deeg, H.J. 2011: Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 17(6): 908-915
Brunstein, C.G.; Gutman, J.A.; Weisdorf, D.J.; Woolfrey, A.E.; Defor, T.E.; Gooley, T.A.; Verneris, M.R.; Appelbaum, F.R.; Wagner, J.E.; Delaney, C. 2010: Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood 116(22): 4693-4699
Rezvani, A.R.; Sandmaier, B.M. 2013: Allogeneic hematopoietic cell transplantation for indolent non-Hodgkin lymphoma: indications and outcomes. Current Opinion in Hematology 20(6): 509-514
Karoopongse, E.; Deeg, H.J. 2012: Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: the past decade. Expert Review of Clinical Immunology 8(4): 373-381
Mukherjee, S.; Boccaccio, D.; Sekeres, M.A.; Copelan, E. 2015: Allogeneic hematopoietic cell transplantation for myelodysplastic syndromes: lingering uncertainties and emerging possibilities. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 21(3): 412-420
Nishihori, T.; Perkins, J.; Kim, J.; Field, T.; Pidala, J.; Roman-Diaz, J.; Komrokji, R.S.; Fernandez, H.F.; Anasetti, C.; Kharfan-Dabaja, M.A. 2010: Allogeneic hematopoietic cell transplantation for myelofibrosis: a 10-year experience at single institution. American Journal of Hematology 85(11): 904-907
Duarte, R.F.; Canals, C.; Onida, F.; Gabriel, I.H.; Arranz, R.; Arcese, W.; Ferrant, A.; Kobbe, G.; Narni, F.; Deliliers, G.Lambertenghi.; Olavarría, E.; Schmitz, N.; Sureda, A. 2010: Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 28(29): 4492-4499
Zang, D.Y.; Deeg, H.J. 2009: Allogeneic hematopoietic cell transplantation for patients with myelofibrosis. Current Opinion in Hematology 16(2): 140-146
Griffith, L.M.; Cowan, M.J.; Kohn, D.B.; Notarangelo, L.D.; Puck, J.M.; Schultz, K.R.; Buckley, R.H.; Eapen, M.; Kamani, N.R.; O'Reilly, R.J.; Parkman, R.; Roifman, C.M.; Sullivan, K.E.; Filipovich, A.H.; Fleisher, T.A.; Shearer, W.T. 2008: Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs. Journal of Allergy and Clinical Immunology 122(6): 1087-1096
Strober, J.; Cowan, M.J.; Horn, B.N. 2009: Allogeneic hematopoietic cell transplantation for refractory myasthenia gravis. Archives of Neurology 66(5): 659-661
Tykodi, S.S.; Sandmaier, B.M.; Warren, E.H.; Thompson, J.A. 2011: Allogeneic hematopoietic cell transplantation for renal cell carcinoma: ten years after. Expert Opinion on Biological Therapy 11(6): 763-773
Passera, R.; Pollichieni, S.; Brunello, L.; Patriarca, F.; Bonifazi, F.; Montefusco, V.; Falda, M.; Montanari, M.; Guidi, S.; Giaccone, L.; Mordini, N.; Carella, A.M.; Bavaro, P.; Milone, G.; Benedetti, F.; Ciceri, F.; Scimè, R.; Benedetti, E.; Castagna, L.; Festuccia, M.; Rambaldi, A.; Bacigalupo, A.; Corradini, P.; Bosi, A.; Boccadoro, M.; Bandini, G.; Fanin, R.; Bruno, B. 2013: Allogeneic hematopoietic cell transplantation from unrelated donors in multiple myeloma: study from the Italian Bone Marrow Donor Registry. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 19(6): 940-948
Lim, S.-N.; Lee, J.-H.; Lee, J.-H.; Kim, D.-Y.; Kim, S.D.; Kang, Y.-A.; Lee, Y.-S.; Lee, K.-H. 2013: Allogeneic hematopoietic cell transplantation in adult patients with myelodysplastic/myeloproliferative neoplasms. Blood Research 48(3): 178-184
Harker-Murray, P.D.; Thomas, A.J.; Wagner, J.E.; Weisdorf, D.; Luo, X.; DeFor, T.E.; Verneris, M.R.; Dusenbery, K.E.; MacMillan, M.L.; Tolar, J.; Baker, K.S.; Orchard, P.J. 2008: Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 14(6): 685-692
Gupta, V.; Tomblyn, M.; Pedersen, T.L.; Atkins, H.L.; Battiwalla, M.; Gress, R.E.; Pollack, M.S.; Storek, J.; Thompson, J.C.; Tiberghien, P.; Young, J-Anne.H.; Ribaud, P.; Horowitz, M.M.; Keating, A. 2009: Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation 15(7): 864-871
Hogan, W.J.; Litzow, M.R.; Tefferi, A. 2007: Allogeneic hematopoietic cell transplantation in myelofibrosis with myeloid metaplasia. Current Hematologic Malignancy Reports 2(1): 34-42
Platzbecker, U.; Schetelig, J.; Finke, J.ür.; Trenschel, R.; Scott, B.L.; Kobbe, G.; Schaefer-Eckart, K.; Bornhäuser, M.; Itzykson, R.; Germing, U.; Beelen, D.; Ehninger, G.; Fenaux, P.; Deeg, H.J.; Adès, L. 2012: Allogeneic hematopoietic cell transplantation in patients age 60-70 years with de novo high-risk myelodysplastic syndrome or secondary acute myelogenous leukemia: comparison with patients lacking donors who received azacitidine. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 18(9): 1415-1421
Grunwald, M.R. 2013: Allogeneic hematopoietic cell transplantation in septuagenarians. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 19(9): 1276-1278
Delioukina, M.L.; Forman, S.J. 2010: Allogeneic hematopoietic cell transplantation in the treatment of chronic lymphocytic leukemia: why and when?. Mediterranean Journal of Hematology and Infectious Diseases 2(2): E2010018
Larson, R.A. 2009: Allogeneic hematopoietic cell transplantation is not recommended for all adults with standard-risk acute lymphoblastic leukemia in first complete remission. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 15(1 Suppl): 11-16
Guo, R.J.; Atenafu, E.G.; Craddock, K.; Chang, H. 2014: Allogeneic hematopoietic cell transplantation may alleviate the negative prognostic impact of monosomal and complex karyotypes on patients with acute myeloid leukemia. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 20(5): 690-695
Doney, K.; Gooley, T.A.; Deeg, H.Joachim.; Flowers, M.E.D.; Storb, R.; Appelbaum, F.R. 2011: Allogeneic hematopoietic cell transplantation with full-intensity conditioning for adult acute lymphoblastic leukemia: results from a single center, 1998-2006. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation 17(8): 1187-1195
Schneidawind, D.; Federmann, B.; Faul, C.; Vogel, W.; Kanz, L.; Bethge, W.A. 2013: Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia. Annals of Hematology 92(10): 1389-1395
Kim, H.; Lee, K.-H.; Kim, I.; Sohn, S.K.; Jung, C.W.; Joo, Y.D.; Kim, S.-H.; Kim, B.S.; Choi, J.H.; Kwak, J.-Y.; Kim, M.K.; Bae, S.H.; Shin, H.J.; Won, J.-H.; Lee, W.S.; Oh, S.; Kim, H.J.; Park, J.-H. 2014: Allogeneic hematopoietic cell transplantation without total body irradiation from unrelated donor in adult patients with idiopathic aplastic anemia: fludarabine versus cyclophosphamide-ATG. Leukemia Research 38(7): 730-736
Gyurkocza, B.; Rezvani, A.; Storb, R.F. 2010: Allogeneic hematopoietic cell transplantation: the state of the art. Expert Review of Hematology 3(3): 285-299
Giralt, S. 2007: Allogeneic hematopoietic progenitor cell transplantation for the treatment of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors: lessons learned to date. Clinical Lymphoma and Myeloma 7(Suppl 3): S102-S104
Kerbauy, F.áb.R.; Rodrigues, M.; de Souza Santos, F.áb.P.; Sobrinho, J.N.; Kutner, J.é M.; Torres, M.A.; Ribeiro, A.A.F.; de Lima, M.; Hamerschlak, N. 2011: Allogeneic hematopoietic stem cell transplant after intravenous busulfan and fludarabine conditioning. Leukemia and Lymphoma 52(2): 321-324
Yokoyama, H.; Yamamoto, J.; Tohmiya, Y.; Yamada, M.F.; Ohguchi, H.; Ohnishi, Y.; Okitsu, Y.; Fukuhara, N.; Ohba-Ohtsuka, R.; Kohata, K.; Ishizawa, K.; Kameoka, J.; Harigae, H. 2010: Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type. Leukemia and Lymphoma 51(8): 1509-1512
Kim, H.; Lee, K-Hyung.; Yoon, S-Soo.; Sohn, S.Kyun.; Joo, Y.Don.; Kim, S.Hyun.; Kim, B.Soo.; Choi, J.Hye.; Kwak, J.Youg.; Hyun, M.Soo.; Bae, S.Hwa.; Shin, H.Jin.; Won, J.Ho.; Oh, S.; Lee, W.Sik.; Park, J-Hoo.; Jung, C.Won. 2012: Allogeneic hematopoietic stem cell transplant for adults over 40 years old with acquired aplastic anemia. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 18(10): 1500-1508
Michallet, M.; Sobh, M.; Serrier, C.; Morisset, S.ép.; Labussière, H.él.èn.; Ducastelle, S.; Barraco, F.; Gilis, L.; Thomas, X.; Nicolini, F.E. 2015: Allogeneic hematopoietic stem cell transplant for hematological malignancies from mismatched 9/10 human leukocyte antigen unrelated donors: comparison with transplants from 10/10 unrelated donors and human leukocyte antigen identical siblings. Leukemia and Lymphoma 56(4): 999-1003
Ramzi, M.; Rezvani, A.; Haghighinejad, H. 2014: Allogeneic hematopoietic stem cell transplant for high-risk adult patients with chronic granulomatous disease: first case report from Iran. Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation 12(5): 490-493
Koh, L.-P.; Rizzieri, D.A.; Chao, N.J. 2007: Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 13(11): 1249-1267
Machaczka, M.; Johansson, J.-E.; Remberger, M.; Hallböök, H.; Malm, C.; Lazarevic, V.L.; Wahlin, A.; Omar, H.; Juliusson, G.; Kimby, E.; Hägglund, H. 2012: Allogeneic hematopoietic stem cell transplant with reduced-intensity conditioning for chronic lymphocytic leukemia in Sweden: does donor T-cell engraftment 3 months after transplant predict survival?. Leukemia and Lymphoma 53(9): 1699-1705
Servais, S.; Baron, F.éd.ér.; Beguin, Y. 2011: Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 44(2): 205-210
Phillips, G.L. 2012: Allogeneic hematopoietic stem cell transplantation (HSCT) for high-risk acute myeloid leukemia (AML)/myelodysplastic syndrome (MDS): how can we improve outcomes in the near future?. Leukemia Research 36(12): 1490-1495
Saussele, S.; Lauseker, M.; Gratwohl, A.; Beelen, D.W.; Bunjes, D.; Schwerdtfeger, R.; Kolb, H.-J.; Ho, A.D.; Falge, C.; Holler, E.; Schlimok, G.ün.; Zander, A.R.; Arnold, R.; Kanz, L.; Dengler, R.; Haferlach, C.; Schlegelberger, B.; Pfirrmann, M.; Müller, M.C.; Schnittger, S.; Leitner, A.; Pletsch, N.; Hochhaus, A.; Hasford, J.; Hehlmann, R.üd. 2010: Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV. Blood 115(10): 1880-1885
Motohashi, K.; Ito, S.; Hagihara, M.; Sakai, R.; Tanaka, M.; Kawano, T.; Maruta, A.; Ishigatsubo, Y.; Kanamori, H. 2009: Allogeneic hematopoietic stem cell transplantation after surgical resection of pulmonary aspergillosis in 5 patients with acute leukemia. Japanese Journal of Clinical Hematology 50(5): 430-434
Ohta, H.; Hashii, Y.; Yoshida, H.; Kusuki, S.; Tokimasa, S.; Yoneda, A.; Fukuzawa, M.; Inoue, N.; Hara, J.; Kusafuka, T.; Ozono, K. 2011: Allogeneic hematopoietic stem cell transplantation against recurrent rhabdomyosarcoma. Journal of Pediatric Hematology/Oncology 33(1): E35-E38
Garnier, A.; Robin, M.; Larosa, F.; Golmard, J-Louis.; Le Gouill, S.; Coiteux, Vérie.; Tabrizi, R.; Bulabois, C-Eric.; Cacheux, V.; Kuentz, M.; Dreyfus, B.; Dreger, P.; Rio, B.; Moles-Moreau, M-Pierre.; Bilger, K.; Bay, J-Olivier.; Leblond, Véronique.; Blaise, D.; Tournilhac, O.; Dhédin, N. 2010: Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström's macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire. Haematologica 95(6): 950-955
Roddie, C.; Paul, J.P.V.; Benjamin, R.; Gallimore, C.I.; Xerry, J.; Gray, J.J.; Peggs, K.S.; Morris, E.C.; Thomson, K.J.; Ward, K.N. 2009: Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 49(7): 1061-1068
Hsu, S-Neng.; Chen, J-Hong.; Kao, W-Yau. 2014: Allogeneic hematopoietic stem cell transplantation as the first-line treatment option in a patient with severe aplastic anemia without a matched related donor: A case report. Oncology Letters 8(4): 1831-1833
Cai, B.; Gao, C.-J.; Li, H.-H.; Bo, J.; Huang, W.-R.; Gao, L.; Sun, J.-F.; Ding, Y.; Wang, L.-L.; Yu, L. 2010: Allogeneic hematopoietic stem cell transplantation combined with imatinib for treatment of Philadelphia chromosome positive acute lymphoblastic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18(1): 173-176
Jiang, J.-L.; Yan, S.-K.; Yang, J.; Cai, Y.; Wan, L.-P.; Qin, Y.-W.; Wang, C. 2008: Allogeneic hematopoietic stem cell transplantation following reduced intensity conditioning regimen for treatment of refractory leukemia. Zhonghua Xue Ye Xue Za Zhi 29(8): 517-521
Shiratori, S.; Fujimoto, K.; Nishimura, M.; Hatanaka, K.C.; Kosugi-Kanaya, M.; Okada, K.; Sugita, J.; Shigematsu, A.; Hashimoto, D.; Endo, T.; Kondo, T.; Abe, R.; Hashino, S.; Matsuno, Y.; Shimizu, H.; Teshima, T. 2016: Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome. Hematological Oncology 34(1): 9-16
Zhai, W.-H.; Wang, M.; Zhou, Z.; Zhai, W.-J.; Zhang, R.-L.; Wang, H.; Song, A.-X.; Feng, S.-Z.; Han, M.-Z. 2007: Allogeneic hematopoietic stem cell transplantation for 16 patients with aplastic anemia. Zhonghua Xue Ye Xue Za Zhi 28(2): 78-82
Sato, E.; Ohga, S.; Kuroda, H.; Yoshiba, F.; Nishimura, M.; Nagasawa, M.; Inoue, M.; Kawa, K. 2008: Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan. American Journal of Hematology 83(9): 721-727
Fagioli, F.; Zecca, M.; Rognoni, C.; Lanino, E.; Balduzzi, A.; Berger, M.; Messina, C.; Favre, C.; Rabusin, M.; Lo Nigro, L.; Masetti, R.; Prete, A.; Locatelli, F. 2012: Allogeneic hematopoietic stem cell transplantation for Philadelphia-positive acute lymphoblastic leukemia in children and adolescents: a retrospective multicenter study of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation 18(6): 852-860
Guillaume, T.; Beguin, Y.; Tabrizi, R.; Nguyen, Séphanie.; Blaise, D.; Deconinck, E.; Redjoul, R.; Cornillon, Jérôme.; Guillerm, Gëlle.; Contentin, N.; Sirvent, A.; Turlure, P.; Salmon, A.; Huynh, A.; François, S.; Peffault de Latour, Régis.; Yakoub-Agha, I.; Mohty, M. 2015: Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC). European journal of haematology 94(3): 265-269
Permaul, P.; Narla, A.; Hornick, J.L.; Pai, S-Yun. 2009: Allogeneic hematopoietic stem cell transplantation for X-linked ectodermal dysplasia and immunodeficiency: case report and review of outcomes. Immunologic Research 44(1-3): 89-98
Yu, G.-P.; Jiang, Q.-L.; Fan, Z.-P.; Zhao, J.; Wei, Q.; Sun, J.; Meng, F.-Y.; Liu, Q.-F. 2011: Allogeneic hematopoietic stem cell transplantation for acute leukemia with Gilbert's syndrome. Journal of Hematology and Oncology 4: 9
Zhang, Y.; Chen, Y.-k.; Liu, Q.-f.; Fan, Z.-p.; Jiang, Q.-l.; Zhao, J.; Wei, Q.; Li, X.-f.; Yu, G.-p.; Sun, J.; Chai, Y.-y. 2011: Allogeneic hematopoietic stem cell transplantation for acute leukemias of ambiguous lineage in adults: a comparison between the conditioning of different intensities. Zhonghua Yi Xue Za Zhi 91(20): 1379-1383
Bondarenko, S.N.; Semenova, E.V.; Vavilov, V.N.; Stancheva, N.V.; Morozova, E.V.; Alianskiĭ, A.L.; Babenko, E.V.; Osipova, N.É; Zubarovskaia, L.S.; Afanas'ev, B.V. 2013: Allogeneic hematopoietic stem cell transplantation for acute myeloblastic leukemia in first remission. Terapevticheskii Arkhiv 85(7): 18-25
Okamoto, S. 2009: Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia--recent progress. Nihon Rinsho. Japanese Journal of Clinical Medicine 67(10): 1944-1950
Weisdorf, D.; Forman, S. 2009: Allogeneic hematopoietic stem cell transplantation for adult acute lymphoblastic leukemia. Cancer Treatment and Research 144: 441-454
Terwey, T.H.; Kim, T.D.; Arnold, R. 2009: Allogeneic hematopoietic stem cell transplantation for adult acute lymphocytic leukemia. Current Hematologic Malignancy Reports 4(3): 139-147
Ennishi, D.; Maeda, Y.; Fujii, N.; Kondo, E.; Shinagawa, K.; Ikeda, K.; Ichimura, K.; Yoshino, T.; Tanimoto, M. 2011: Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type. Leukemia and Lymphoma 52(7): 1255-1261
Lu, Y.; Sun, Z.; Liu, H.; Geng, L.; Tong, J.; Tang, B.; Zheng, C.; Yao, W.; Song, K. 2014: Allogeneic hematopoietic stem cell transplantation for aggressive-phase chronic myeloid leukemia -- outcomes of unrelated umbilical cord blood and sibling donor. Zhonghua Xue Ye Xue Za Zhi 35(3): 253-255
Chun, C.; Fang, J.-p.; Xue, H.-m.; Zhou, D.-h.; Huang, K.; Xu, H.-g.; Huang, S.-l. 2011: Allogeneic hematopoietic stem cell transplantation for childhood aplastic anemia: prospective trial in China. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 44(1): 41-47
Hutspardol, S.; Sirachainan, N.; Anurathapan, U.; Pakakasama, S.; Songdej, D.; Chuansumrit, A.; Sirireung, S.; Panthangkool, W.; Hongeng, S. 2013: Allogeneic hematopoietic stem cell transplantation for children with severe aplastic anemia. Journal of the Medical Association of Thailand 96(Suppl 1): S18-S24
Shao, Q.; Wang, Z.-D.; Zheng, X.-L.; Dong, L.; Han, D.-M.; Yan, H.-M.; Wang, H.-X.; Duan, L.-N. 2014: Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 22(4): 1058-1062
Sun, Y-qian.; Xu, L-ping.; Liu, D-hong.; Zhang, X-hui.; Han, W.; Chen, H.; Wang, F-rong.; Wang, J-zhi.; Wang, Y.; Chen, Y-hong.; Liu, K-yan.; Huang, X-jun. 2013: Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: a report of 12 patients. Zhonghua Xue Ye Xue Za Zhi 34(2): 113-116
Sun, R.; Xiao, J.; Zhang, J.; Lu, Y.; Wei, Z.; Zhu, H.; Sun, Y. 2014: Allogeneic hematopoietic stem cell transplantation for hemophagocytic syndrome. Zhonghua Er Ke Za Zhi 52(2): 94-98
Wang, Y.; Liu, K.-y.; Xu, L.-p.; Liu, D.-h.; Chen, H.; Han, W.; Chen, Y.-h.; Shi, H.-x.; Zhang, Y.-c.; Wang, J.-z.; Zhang, X.-u.; Chen, Y.; Huang, X.-j.; Lu, D.-p. 2007: Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia. Zhonghua Nei Ke Za Zhi 46(11): 903-906
Hussein, A.A.; Hamadah, T.; Domm, J.; Al-Zaben, A.; Frangoul, H. 2013: Allogeneic hematopoietic stem cell transplantation for infants with idiopathic myelofibrosis. Pediatric Transplantation 17(8): 815-819
Chevallier, P.; Labopin, M.; Cornelissen, J.; Socié, Gérard.; Rocha, V.; Mohty, M. 2011: Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation. Haematologica 96(9): 1391-1394
Koehne, G.; Giralt, S. 2012: Allogeneic hematopoietic stem cell transplantation for multiple myeloma: curative but not the standard of care. Current Opinion in Oncology 24(6): 720-726
Giralt, S.; Koehne, G. 2013: Allogeneic hematopoietic stem cell transplantation for multiple myeloma: what place, if any?. Current Hematologic Malignancy Reports 8(4): 284-290
Oran, B.; Popat, U.; Andersson, B.; Champlin, R. 2013: Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes. Clinical Lymphoma Myeloma and Leukemia 13(Suppl 2): S282-S288
Rondelli, D. 2008: Allogeneic hematopoietic stem cell transplantation for myelofibrosis. Haematologica 93(10): 1449-1450
Greco, R.; Bondanza, A.; Vago, L.; Moiola, L.; Rossi, P.; Furlan, R.; Martino, G.; Radaelli, M.; Martinelli, V.; Carbone, M.R.; Lupo Stanghellini, M.T.; Assanelli, A.; Bernardi, M.; Corti, C.; Peccatori, J.; Bonini, C.; Vezzulli, P.; Falini, A.; Ciceri, F.; Comi, G. 2014: Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. Annals of Neurology 75(3): 447-453
Wang, X-Jing.; Chen, L.; Sai, Y. 2011: Allogeneic hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria-aplastic anemia syndrome: a case report. Zhonghua Xue Ye Xue Za Zhi 32(8): 563
Chen, Y.; Xu, Y.; Fu, G.; Liu, Y.; Peng, J.; Fu, B.; Yuan, X.; Xin, H.; Zhu, Y.; He, Q.; Wu, D.; Shu, Y.; Li, X.; Zhao, X.; Chen, F. 2013: Allogeneic hematopoietic stem cell transplantation for patients with acute leukemia. Chinese Journal of Cancer Research 25(4): 389-396
Kobos, R.; Steinherz, P.G.; Kernan, N.A.; Prockop, S.E.; Scaradavou, A.; Small, T.N.; Shukla, N.; Khalaf, R.; O'Reilly, R.J.; Boulad, F. 2012: Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 18(3): 473-480
Hamadani, M.; Awan, F.T.; Elder, P.; Lin, T.S.; Porcu, P.; Blum, K.A.; Devine, S.M. 2008: Allogeneic hematopoietic stem cell transplantation for peripheral T cell lymphomas; evidence of graft-versus-T cell lymphoma effect. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 14(4): 480-483
Gratwohl, A. 2008: Allogeneic hematopoietic stem cell transplantation for severe autoimmune diseases. Autoimmunity 41(8): 673-678
Pan, J.; Geng, Z.; Jiang, H. 2013: Allogeneic hematopoietic stem cell transplantation for the treatment of Niemann-Pick disease type A: a case report. Zhongguo Dang Dai Er Ke Za Zhi 15(9): 782-784
Xu, L.-p.; Huang, X.-j. 2013: Allogeneic hematopoietic stem cell transplantation for the treatment of chronic myeloid leukemia in the era of tyrosine kinase inhibitors. Chinese Medical Journal 126(4): 768-774
Oran, B.; Giralt, S.; Saliba, R.; Hosing, C.; Popat, U.; Khouri, I.; Couriel, D.; Qazilbash, M.; Anderlini, P.; Kebriaei, P.; Ghosh, S.; Carrasco-Yalan, A.; de Meis, E.; Anagnostopoulos, A.; Donato, M.; Champlin, R.E.; de Lima, M. 2007: Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 13(4): 454-462
Maeda, Y. 2014: Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk myelodysplastic syndrome. Japanese Journal of Clinical Hematology 55(10): 1870-1881
Machaczka, M. 2013: Allogeneic hematopoietic stem cell transplantation for treatment of Gaucher disease. Pediatric Hematology and Oncology 30(5): 459-461
Hyo, R.; Taguchi, J.; Kamijo, A.; Tanaka, M.; Hashimoto, C.; Kanamori, H.; Motomura, S.; Maruta, A.; Ishigatsubo, Y. 2009: Allogeneic hematopoietic stem cell transplantation from HLA one-locus-mismatched related donors. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(11): 1845-1849
Zhou, Y.; Huang, W.-R.; Li, H.-H.; Gao, C.-J.; Yu, L. 2010: Allogeneic hematopoietic stem cell transplantation from HLA-matched donor for 14 patients with myelodysplastic syndrome. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18(3): 731-734
Xue, M.; Wang, H.-X.; Yan, H.-M.; Ding, L.; Liu, J.; Zhu, L.; Duan, L.-N. 2009: Allogeneic hematopoietic stem cell transplantation in 6 patients with myelodysplastic syndrome. Zhongguo Shi Yan Xue Ye Xue Za Zhi 17(3): 719-722
Peffault de Latour, R.ég.; Porcher, R.; Dalle, J.-H.; Aljurf, M.; Korthof, E.T.; Svahn, J.; Willemze, R.; Barrenetxea, C.; Mialou, V.; Soulier, J.; Ayas, M.; Oneto, R.; Bacigalupo, A.; Marsh, J.C.W.; Peters, C.; Socie, G.; Dufour, C. 2013: Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. Blood 122(26): 4279-4286
Hwang, Y.Y.; Mohty, M.; Chim, C.S. 2015: Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond. Hematology 20(2): 61-71
Bakr, M.; Rasheed, W.; Mohamed, S.Y.; Al-Mohareb, F.; Chaudhri, N.; Al-Sharif, F.; Al-Zahrani, H.; Al-Dawsari, G.; Saleh, A.J.; Nassar, A.; Ahmed, S.; Elghazaly, A.; Ahmed, S.O.; Ibrahim, K.; Chebbo, W.; El Gohary, G.M.; Al Mahayni, M.H.; Hussain, F.; Nurgat, Z.; Elhassan, T.A.; Walter, C.U.; Aljurf, M. 2012: Allogeneic hematopoietic stem cell transplantation in adolescent and adult patients with high-risk T cell acute lymphoblastic leukemia. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 18(12): 1897-1904
Kumar, P.; Defor, T.E.; Brunstein, C.; Barker, J.N.; Wagner, J.E.; Weisdorf, D.J.; Burns, L.J. 2008: Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 14(12): 1394-1400
Claviez, A.; Canals, C.; Dierickx, D.; Stein, J.; Badell, I.; Pession, A.; Mackinnon, S.; Slavin, S.; Dalle, J.-H.; Chacón, M.J.; Sarhan, M.; Wynn, R.F.; Suttorp, M.; Dini, G.; Sureda, A.; Schmitz, N.; Dierickx, D.; Stein, J.; Badell, I.; Pession, A.; Mackinnon, S.; Slavin, S.; Dalle, J.H.; Jurado Chacon, M.; Sarhan, M.; Wynn, R.F.; Buzyn, A.; Sucak, G.; Willemze, R.; Carreras, E.; Bacigalupo, A.; Thomson, K.; Johnson, P.; Falda, M.; Foa, R.; Schattenberg, A.; Baccarani, M.; Biron, P.; Cornelissen, J.; Witz, F.; Harousseau, J.L.; Littlewood, T.; Schrappe, A.; Brown, P.; Jouet, P.; Messina, C.; Rossi, G.; Brune, M.; Campos, A.; Morra, E.; Bosi, A.; Pastore, M.; Königsmann, M.; Bazarbachi, A.; Craddock, C.; Niederwieser; Peters, C.; Scheid, 2009: Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and Marrow Transplantation. Blood 114(10): 2060-2067
Castagna, L.; Blaise, D.; Furst, S. 2011: Allogeneic hematopoietic stem cell transplantation in elderly. Bulletin du Cancer 98(8): 915-925
Al-Dhekri, H.; Al-Mousa, H.; Ayas, M.; Al-Muhsen, S.; Al-Ghonaium, A.; Al-Ghanam, G.; Al-Saud, B.; Arnaout, R.; Al-Seraihy, A.; Al-Ahmari, A.; Al-Jefri, A.; Al-Mahr, M.; El-Solh, H. 2011: Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type 1: a single center experience. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 17(8): 1245-1249
Atalla, A.; Hallack Neto, A.ão.E.; Siqueira, D.B.; Toledo, G.C. 2013: Allogeneic hematopoietic stem cell transplantation in mycosis fungoides. Anais Brasileiros de Dermatologia 88(6 Suppl 1: 216-219
Patriarca, F.; Bacigalupo, A.; Sperotto, A.; Isola, M.; Soldano, F.; Bruno, B.; van Lint, M.T.; Iori, A.P.; Santarone, S.; Porretto, F.; Pioltelli, P.; Visani, G.; Iacopino, P.; Fanin, R.; Bosi, A.; Milone, G.; Mauro, M.; La Nasa, G.; Dessalvi, P.; Bonifazi, F.; Servida, P.; Lambertenghi, G.; Corradini, P.; Falda, M.; Mazza, P.; Benedetti, F.; Raimondi, R.; Selleri, C.; Locasciulli, A.; Alessandrino, P.; Narni, F.; Papineschi, F. 2008: Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Haematologica 93(10): 1514-1522
Bay, J.-O.; Cabrespine-Faugeras, A.él.; Tabrizi, R.; Blaise, D.; Viens, P.; Ehninger, G.; Bornhauser, M.; Slavin, S.; Rosti, G.; Peccatori, J.; Demirer, T.; Bregni, M. 2010: Allogeneic hematopoietic stem cell transplantation in ovarian cancer-the EBMT experience. International Journal of Cancer 127(6): 1446-1452
Lussana, F.; Rambaldi, A.; Finazzi, M.Chiara.; van Biezen, A.; Scholten, M.; Oldani, E.; Carobbio, A.; Iacobelli, S.; Finke, J.; Nagler, A.; Volin, L.; Lamy, T.; Arnold, R.; Mohty, M.; Michallet, M.; de Witte, T.; Olavarria, E.; Kröger, N. 2014: Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation. Haematologica 99(5): 916-921
Unal, S.; Fidan, G.; Tavil, B.; Cetin, M.; Cetinkaya, D.U.çk. 2007: Allogeneic hematopoietic stem cell transplantation in pediatric chronic myelogenous leukemia cases: Hacettepe experience. Pediatric Transplantation 11(6): 645-649
Basquiera, A.L.; Pizzi, S.; Correas, A.ín.G.ál.; Longo, P.G.; Goldman, W.C.; Prates, M.ía.V.; Formisano, S.; Kusminisky, G.; Feldman, L.; Berretta, A.R.; García, J.J.; Staciuk, R. 2015: Allogeneic hematopoietic stem cell transplantation in pediatric myelodysplastic syndromes: a multicenter experience from Argentina. Pediatric Blood and Cancer 62(1): 153-157
George, B.; Mathews, V.; Viswabandya, A.; Lakshmi, K.M.; Srivastava, A.; Chandy, M. 2010: Allogeneic hematopoietic stem cell transplantation is superior to immunosuppressive therapy in Indian children with aplastic anemia--a single-center analysis of 100 patients. Pediatric Hematology and Oncology 27(2): 122-131
Ciccocioppo, R.; Bernardo, M.Ester.; Russo, M.Luisa.; Vanoli, A.; Franco, C.; Martinetti, M.; Catenacci, L.; Giorgiani, G.; Zecca, M.; Piralla, A.; Baldanti, F.; Locatelli, F.; Corazza, G.Roberto. 2013: Allogeneic hematopoietic stem cell transplantation may restore gluten tolerance in patients with celiac disease. Journal of Pediatric Gastroenterology and Nutrition 56(4): 422-427
Baker, J.M.; Lewis, V.A.; Fernandez, C.V.; Duval, M.; Crooks, B.N.; Yuille, K.; Freedman, M.H.; Doyle, J.J.; Dror, Y. 2009: Allogeneic hematopoietic stem cell transplantation of patients with FA and high risk features using fludarabine without radiation. Pediatric Blood and Cancer 52(5): 683-685
Bachanova, V.; Sandhu, K.; Yohe, S.; Cao, Q.; Burke, M.J.; Verneris, M.R.; Weisdorf, D. 2011: Allogeneic hematopoietic stem cell transplantation overcomes the adverse prognostic impact of CD20 expression in acute lymphoblastic leukemia. Blood 117(19): 5261-5263
D'Orsogna, L.J.; Wright, M.P.; Krueger, R.G.; McKinnon, E.J.; Buffery, S.I.; Witt, C.S.; Staples, N.; Loh, R.; Cannell, P.K.; Christiansen, F.T.; French, M.A. 2009: Allogeneic hematopoietic stem cell transplantation recipients have defects of both switched and igm memory B cells. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 15(7): 795-803
Tanosaki, R.; Uike, N.; Utsunomiya, A.; Saburi, Y.; Masuda, M.; Tomonaga, M.; Eto, T.; Hidaka, M.; Harada, M.; Choi, I.; Yamanaka, T.; Kannagi, M.; Matsuoka, M.; Okamura, J. 2008: Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 14(6): 702-708
Nakamura, Y.; Mori, T.; Kato, J.; Aisa, Y.; Nakazato, T.; Shigematsu, N.; Okamoto, S. 2012: Allogeneic hematopoietic stem cell transplantation with fludarabine, melphalan, and total body irradiation as a conditioning for elderly patients with myeloid malignancies. Japanese Journal of Clinical Hematology 53(3): 318-322
Ohta, H.; Kusuki, S.; Yoshida, H.; Sato, E.; Hashii, Y.; Ozono, K. 2010: Allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning for a child with recurrent anaplastic large cell lymphoma. International Journal of Hematology 92(1): 190-193
Weber, T.; Ocheni, S.; Binder, M.; Theurich, S.; Scheid, C.; Schmid, C.; Müller, L.P.; Christopeit, M.; Bacher, U. 2013: Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignancies. Acta Haematologica 129(3): 135-136
Salit, R.B.; Bishop, M.R.; Pavletic, S.Z. 2010: Allogeneic hematopoietic stem cell transplantation: does it have a place in treating Hodgkin lymphoma?. Current Hematologic Malignancy Reports 5(4): 229-238
Servais, S.; Willems, E.; Beguin, Y.; Baron, F. 2013: Allogeneic hematopoietic stem cell transplantation: what is the upper age limit?. Revue Medicale de Liege 68(1): 38-43
Michallet, M. 2011: Allogeneic hematopoietic stem cell transplantations. Transfusion Clinique et Biologique: Journal de la Societe Francaise de Transfusion Sanguine 18(2): 235-245
Baron, F. 2011: Allogeneic hematopoietic stem cell treatment after non-myeloablation (minigraft). Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 166(1-2): 39-45; Discussion: 46-48
Nagler, A.; Rocha, V.; Labopin, M.; Unal, A.; Ben Othman, T.; Campos, A.; Volin, L.; Poire, X.; Aljurf, M.; Masszi, Tás.; Socie, G.; Sengelov, H.; Michallet, M.; Passweg, J.; Veelken, H.; Yakoub-Agha, I.; Shimoni, A.; Mohty, M. 2013: Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 31(28): 3549-3556
Schetelig, J.; van Biezen, A.; Brand, R.; Caballero, D.; Martino, R.; Itala, M.; García-Marco, Jé.A.; Volin, L.; Schmitz, N.; Schwerdtfeger, R.; Ganser, A.; Onida, F.; Mohr, B.; Stilgenbauer, S.; Bornhäuser, M.; de Witte, T.; Dreger, P. 2008: Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26(31): 5094-5100
Qasim, W.; Cavazzana-Calvo, M.; Davies, E.G.; Davis, J.; Duval, M.; Eames, G.; Farinha, N.; Filopovich, A.; Fischer, A.; Friedrich, W.; Gennery, A.; Heilmann, C.; Landais, P.; Horwitz, M.; Porta, F.; Sedlacek, P.; Seger, R.; Slatter, M.; Slatten, M.; Teague, L.; Eapen, M.; Veys, P. 2009: Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency. Pediatrics 123(3): 836-840
Cutler, C. 2010: Allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndrome. HEMATOLOGY. American Society of Hematology. Education Program 2010: 325-329
Chevallier, P.; Mohty, M.; Lioure, B.; Michel, G.; Contentin, N.; Deconinck, E.; Bordigoni, P.; Vernant, J-Paul.; Hunault, M.; Vigouroux, Séphane.; Blaise, D.; Tabrizi, R.; Buzyn, A.; Socie, G.; Michallet, M.; Volteau, C.; Harousseau, J-Luc. 2008: Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 26(30): 4940-4943
Gratwohl, A. 2011: Allogeneic hematopoietic stem-cell transplantation for myeloma: it's time for the appropriate studies. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 29(16): e483; author reply e484
Lim, Z.; Brand, R.; Martino, R.; van Biezen, A.; Finke, Jürgen.; Bacigalupo, A.; Beelen, D.; Devergie, A.; Alessandrino, E.; Willemze, R.; Ruutu, T.; Boogaerts, M.; Falda, M.; Jouet, J-Pierre.; Niederwieser, D.; Kroger, N.; Mufti, G.J.; De Witte, T.M. 2010: Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 28(3): 405-411
Hsieh, M.M.; Kang, E.M.; Fitzhugh, C.D.; Link, M.Beth.; Bolan, C.D.; Kurlander, R.; Childs, R.W.; Rodgers, G.P.; Powell, J.D.; Tisdale, J.F. 2009: Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. New England Journal of Medicine 361(24): 2309-2317
Casper, J.; Wolff, D.; Knauf, W.; Blau, I.W.; Ruutu, T.; Volin, L.; Wandt, H.; Schäfer-Eckart, K.; Holowiecki, J.; Giebel, S.; Aschan, J.; Zander, A.R.; Kröger, N.; Hilgendorf, I.; Baumgart, J.; Mylius, H.A.; Pichlmeier, U.; Freund, M. 2010: Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioning. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 28(20): 3344-3351
Kuppen, P.J.K. 2008: Allogeneic hematopoietic transplantation and leukemia: a second chance for T cells?. Transplantation 85(1): 7-8
Dong, W.-M.; Cao, X.-S.; Wang, B.; Lin, Y.; Hua, X.-Y.; Qiu, G.-Q.; Gu, W.-Y.; Xie, X.-B. 2014: Allogeneic hemopietic stem cell transplants for the treatment of B cell acute lymphocytic leukemia. Asian Pacific Journal of Cancer Prevention: Apjcp 15(15): 6127-6130
Muñoz, A.; Diaz-Heredia, C.; Diaz, M.A.; Badell, I.; Verdeguer, A.; Martinez, A.; Gomez, P.; Perez-Hurtado, J.M.; Bureo, E.; Fernandez-Delgado, R.; Gonzalez-Valentin, M.E.; Maldonado, M.S. 2008: Allogeneic hemopoietic stem cell transplantation for childhood acute lymphoblastic leukemia in second complete remission-similar outcomes after matched related and unrelated donor transplant: a study of the Spanish Working Party for Blood and Marrow Transplantation in Children (Getmon). Pediatric Hematology and Oncology 25(4): 245-259
Kurtzberg, J.; Prockop, S.; Teira, P.; Bittencourt, H.; Lewis, V.; Chan, K.W.; Horn, B.; Yu, L.; Talano, J.-A.; Nemecek, E.; Mills, C.R.; Chaudhury, S. 2014: Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 20(2): 229-235
Lee, J.W.; Fang, X.; Gupta, N.; Serikov, V.; Matthay, M.A. 2009: Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proceedings of the National Academy of Sciences of the United States of America 106(38): 16357-16362
Fang, X.; Neyrinck, A.P.; Matthay, M.A.; Lee, J.W. 2010: Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type Ii cells by secretion of angiopoietin-1. Journal of Biological Chemistry 285(34): 26211-26222
Quint, C.; Arief, M.; Muto, A.; Dardik, A.; Niklason, L.E. 2012: Allogeneic human tissue-engineered blood vessel. Journal of Vascular Surgery 55(3): 790-798
Tam, C.S. 2013: Allogeneic immunity and anti-CD20 therapy: a potent combination in the treatment of a patient with Richter transformation of chronic lymphocytic leukemia. Leukemia and Lymphoma 54(1): 7-8
Porter, D.L. 2011: Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversies. HEMATOLOGY. American Society of Hematology. Education Program 2011: 292-298
Stroopinsky, D.; Avivi, I.; Rowe, J.M.; Avigan, D.; Katz, T. 2009: Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity. European Journal of Immunology 39(10): 2703-2715
Ishikane, S.; Ohnishi, S.; Yamahara, K.; Sada, M.; Harada, K.; Mishima, K.; Iwasaki, K.; Fujiwara, M.; Kitamura, S.; Nagaya, N.; Ikeda, T. 2008: Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia. Stem Cells 26(10): 2625-2633
Kushida, T.; Ueda, Y.; Umeda, M.; Oe, K.; Okamoto, N.; Iida, H.; Abraham, N.G.; Gershwin, M.Eric.; Ikehara, S. 2009: Allogeneic intra-bone marrow transplantation prevents rheumatoid arthritis in SKG/Jcl mice. Journal of Autoimmunity 32(3-4): 216-222
Marzorati, S.; Pileggi, A.; Ricordi, C. 2007: Allogeneic islet transplantation. Expert Opinion on Biological Therapy 7(11): 1627-1645
Stein, K.; Maruschke, M.; Protzel, C.; Hakenberg, O.W. 2014: Allogeneic kidney transplantation. Preoperative, perioperative and postoperative management. Der Urologe. Ausg. a 53(1): 91
Perotti, C.; Arici, V.; Cervio, M.; Del Fante, C.; Calliada, F.; Gnecchi, M.; Ciuffreda, M.C.; Scudeller, L.; Bozzani, A.; Ragni, F.; Viarengo, G.; Cervio, E.; Odero, A.; Redi, C.A. 2013: Allogeneic lethally irradiated cord blood mononuclear cells in no-option critical limb ischemia: a "box of rain". Stem Cells and Development 22(20): 2806-2812
Kong, L.-h.; Liu, Z.; Li, H.; Chen, S.-m.; Xing, F.-q. 2008: Allogeneic leukocyte immunization combined with IVF-ET for treatment of infertility induced by recurrent spontaneous abortion. Nan Fang Yi Ke da Xue Xue Bao 28(7): 1300-1301
Mee, E.T.; Stebbings, R.; Hall, J.; Giles, E.; Almond, N.; Rose, N.J. 2014: Allogeneic lymphocyte transfer in MHC-identical siblings and MHC-identical unrelated Mauritian cynomolgus macaques. Plos one 9(2): E88670
Chen, J.-C.; Ou, L.-S.; Yu, H.-Y.; Chang, H.-L.; Chang, P.-Y.; Kuo, M.-L. 2013: Allogeneic lymphocytes exerted graft-versus-host rather than tolerogenic effects on preimmune fetuses. Journal of Surgical Research 183(1): 405-411
Greene, J.M.; Burwitz, B.J.; Blasky, A.J.; Mattila, T.L.; Hong, J.J.; Rakasz, E.G.; Wiseman, R.W.; Hasenkrug, K.J.; Skinner, P.J.; O'Connor, S.L.; O'Connor, D.H. 2008: Allogeneic lymphocytes persist and traffic in feral MHC-matched mauritian cynomolgus macaques. Plos one 3(6): E2384
Krasny, M.; Krasny, K.; Kamiński, A.; Fiedor, P. 2014: Allogeneic materials in complications associated with pre-implantation restoration of maxillary and mandibular alveolar processes. A four case report. Cell and Tissue Banking 15(3): 381-389
Rossi, G.R.; Mautino, M.R.; Awwad, D.Z.; Husske, K.; Lejukole, H.; Koenigsfeld, M.; Ramsey, W.J.; Vahanian, N.; Link, C.J. 2008: Allogeneic melanoma vaccine expressing alpha Gal epitopes induces antitumor immunity to autologous antigens in mice without signs of toxicity. Journal of ImmunoTherapy 31(6): 545-554
Chen, B.J. 2008: Allogeneic memory T cell response. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 14(1 Suppl. 1): 20-22
Hamamoto, H.; Gorman, J.H.; Ryan, L.P.; Hinmon, R.; Martens, T.P.; Schuster, M.D.; Plappert, T.; Kiupel, M.; St John-Sutton, M.G.; Itescu, S.; Gorman, R.C. 2009: Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage. Annals of Thoracic Surgery 87(3): 794-801
Wheeler, D.L.; Lane, J.M.; Seim, H.B.; Puttlitz, C.M.; Itescu, S.; Turner, A.Simon. 2014: Allogeneic mesenchymal progenitor cells for posterolateral lumbar spine fusion in sheep. Spine Journal: Official Journal of the North American Spine Society 14(3): 435-444
Belingheri, M.; Lazzari, L.; Parazzi, V.; Groppali, E.; Biagi, E.; Gaipa, G.; Giordano, R.; Rastaldi, M.P.; Croci, D.; Biondi, A.; Rebulla, P.; Edefonti, A.; Ghio, L. 2013: Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis. Biologicals: Journal of the International Association of Biological Standardization 41(6): 439-445
Li, Y.; Xu, J.; Mao, L.; Liu, Y.; Gao, R.; Zheng, Z.; Chen, W.; Le, A.; Shi, S.; Wang, S. 2013: Allogeneic mesenchymal stem cell therapy for bisphosphonate-related jaw osteonecrosis in Swine. Stem Cells and Development 22(14): 2047-2056
Gu, F.; Wang, D.; Zhang, H.; Feng, X.; Gilkeson, G.S.; Shi, S.; Sun, L. 2014: Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy. Clinical Rheumatology 33(11): 1611-1619
Wang, D.; Zhang, H.; Liang, J.; Li, X.; Feng, X.; Wang, H.; Hua, B.; Liu, B.; Lu, L.; Gilkeson, G.S.; Silver, R.M.; Chen, W.; Shi, S.; Sun, L. 2013: Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell transplantation 22(12): 2267-2277
Xu, J.; Wang, D.; Liu, D.; Fan, Z.; Zhang, H.; Liu, O.; Ding, G.; Gao, R.; Zhang, C.; Ding, Y.; Bromberg, J.S.; Chen, W.; Sun, L.; Wang, S. 2012: Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome. Blood 120(15): 3142-3151
Youd, M.; Blickarz, C.; Woodworth, L.; Touzjian, T.; Edling, A.; Tedstone, J.; Ruzek, M.; Tubo, R.; Kaplan, J.; Lodie, T. 2010: Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease. Clinical and Experimental Immunology 161(1): 176-186
Kavanagh, H.; Mahon, B.P. 2011: Allogeneic mesenchymal stem cells prevent allergic airway inflammation by inducing murine regulatory T cells. Allergy 66(4): 523-531
Quevedo, H.C.; Hatzistergos, K.E.; Oskouei, B.N.; Feigenbaum, G.S.; Rodriguez, J.E.; Valdes, D.; Pattany, P.M.; Zambrano, J.P.; Hu, Q.; McNiece, I.; Heldman, A.W.; Hare, J.M. 2009: Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proceedings of the National Academy of Sciences of the United States of America 106(33): 14022-14027
Liang, J.; Zhang, H.; Hua, B.; Wang, H.; Wang, J.; Han, Z.; Sun, L. 2009: Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Multiple Sclerosis 15(5): 644-646
Clover, A.J.P.; Kumar, A.H.S.; Isakson, M.; Whelan, D.; Stocca, A.; Gleeson, B.M.; Caplice, N.M. 2015: Allogeneic mesenchymal stem cells, but not culture modified monocytes, improve burn wound healing. Burns: Journal of the International Society for Burn Injuries 41(3): 548-557
English, K.; Mahon, B.P. 2011: Allogeneic mesenchymal stem cells: agents of immune modulation. Journal of Cellular Biochemistry 112(8): 1963-1968
Lazebnik, L.B.; Kniazev, O.V.; Konopliannikov, A.G.; Parfenov, A.I.; Ruchkina, I.N.; Mikhaĭlova, Z.F.; Tsaregorodtseva, T.M.; Khomeriki, S.G.; Rogozina, V.A.; Gudkova, R.B.; Shcherbakov, P.L.; Konopliannikova, O.A. 2010: Allogeneic mesenchymal stromal cells in patients with ulcerative colitis: two years of observation. Eksperimental'naia i Klinicheskaia Gastroenterologiia 2010(11): 3-15
Roh, J.S.; Yeung, C.A.; Field, J.S.; McClellan, R.T. 2013: Allogeneic morphogenetic protein vs. recombinant human bone morphogenetic protein-2 in lumbar interbody fusion procedures: a radiographic and economic analysis. Journal of Orthopaedic Surgery and Research 8: 49
Sullivan, C.; Barry, F.; Ritter, T.; O'Flatharta, C.; Howard, L.; Shaw, G.; Anegon, I.; Murphy, M. 2013: Allogeneic murine mesenchymal stem cells: migration to inflamed joints in vivo and amelioration of collagen induced arthritis when transduced to express CTLA4Ig. Stem Cells and Development 22(24): 3203-3213
Bachanova, V.; Burns, L.J.; McKenna, D.H.; Curtsinger, J.; Panoskaltsis-Mortari, A.; Lindgren, B.R.; Cooley, S.; Weisdorf, D.; Miller, J.S. 2010: Allogeneic natural killer cells for refractory lymphoma. Cancer Immunology Immunotherapy: Cii 59(11): 1739-1744
Fricke, S.; Ackermann, M.; Stolzing, A.; Schimmelpfennig, C.; Hilger, N.; Jahns, J.; Hildebrandt, G.; Emmrich, F.; Ruschpler, P.; Pösel, C.; Kamprad, M.; Sack, U. 2009: Allogeneic non-adherent bone marrow cells facilitate hematopoietic recovery but do not lead to allogeneic engraftment. Plos one 4(7): E6157
Flörcken, A.; Kopp, J.; van Lessen, A.; Movassaghi, K.; Takvorian, A.; Jöhrens, K.; Möbs, M.; Schönemann, C.; Sawitzki, B.; Egerer, K.; Dörken, B.; Pezzutto, A.; Westermann, J.ör. 2013: Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/Ii study. Human Vaccines and Immunotherapeutics 9(6): 1217-1227
Ding, G.; Liu, Y.; Wang, W.; Wei, F.; Liu, D.; Fan, Z.; An, Y.; Zhang, C.; Wang, S. 2010: Allogeneic periodontal ligament stem cell therapy for periodontitis in swine. Stem Cells 28(10): 1829-1838
Zhu, H-Yan.; Da, W-Ming.; Gao, C-Ji.; Han, X-Ping.; Wang, S-Hong.; Jing, Y.; Bo, J.; Jin, H-jie.; Li, M. 2008: Allogeneic peripheral blood hematopoietic stem cell transplantation for post-operatively treating acute non-lymphocytic leukemia patient complicated with renal cell carcinoma: one case report. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16(1): 203-206
Wu, H.-X.; Qian, S.-X.; Hong, M.; Zhang, Y.-P.; Lu, H.; Zhang, R.; Zhang, X.-Y.; Chen, L.-J.; Lu, R.-N.; Zhang, S.-J.; Liu, P.; Ge, Z.; Fan, L.; Wang, L.; Xu, J.; Tian, T.; Zhu, Y.; Qiu, H.-X.; Xu, W.; Sheng, R.-L.; Li, J.-Y. 2008: Allogeneic peripheral blood stem cell transplantation for 75 cases of hematologic malignancies. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16(6): 1330-1333
Lan, H.-f.; Yuan, Z.-g.; Zhang, C.-y.; Chen, Y.-b.; Fu, W.-j.; Jiang, H.; Xi, H.; Hou, J. 2012: Allogeneic peripheral blood stem cell transplantation from sibling donors for 10 patients with multiple myeloma. Zhonghua Xue Ye Xue Za Zhi 33(3): 191-194
Alam, N.; Marras, T.K.; Atenafu, E.G.; Gupta, V.; Kuruvilla, J.; Lipton, J.H.; Messner, H.A.; Kim, D.D.H. 2012: Allogeneic peripheral blood stem cell transplantation significantly increases risk of chronic graft-versus-host disease of lung compared with bone marrow transplantation. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 18(12): 1905-1910
Gutiérrez-Aguirre, C.H.; Gómez-De-León, A.és.; Alatorre-Ricardo, J.; Cantú-Rodríguez, O.G.; González-Llano, O.; Jaime-Pérez, J.é C.; Mancías-Guerra, C.; Flores-Jiménez, J.A.; Gómez-Almaguer, D. 2014: Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?. Transfusion 54(5): 1269-1277
Perotti, G.; Stronati, M.; Figar, T.; Del Fante, C.; Scudeller, L.; Perotti, C. 2012: Allogeneic platelet leucocyte-gel to treat occipital decubitus ulcer in a neonate: a case report. Blood Transfusion 10(3): 387-389
Guo, L.; Yang, L.; Speck, E.R.; Aslam, R.; Kim, M.; McKenzie, C.G.J.; Lazarus, A.H.; Ni, H.; Hou, M.; Freedman, J.; Semple, J.W. 2014: Allogeneic platelet transfusions prevent murine T-cell-mediated immune thrombocytopenia. Blood 123(3): 422-427
Ogulur, I.; Gurhan, G.; Kombak, F.E.; Filinte, D.; Barlan, I.; Akkoc, T. 2014: Allogeneic pluripotent stem cells suppress airway inflammation in murine model of acute asthma. International Immunopharmacology 22(1): 31-40
Madjdpour, C.; Spahn, D.R. 2007: Allogeneic red blood cell transfusion: physiology of oxygen transport. Best Practice and Research. Clinical Anaesthesiology 21(2): 163-171
Chae, E.Y.; Song, E.J.; Sohn, J.Y.; Kim, S.-T.; Woo, C.W.; Gong, G.; Kang, H.J.; Lee, J.S. 2010: Allogeneic renal graft rejection in a rat model: in vivo MR imaging of the homing trait of macrophages. Radiology 256(3): 847-854
Brill, T.H.; Kübler, H.R.; von Randenborgh, H.; Fend, F.; Pohla, H.; Breul, J.; Hartung, R.; Paul, R.; Schendel, D.J.; Gansbacher, B. 2007: Allogeneic retrovirally transduced, IL-2- and IFN-gamma-secreting cancer cell vaccine in patients with hormone refractory prostate cancer--a phase I clinical trial. Journal of Gene Medicine 9(7): 547-560
Na, K.-S.; Kim, M.S. 2012: Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 28(5): 479-483
Chiang, C.-C.; Lin, J.-M.; Chen, W.-L.; Tsai, Y.-Y. 2007: Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Cornea 26(7): 861-863
Fawaz, F.S.; Hermiston, T.W.; Dinter, H. 2010: Allogeneic somatic cell therapy: process development challenges and future opportunities. Current Opinion in Molecular Therapeutics 12(4): 383-385
Martinu, T.; Kinnier, C.V.; Sun, J.; Kelly, F.L.; Nelson, M.E.; Garantziotis, S.; Foster, W.M.; Palmer, S.M. 2014: Allogeneic splenocyte transfer and lipopolysaccharide inhalations induce differential T cell expansion and lung injury: a novel model of pulmonary graft-versus-host disease. Plos one 9(5): E97951
Berg, J.O.; Vindeløv, L.; Schmidt, G.; Drzewiecki, K.T. 2008: Allogeneic split-skin grafting in stem cell transplanted patients. Journal of Plastic Reconstructive and Aesthetic Surgery: Jpras 61(12): 1512-1515
Nishiwaki, S.; Miyamura, K. 2012: Allogeneic stem cell transplant for adult Philadelphia chromosome-negative acute lymphoblastic leukemia. Leukemia and Lymphoma 53(4): 550-556
Busca, A.; Pecoraro, C.; Giaccone, L.; Bruno, B.; Allione, B.; Corsetti, M.T.; Pini, M.; Marmont, F.; Audisio, E.; D'Ardia, S.; Frairia, C.; Castiglione, A.; Ciccone, G.; Levis, A.; Vitolo, U.; Falda, M. 2014: Allogeneic stem cell transplant for adults with myelodysplastic syndromes: relevance of pre-transplant disease status. Leukemia and Lymphoma 55(4): 863-869
Stamatović, D.; Balint, B.; Tukić, L.; Elez, M.; Tarabar, O.; Todorović, M.; Todorić-Zivanović, B.; Ostojić, G.; Tatomirović, Z.; Marjanović, S.; Malesević, M. 2012: Allogeneic stem cell transplant for chronic myeloid leukemia as a still promising option in the era of the new target therapy. Vojnosanitetski Pregled 69(1): 37-42
Hübel, K.; Weingart, O.; Naumann, F.; Bohlius, J.; Fresen, M.M.; Engert, A.; Wheatley, K. 2011: Allogeneic stem cell transplant in adult patients with acute myelogenous leukemia: a systematic analysis of international guidelines and recommendations. Leukemia and Lymphoma 52(3): 444-457
Poon, M.L.; Fox, P.S.; Samuels, B.I.; O'Brien, S.; Jabbour, E.; Hsu, Y.; Gulbis, A.; Korbling, M.; Champlin, R.; Abruzzo, L.V.; Bassett, R.L.; Khouri, I.F. 2015: Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion: consult-transplant versus consult- no-transplant analysis. Leukemia and Lymphoma 56(3): 711-715
Van Besien, K.; Schouten, V.; Parsad, S.; Smith, S.; Odenike, O.; Artz, A.S. 2012: Allogeneic stem cell transplant in renal failure: engraftment and prolonged survival, but high incidence of neurologic toxicity. Leukemia and Lymphoma 53(1): 158-159
Sureda, A.; Canals, C.; Arranz, R.; Caballero, D.; Ribera, J.M.; Brune, M.; Passweg, J.; Martino, R.; Valcárcel, D.; Besalduch, J.; Duarte, R.; León, A.; Pascual, M.J.; García-Noblejas, A.; López Corral, L.; Xicoy, B.; Sierra, J.; Schmitz, N. 2012: Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Haematologica 97(2): 310-317
Valcárcel, D.; Martino, R.; Piñana, J.L.; Sierra, J. 2009: Allogeneic stem cell transplantation after reduced-intensity conditioning for acute myeloid leukaemia: impact of chronic graft-versus-host disease. Current Opinion in Oncology 21(Suppl 1): S35-S37
Kröger, N.; Holler, E.; Kobbe, G.; Bornhäuser, M.; Schwerdtfeger, R.; Baurmann, H.; Nagler, A.; Bethge, W.; Stelljes, M.; Uharek, L.; Wandt, H.; Burchert, A.; Corradini, P.; Schubert, J.ör.; Kaufmann, M.; Dreger, P.; Wulf, G.G.; Einsele, H.; Zabelina, T.; Kvasnicka, H.M.; Thiele, J.ür.; Brand, R.; Zander, A.R.; Niederwieser, D.; de Witte, T.M. 2009: Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Blood 114(26): 5264-5270
Danylesko, I.; Shimoni, A.; Nagler, A. 2013: Allogeneic stem cell transplantation and targeted immunotherapy for multiple myeloma. Clinical Lymphoma Myeloma and Leukemia 13(Suppl 2): S330-S348
Hu, B.; Vikas, P.; Mohty, M.; Savani, B.N. 2014: Allogeneic stem cell transplantation and targeted therapy for FLT3/ITD+ acute myeloid leukemia: an update. Expert Review of Hematology 7(2): 301-315
Goodyer, M.; Sargent, J.; Bond, J.; McMahon, C.; Dunne, B.; Smith, O. 2013: Allogeneic stem cell transplantation as immunotherapy for X-linked lymphoproliferative disease-associated cerebral T-cell lymphoma. British Journal of Haematology 163(1): 133-135
Jabbour, E.; Daver, N.; Champlin, R.; Mathisen, M.; Oran, B.; Ciurea, S.; Khouri, I.; Cornelison, A.M.; Ghanem, H.; Cardenas-Turanzas, M.; Popat, U.; Ravandi, F.; Giralt, S.; Garcia-Manero, G.; Cortes, J.; Kantarjian, H.; de Lima, M. 2014: Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy. American Journal of Hematology 89(4): 395-398
Ikegame, K.; Yoshihara, S.; Taniguchi, Y.; Kaida, K.; Inoue, T.; Okada, M.; Taniguchi, K.; Hasei, H.; Tamaki, H.; Fujioka, T.; Kato, R.; Soma, T.; Ogawa, H. 2011: Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation. Experimental Hematology 39(8): 880-890
Castagna, L.; Sarina, B.; Todisco, E.; Magagnoli, M.; Balzarotti, M.; Bramanti, S.; Mazza, R.; Anastasia, A.; Bacigalupo, A.; Aversa, F.; Soligo, D.; Giordano, L.; Santoro, A. 2009: Allogeneic stem cell transplantation compared with chemotherapy for poor-risk Hodgkin lymphoma. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 15(4): 432-438
Rahman, S.; Hargreaves, I.P. 2007: Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 68(21): 1872; Author Reply 1872; Discussion 1872-3
Lau, A.A.; Hannouche, H.; Rozaklis, T.; Hassiotis, S.; Hopwood, J.J.; Hemsley, K.M. 2010: Allogeneic stem cell transplantation does not improve neurological deficits in mucopolysaccharidosis type IIIA mice. Experimental Neurology 225(2): 445-454
Song, A.-X.; Yang, D.-L.; Wei, J.-L.; Yan, Z.-S.; Wang, M.; Jiang, E.-L.; Huang, Y.; Liu, Q.-G.; Ma, Q.-L.; Zhai, W.-H.; Zhang, R.-L.; Feng, S.-Z.; Han, M.-Z. 2010: Allogeneic stem cell transplantation for 75 cases of acute myeloid leukemia in complete remission: outcome and prognostic analysis. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18(1): 161-166
Zhu, G.-h.; Qin, M.-q.; Wang, B.; Zhou, X.; Yang, J.; Jia, C.-g.; Wu, Y.; Wang, X.-s.; Wu, M.-y. 2012: Allogeneic stem cell transplantation for 8 patients with malignant infantile osteopetrosis in China. Zhonghua Er Ke Za Zhi 50(11): 807-812
Ishaqi, M.K.; El-Hayek, M.; Gassas, A.; Khanani, M.; Trad, O.; Baroudi, M.; Jamil, A. 2009: Allogeneic stem cell transplantation for Glanzmann thrombasthenia. Pediatric Blood and Cancer 52(5): 682-683
Bhatt, V.R.; Akhtari, M.; Bociek, R.G.; Sanmann, J.N.; Yuan, J.; Dave, B.J.; Sanger, W.G.; Kessinger, A.; Armitage, J.O. 2014: Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute myeloid leukemia. Journal of the National Comprehensive Cancer Network: Jnccn 12(7): 963-968
Peccatori, J.; Ciceri, F. 2010: Allogeneic stem cell transplantation for acute myeloid leukemia. Haematologica 95(6): 857-859
Schneidawind, D.; Dorn, C.; Faul, C.; Vogel, W.; Berg, C.; Beck, R.; Korn, K.; Dittmann, H.; Schleicher, J.; Erbersdobler, A.; Jahn, G.; Kanz, L.; Bethge, W. 2012: Allogeneic stem cell transplantation for acute myeloid leukemia and HIV infection--case 3/2012. Deutsche Medizinische Wochenschrift 137(10): 495
Lekakis, L.J.; Cooper, B.W.; de Lima, M.G. 2014: Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: are we closer to knowing who needs it?. Current Hematologic Malignancy Reports 9(2): 128-137
Koreth, J.; Schlenk, R.; Kopecky, K.J.; Honda, S.; Sierra, J.; Djulbegovic, B.J.; Wadleigh, M.; DeAngelo, D.J.; Stone, R.M.; Sakamaki, H.; Appelbaum, F.R.; Döhner, H.; Antin, J.H.; Soiffer, R.J.; Cutler, C. 2009: Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA 301(22): 2349-2361
DeFilipp, Z.; Huynh, D.V.; Fazal, S.; Sahovic, E. 2012: Allogeneic stem cell transplantation for acute myeloid leukemia with del(7q) following untreated chronic lymphocytic leukemia. Hematology/Oncology and Stem Cell Therapy 5(3): 165-168
Nishiwaki, S.; Inamoto, Y.; Sakamaki, H.; Kurokawa, M.; Iida, H.; Ogawa, H.; Fukuda, T.; Ozawa, Y.; Kobayashi, N.; Kasai, M.; Mori, T.; Iwato, K.; Yoshida, T.; Onizuka, M.; Kawa, K.; Morishima, Y.; Suzuki, R.; Atsuta, Y.; Miyamura, K. 2010: Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission. Blood 116(20): 4368-4375
Ribera, J.-M. 2011: Allogeneic stem cell transplantation for adult acute lymphoblastic leukemia: when and how. Haematologica 96(8): 1083-1086
Warlick, E.D.; Cioc, A.; Defor, T.; Dolan, M.; Weisdorf, D. 2009: Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 15(1): 30-38
de Masson, Aèle.; Beylot-Barry, M.; Bouaziz, J-David.; Peffault de Latour, Régis.; Aubin, Fçois.; Garciaz, S.; d'Incan, M.; Dereure, O.; Dalle, Séphane.; Dompmartin, A.; Suarez, F.; Battistella, M.; Vignon-Pennamen, M-Dominique.; Rivet, J.; Adamski, H.; Brice, P.; François, S.; Lissandre, Séverine.; Turlure, P.; Wierzbicka-Hainaut, E.; Brissot, E.; Dulery, Rémy.; Servais, S.; Ravinet, Aélie.; Tabrizi, R.; Ingen-Housz-Oro, S.; Joly, P.; Socié, Gérard.; Bagot, M. 2014: Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas. Haematologica 99(3): 527-534
Armand, P.; Antin, J.H. 2007: Allogeneic stem cell transplantation for aplastic anemia. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 13(5): 505-516
Fagioli, F.; Zecca, M.; Locatelli, F.; Lanino, E.; Uderzo, C.; Di Bartolomeo, P.; Berger, M.; Favre, C.; Rondelli, R.; Pession, A.; Messina, C.; Locatelli, F.; Dini, G.; Uderzo, C.; Messina, C.; Di Bartolomeo, P.; Fagioli, F.; Favre, C.; Pession, A. 2008: Allogeneic stem cell transplantation for children with acute myeloid leukemia in second complete remission. Journal of Pediatric Hematology/Oncology 30(8): 575-583
Böttcher, S.; Ritgen, M.; Dreger, P. 2011: Allogeneic stem cell transplantation for chronic lymphocytic leukemia: lessons to be learned from minimal residual disease studies. Blood Reviews 25(2): 91-96
Champlin, R.; Jabbour, E.; Kebriaei, P.; Anderlini, P.; Andersson, B.; de Lima, M. 2011: Allogeneic stem cell transplantation for chronic myeloid leukemia resistant to tyrosine kinase inhibitors. Clinical Lymphoma Myeloma and Leukemia 11(Suppl 1): S96-100
Park, S.; Labopin, M.; Yakoub-Agha, I.; Delaunay, J.; Dhedin, N.; Deconinck, E.; Michallet, M.; Robin, M.; De Revel, T.; Bernard, M.; Vey, N.; Lioure, B.; Lapusan, S.; Tabrizi, R.; Bourhis, J-Henri.; Huynh, A.; Beguin, Y.; Socié, Gérard.; Dreyfus, Fçois.; Fenaux, P.; Mohty, M. 2013: Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. European journal of haematology 90(5): 355-364
Konuma, T.; Ooi, J.; Takahashi, S.; Tomonari, A.; Tsukada, N.; Kobayashi, T.; Sato, A.; Tojo, A.; Asano, S. 2007: Allogeneic stem cell transplantation for hepatosplenic gammadelta T-cell lymphoma. Leukemia and Lymphoma 48(3): 630-632
Ting, A.E.; Sherman, W. 2012: Allogeneic stem cell transplantation for ischemic myocardial dysfunction. Current Opinion in Organ Transplantation 17(6): 675-680
Krüger, W.H.; Hirt, C.; Basara, N.; Sayer, H.G.; Behre, G.; Fischer, T.; Grobe, N.; Maschmeyer, G.; Niederwieser, D.; Dölken, G. 2014: Allogeneic stem cell transplantation for mantle cell lymphoma--final report from the prospective trials of the East German Study Group Haematology/Oncology (OSHO). Annals of Hematology 93(9): 1587-1597
Bensinger, W. 2014: Allogeneic stem cell transplantation for multiple myeloma. Hematology/Oncology Clinics of North America 28(5): 891-902
Barrett, A.J.; Savani, B.N. 2008: Allogeneic stem cell transplantation for myelodysplastic syndrome. Seminars in Hematology 45(1): 49-59
Muñoz, A.; Díaz-Heredia, C.; Badell, I.; Bureo, E.; Gómez, P.; Martínez, A.; Verdeguer, A.; Pérez-Hurtado, Jé.María.; Fernández-Delgado, R.; González-Vicent, M.; Maldonado, Mía.Soledad. 2009: Allogeneic stem cell transplantation for myelodysplastic syndromes in children: a report from the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON). Pediatric hematology and oncology 26(5): 345-355
Kröger, N.; Zabelina, T.; van Biezen, A.; Brand, R.; Niederwieser, D.; Martino, R.; Lim, Z.Y.; Onida, F.; Schmid, C.; Garderet, L.; Robin, M.; van Gelder, M.; Marks, R.; Symeonidis, A.; Kobbe, G.; de Witte, T. 2011: Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis. Haematologica 96(2): 291-297
De Witte, T. 2011: Allogeneic stem cell transplantation for myelodysplastic syndromes: critical for cure?. Clinical Lymphoma Myeloma and Leukemia 11(Suppl 1): S46-S48
Ciurea, S.O.; de Lima, M.; Giralt, S.; Saliba, R.; Bueso-Ramos, C.; Andersson, B.S.; Hosing, C.M.; Verstovsek, S.; Champlin, R.E.; Popat, U. 2010: Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 16(4): 555-559
Alchalby, H.; Zabelina, T.; Stübig, T.; van Biezen, A.; Bornhäuser, M.; Di Bartolomeo, P.; Beelen, D.; Cahn, J.Yves.; Dreger, P.; Schroyens, W.; de Witte, T.; Olavarria, E.; Kröger, N. 2014: Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation: a study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 20(2): 279-281
Cherington, C.; Slack, J.L.; Leis, J.; Adams, R.H.; Reeder, C.B.; Mikhael, J.R.; Camoriano, J.; Noel, P.; Fauble, V.; Betcher, J.; Higgins, M.S.; Gillette-Kent, G.; Tremblay, L.D.; Peterson, M.E.; Olsen, J.J.; Tibes, R.; Mesa, R.A. 2012: Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase. Leukemia Research 36(9): 1147-1151
Sung, K.W. 2012: Allogeneic stem cell transplantation for neuroblastoma. Korean Journal of Hematology 47(1): 3-5
Nicolini, F.E.; Basak, G.W.; Soverini, S.; Martinelli, G.; Mauro, M.J.; Müller, M.C.; Hochhaus, A.; Chuah, C.; Dufva, I.H.; Rege-Cambrin, G.; Saglio, G.; Michallet, M.; Labussière, H.él.èn.; Morisset, S.ép.; Hayette, S.; Etienne, G.; Olavarria, E.; Zhou, W.; Peter, S.; Apperley, J.F.; Cortes, J. 2011: Allogeneic stem cell transplantation for patients harboring T315i BCR-ABL mutated leukemias. Blood 118(20): 5697-5700
Han, W.; Liu, K.-y.; Xu, L.-p.; Chen, H.; Liu, D.-h.; Chen, Y.-h.; Zhang, X.-h.; Zhang, Y.-c.; Chen, Y.; Wang, Y.; Wang, J.; Lu, D.-p.; Huang, X.-j. 2008: Allogeneic stem cell transplantation for patients with Philadelphia positive leukemia resistant to imatinib. Zhonghua Yi Xue Za Zhi 88(28): 1974-1977
Ebihara, Y.; Ishikawa, K.; Mochizuki, S.; Tanaka, R.; Manabe, A.; Iseki, T.; Maekawa, T.; Tsuji, K. 2014: Allogeneic stem cell transplantation for patients with acute myeloid leukaemia developing from severe congenital neutropenia. British Journal of Haematology 164(3): 459-461
De Witte, T.; Brand, R.; van Biezen, A.; Mufti, G.; Ruutu, T.; Finke, J.ür.; von dem Borne, P.; Vitek, A.; Delforge, M.; Alessandrino, P.; Harlahakis, N.; Russell, N.; Martino, R.; Verdonck, L.; Kröger, N.; Niederwieser, D. 2009: Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: delay of the transplant is associated with inferior survival. British Journal of Haematology 146(6): 627-636
Hamadani, M.; Benson, D.M.; Hofmeister, C.C.; Elder, P.; Blum, W.; Porcu, P.; Garzon, R.; Blum, K.A.; Lin, T.S.; Marcucci, G.; Devine, S.M. 2009: Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 15(5): 547-553
Bregni, M.; Herr, W.; Blaise, D. 2011: Allogeneic stem cell transplantation for renal cell carcinoma. Expert Review of Anticancer Therapy 11(6): 901-911
Hügle, T.; van Laar, J.M. 2010: Allogeneic stem cell transplantation for rheumatic autoimmune diseases. F1000 Medicine Reports 2
Okamoto, S. 2008: Allogeneic stem cell transplantation for severe aplastic anemia and myelodysplasia. Nihon Rinsho. Japanese Journal of Clinical Medicine 66(3): 575-583
Aki, S.Z.; Sucak, G.ül.T.ür.öz.; Ozkurt, Z.üb.N.; Yeğin, Z.A.; Yağci, M.ün.; Haznedar, R. 2009: Allogeneic stem cell transplantation for severe aplastic anemia: graft rejection remains a problem. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 40(1): 5-11
Shayegi, N.; Alakel, N.; Middeke, J.M.; Schetelig, J.; Mantovani-Löffler, L.; Bornhäuser, M. 2015: Allogeneic stem cell transplantation for the treatment of refractory scleromyxedema. Translational Research: the Journal of Laboratory and Clinical Medicine 165(2): 321-324
Blaise, D.; Nguyen, S.; Bay, J.-O.; Chevallier, P.; Contentin, N.; Dhédin, N.; Duléry, R.; Eliaou, J.-F.; Rubio, M.-T.; Suarez, F.; Bulabois, C.-E.; Cornillon, J.; Huynh, A.; Magro, L.; Michallet, M.; Paillard, C.; Turlure, P.; Yakoub-Agha, I. 2014: Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (Part 1). Pathologie-Biologie 62(4): 180-184
Nguyen, S.; Blaise, D.; Bay, J.-O.; Chevallier, P.; Contentin, N.; Dhédin, N.; Duléry, R.; Eliaou, J.-F.; Rubio, M.-T.; Suarez, F.; Bulabois, C.-E.; Cornillon, J.; Huynh, A.; Magro, L.; Michallet, M.; Paillard, C.; Turlure, P.; Yakoub-Agha, I. 2014: Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (part 2). Pathologie-Biologie 62(4): 185-189
Buchholz, S.; Dammann, E.; Koenecke, C.; Stadler, M.; Franzke, A.; Blasczyk, R.; Bremer, M.; Krauter, J.; Hertenstein, B.; Ganser, A.; Eder, M. 2008: Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience. Annals of Hematology 87(7): 551-556
Platzbecker, U.; Mufti, G. 2013: Allogeneic stem cell transplantation in MDS: how? When?. Best Practice and Research. Clinical Haematology 26(4): 421-429
Brinch, L.; Tjønnfjord, G.; Gedde-Dahl, T.; Heldal, D.; Holme, Pål.André.; Dybedal, I. 2008: Allogeneic stem cell transplantation in acute myelogenous leukemia. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 128(15): 1681-2; Author Reply 1682
Ali, N.; Adil, S.N.; Shaikh, M.U.; Masood, N. 2012: Allogeneic stem cell transplantation in acute myeloid leukemia. Hematology Reports 4(4): E25
Meijer, E.; Cornelissen, J.J. 2008: Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for non-relapse mortality. Seminars in Oncology 35(4): 449-457
Lodewyck, T.; Cornelissen, J.J. 2008: Allogeneic stem cell transplantation in acute myeloid leukemia: a risk-adapted approach. Blood Reviews 22(6): 293-302
Zander, A.R.; Bacher, U.; Finke, J.ür. 2008: Allogeneic stem cell transplantation in acute myeloid leukemia: establishment of indications on the basis of individual risk stratification. Deutsches Arzteblatt International 105(39): 663-669
Fløisand, Y.; Brinch, L.; Dybedal, I.; Gedde-Dahl, T.; Heldal, D.; Holme, P.ål.A.é; Egeland, T.; Tjønnfjord, G.E. 2008: Allogeneic stem cell transplantation in adults with acute lymphoblastic leukaemia. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 128(22): 2563-2566
Sedlacek, P.; Formankova, R.; Mejstrikova, E.; Keslova, P.; Hubacek, P.; Dobrovolna, M.; Vrana, M.; Kupkova, L.; Pittrova, H.; Stary, J. 2008: Allogeneic stem cell transplantation in children with leukemia using human leukocyte antigen-mismatched unrelated donors. Pediatric Transplantation 12(1): 24-31
Oran, B.; Weisdorf, D.J. 2011: Allogeneic stem cell transplantation in first complete remission. Current Opinion in Hematology 18(6): 395-400
Lee, S.; Cho, B.-S.; Kim, S.-Y.; Choi, S.-M.; Lee, D.-G.; Eom, K.-S.; Kim, Y.-J.; Kim, H.-J.; Min, C.-K.; Cho, S.-G.; Kim, D.-W.; Lee, J.-W.; Min, W.-S.; Shin, W.-S.; Kim, C.-C. 2007: Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 13(9): 1083-1094
Van Besien, K. 2009: Allogeneic stem cell transplantation in follicular lymphoma: recent progress and controversy. HEMATOLOGY. American Society of Hematology. Education Program 2009: 610-618
Späth, C.; Busemann, C.; Krüger, W.H. 2014: Allogeneic stem cell transplantation in patients above 55: suggestion for a further stratification of the HCT-Ci. Journal of Cancer Research and Clinical Oncology 140(11): 1981-1988
Moritz, R.K.C.; Ditschkowski, M.; Klemke, C.-D.; Terras, S.; Schlaak, M.; Knorr, M.; Theurich, S.; Hegenbart, U.; Kremens, B.; Beelen, D.W.; Stücker, M.; Kreuter, A. 2014: Allogeneic stem cell transplantation in patients with aggressive primary cutaneous T-cell lymphoma - a case series of the ADF working group "cutaneous lymphomas". Journal der Deutschen Dermatologischen Gesellschaft 12(1): 39-46
Kim, J.-W.; Kim, S.-W.; Tada, K.; Fukuda, T.; Lee, J.-H.; Lee, J.-J.; Kwon, J.-H.; Bang, S.-M.; Kim, I.; Yoon, S.-S.; Lee, J.S.; Park, S. 2014: Allogeneic stem cell transplantation in patients with de novo diffuse large B-cell lymphoma who experienced relapse or progression after autologous stem cell transplantation: a Korea-Japan collaborative study. Annals of Hematology 93(8): 1345-1351
Rubio, S.; Martins, C.; Lacerda, J.F.; Carmo, J.A.; Lourenço, F.; Lacerda, J.M.F. 2006: Allogeneic stem cell transplantation in patients with myelodysplastic syndrome: outcome analysis according to the International Prognostic Scoring System. Acta Medica Portuguesa 19(5): 343-347
Kim, J.-W.; Kim, B.-S.; Bang, S.-M.; Kim, I.; Kim, D.H.; Kim, W.S.; Yang, D.-H.; Lee, J.-J.; Lee, J.-H.; Kim, J.S.; Sohn, S.-K.; Yhim, H.-Y.; Kwak, J.-Y.; Yoon, S.-S.; Lee, J.S.; Park, S.; Kim, B.K. 2011: Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation. Annals of Hematology 90(12): 1409-1418
Al-Jefri, A.; Ayas, A.; Al Musa, A.; Al Mahr, M.; Al Saleh, M.; Rifai, S.; Sabbah, R.; Al Seraihy, A.; Al Ahmari, A.; Khairy, E.; Al Hassan, I.; El Solh, H. 2009: Allogeneic stem cell transplantation in patients with β-thalassemia: King Faisal specialist hospital and research centre experience. Hemoglobin 33(Suppl 1): S183-S187
Schmid, C.; Kolb, H.-J. 2007: Allogeneic stem cell transplantation in the management of acute myeloid leukemia. Medizinische Klinik 102(4): 317-323
Spina, F.; Alessandrino, P.E.; Milani, R.; Bonifazi, F.; Bernardi, M.; Luksch, R.; Fagioli, F.; Formica, C.; Farina, L. 2012: Allogeneic stem cell transplantation in therapy-related acute myeloid leukemia and myelodysplastic syndromes: impact of patient characteristics and timing of transplant. Leukemia and Lymphoma 53(1): 96-102
Kyriakou, C.; Canals, C.; Finke, Jürgen.; Kobbe, G.; Harousseau, J-Luc.; Kolb, H-Jochem.; Novitzky, N.; Goldstone, A.H.; Sureda, A.; Schmitz, N. 2009: Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27(24): 3951-3958
Dreger, P.; Döhner, H.; Ritgen, M.; Böttcher, S.; Busch, R.; Dietrich, S.; Bunjes, D.; Cohen, S.; Schubert, J.ör.; Hegenbart, U.; Beelen, D.; Zeis, M.; Stadler, M.; Hasenkamp, J.; Uharek, L.; Scheid, C.; Humpe, A.; Zenz, T.; Winkler, D.; Hallek, M.; Kneba, M.; Schmitz, N.; Stilgenbauer, S.; Uharek, L.; Beelen, D.; Glass, B.; Schmitz, N.; Hertenstein, B.; Stadler, M.; Eder, M.; Dreger, P.; Hegenbart, U.; Schubert, J.ör.; Basara, N.žd.; Gramatzki, M.; Kneba, M.; Hallek, M.; Scheid, C.; Burchert, A.; Cohen, S.; Niederwieser, D.; Holler, E.; Bunjes, D.; Stilgenbauer, S.; Döhner, H. 2010: Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial. Blood 116(14): 2438-2447
Al-Mousa, H.; Al-Shammari, Z.; Al-Ghonaium, A.; Al-Dhekri, H.; Al-Muhsen, S.; Al-Saud, B.; Arnaout, R.; Al-Seraihy, A.; Al-Jefri, A.; Al-Ahmari, A.; Ayas, M.; El-Solh, H. 2010: Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class Ii deficiency. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 16(6): 818-823
Schlaak, M.; Pickenhain, J.; Theurich, S.; Skoetz, N.; von Bergwelt-Baildon, M.; Kurschat, P. 2013: Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma. Cochrane Database of Systematic Reviews 2013(8): Cd008908
Czajczynska, A.; Günther, A.; Repp, R.; Humpe, A.; Schub, N.; Raff, T.; Nickelsen, M.; Schrauder, A.é; Schrappe, M.; Kneba, M.; Gramatzki, M. 2013: Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 19(11): 1632-1637
Poiré, X.; Artz, A.; Larson, R.A.; Kline, J.; Odenike, O.; Rich, E.; Godley, L.; Stock, W.; van Besien, K. 2009: Allogeneic stem cell transplantation with alemtuzumab-based conditioning for patients with advanced chronic myelogenous leukemia. Leukemia and Lymphoma 50(1): 85-91
Fu, X.; Jin, L.; Ma, P.; Fan, Z.; Wang, S. 2014: Allogeneic stem cells from deciduous teeth in treatment for periodontitis in miniature swine. Journal of Periodontology 85(6): 845-851
Van Kampen, R.J.W.; Canals, C.; Schouten, H.C.; Nagler, A.; Thomson, K.J.; Vernant, J.-P.; Buzyn, A.; Boogaerts, M.A.; Luan, J.-J.; Maury, S.éb.; Milpied, N.J.; Jouet, J.-P.; Ossenkoppele, G.J.; Sureda, A. 2011: Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation Registry. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 29(10): 1342-1348
Ham, J.C.; Janssen, J.J.W.M.; Boers, J.E.; Kluin, P.M.; Verdonck, L.F. 2012: Allogeneic stem-cell transplantation for blastic plasmacytoid dendritic cell neoplasm. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 30(8): E102-E103
Wei, J.; Xu, J.; Cao, Y.; Zhou, J.; Zhang, Y. 2015: Allogeneic stem-cell transplantation for peripheral T-cell lymphoma: a systemic review and meta-analysis. Acta Haematologica 133(2): 136-144
Husøy, M.Andreas.Rognlien.; Brinch, L.; Tjønnfjord, G.E.; Gedde-Dahl, T.; Heldal, D.; Holme, Pål.André.; Dybedal, I.; Kolstad, A.; Akkök, Çiğdem.Akalin.; Rollag, H.; Gaustad, P.; Bergan, S.; Egeland, T.; Josefsen, D.; Kvalheim, G.; Fløisand, Y. 2014: Allogeneic stem-cell transplantation in adults 1985-2012: results and development. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 134(16): 1569-1575
Kyriakou, C.; Canals, C.; Cornelissen, J.J.; Socié, G.; Willemze, R.; Ifrah, N.; Greinix, H.T.; Blaise, D.; Deconinck, E.; Ferrant, A.; Schattenberg, A.; Harousseau, J-Luc.; Sureda, A.; Schmitz, N. 2010: Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 28(33): 4926-4934
Forster, M.R.; Bickerstaff, A.A.; Wang, J.-J.; Zimmerman, P.D.; Cook, C.H. 2009: Allogeneic stimulation causes transcriptional reactivation of latent murine cytomegalovirus. Transplantation Proceedings 41(5): 1927-1931
Coenen, J.J.A.; Koenen, H.J.P.M.; Emmer, P.M.; van Rijssen, E.; Hilbrands, L.B.; Joosten, I. 2007: Allogeneic stimulation of naturally occurring CD4+CD25+ T cells induces strong regulatory capacity with increased donor-reactivity. Transplant Immunology 17(4): 237-242
Lui, P.P.Y.; Kong, S.K.; Lau, P.M.; Wong, Y.M.; Lee, Y.W.; Tan, C.; Wong, O.T. 2014: Allogeneic tendon-derived stem cells promote tendon healing and suppress immunoreactions in hosts: in vivo model. Tissue Engineering. Part a 20(21-22): 2998-3009
Brookfield, K.F.; Brown, M.D.; Henriques, S.M.; Buttacavoli, F.A.; Seitz, A.P. 2008: Allogeneic transfusion after predonation of blood for elective spine surgery. Clinical Orthopaedics and Related Research 466(8): 1949-1953
Illidge, T.; Bouabdallah, R.; Chen, R.; Gopal, A.K.; Moskowitz, C.H.; Ramchandren, R.; Shustov, A.R.; Tilly, H.; Trippett, T.M.; Gibb, A.; Grove, L.E.; Advani, R. 2015: Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma. Leukemia and Lymphoma 56(3): 703-710
Radich, J.P. 2010: Allogeneic transplant for chronic myeloid leukemia in 2010. Therapeutic Advances in Hematology 1(1): 5-13
El-Cheikh, J.; Crocchiolo, R.; Boher, J.-M.; Fürst, S.; Stoppa, A.M.; Faucher, C.; Castagna, L.; Granata, A.; Oudin, C.; De Colella, J.-M.S.; Coso, D.; Bouabdallah, R.; Mohty, M.; Blaise, D. 2012: Allogeneic transplant for myeloma in the era of new drugs: have the outcomes improved?. Leukemia and Lymphoma 53(8): 1630-1632
Ramsdale, E.; Van Besien, K. 2011: Allogeneic transplant for peripheral T-cell lymphoma: a sparkle of hope and many questions. Leukemia and Lymphoma 52(8): 1415-1417
Nikolousis, E.; Nagra, S.; Paneesha, S.; Delgado, J.; Holder, K.; Bratby, L.; Chaganti, S.; Lovell, R.; Milligan, D. 2010: Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies. Annals of Hematology 89(11): 1141-1145
Majhail, N.S.; Murphy, E.A.; Omondi, N.A.; Robinett, P.; Gajewski, J.L.; LeMaistre, C.F.; Confer, D.; Rizzo, J.D. 2011: Allogeneic transplant physician and center capacity in the United States. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 17(7): 956-961
McMilin, K.D.; Dasgupta, S. 2007: Allogeneic transplantation and the risk for transmission of genetic disease: the heritable cancer disorders. Stem Cells and Development 16(2): 191-212
Parmar, S.; Ritchie, D.S. 2014: Allogeneic transplantation as anticancer immunotherapy. Current Opinion in Immunology 27: 38-45
Schiller, G.J. 2014: Allogeneic transplantation as therapy for acute myelogenous leukemia in the elderly. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 20(4): 437-438
Van Besien, K. 2013: Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence. HEMATOLOGY. American Society of Hematology. Education Program 2013: 56-62
Peggs, K.S.; Anderlini, P.; Sureda, A. 2008: Allogeneic transplantation for Hodgkin lymphoma. British Journal of Haematology 143(4): 468-480
Corradini, P.; Sarina, B.; Farina, L. 2011: Allogeneic transplantation for Hodgkin's lymphoma. British Journal of Haematology 152(3): 261-272
Russell, J.A.; Savoie, M.L.; Balogh, A.; Turner, A.R.; Larratt, L.; Chaudhry, M.A.; Storek, J.; Bahlis, N.J.; Brown, C.B.; Quinlan, D.; Geddes, M.; Stewart, D.A. 2007: Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 13(7): 814-821
Eapen, M. 2012: Allogeneic transplantation for aplastic anemia. Hematology 17(Suppl 1): S15-S17
Schmitz, N.; Sureda, A.; Dini, G.; Claviez, A. 2009: Allogeneic transplantation for children and adolescents with Hodgkin lymphoma. Blood 114(20): 4605-4606
Laurenti, L.; Tarnani, M.; Chiusolo, P.; Sorà, F.; Sica, S. 2010: Allogeneic transplantation for chronic lymphocytic leukemia. Mediterranean Journal of Hematology and Infectious Diseases 2(2): E2010026
Corradini, P.; Farina, L. 2010: Allogeneic transplantation for lymphoma: long-term outcome. Current Opinion in Hematology 17(6): 522-530
Smith, M.R. 2014: Allogeneic transplantation for lymphoma: risk-benefit balance is in the eye of the beholder. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 20(7): 905-906
Babushok, D.; Hexner, E. 2014: Allogeneic transplantation for myelofibrosis: for whom, when, and what are the true benefits?. Current Opinion in Hematology 21(2): 114-122
Pulsipher, M.A.; Bader, P.; Klingebiel, T.; Cooper, L.J.N. 2009: Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 15(1 Suppl): 62-71
Litzow, M.R.; Tarima, S.; Pérez, W.S.; Bolwell, B.J.; Cairo, M.S.; Camitta, B.M.; Cutler, C.S.; de Lima, M.; Dipersio, J.F.; Gale, R.P.; Keating, A.; Lazarus, H.M.; Luger, S.; Marks, D.I.; Maziarz, R.T.; McCarthy, P.L.; Pasquini, M.C.; Phillips, G.L.; Rizzo, J.D.; Sierra, J.; Tallman, M.S.; Weisdorf, D.J. 2010: Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 115(9): 1850-1857
Sarina, B.; Castagna, L.; Farina, L.; Patriarca, F.; Benedetti, F.; Carella, A.M.; Falda, M.; Guidi, S.; Ciceri, F.; Bonini, A.; Ferrari, S.; Malagola, M.; Morello, E.; Milone, G.; Bruno, B.; Mordini, N.; Viviani, S.; Levis, A.; Giordano, L.; Santoro, A.; Corradini, P. 2010: Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability. Blood 115(18): 3671-3677
Schmitz, N.; Wu, H.-S.; Glass, B. 2014: Allogeneic transplantation in T-cell lymphomas. Seminars in Hematology 51(1): 67-72
Gahrton, G.ös. 2011: Allogeneic transplantation in multiple myeloma. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 183: 273-284
Gahrton, G.ös.; Krishnan, A. 2014: Allogeneic transplantation in multiple myeloma. Expert Review of Hematology 7(1): 79-90
Pérez-Simón, J.A. 2010: Allogeneic transplantation in multiple myeloma patients: results and recommendations in February 2010. Methods and Findings in Experimental and Clinical Pharmacology 32 Suppl A: 53-56
Richardson, P. 2014: Allogeneic transplantation in multiple myeloma: a potential renaissance in the era of novel therapies?. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 20(8): 1078-1079
Hütter, G.; Thiel, E. 2011: Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2. Aids 25(2): 273-274
Ishikane, S.; Hosoda, H.; Yamahara, K.; Akitake, Y.; Kyoungsook, J.; Mishima, K.; Iwasaki, K.; Fujiwara, M.; Miyazato, M.; Kangawa, K.; Ikeda, T. 2013: Allogeneic transplantation of fetal membrane-derived mesenchymal stem cell sheets increases neovascularization and improves cardiac function after myocardial infarction in rats. Transplantation 96(8): 697-706
Berman, A.; Pawelec, K.; Fiedor, P. 2009: Allogeneic transplantation of isolated islet cells in clinical practice. Polskie Archiwum Medycyny Wewnetrznej 119(5): 326-332
Gluckman, E. 2013: Allogeneic transplantation strategies including haploidentical transplantation in sickle cell disease. HEMATOLOGY. American Society of Hematology. Education Program 2013: 370-376
Pai, S.-Y.; Levy, O.; Jabara, H.H.; Glickman, J.N.; Stoler-Barak, L.; Sachs, J.; Nurko, S.; Orange, J.S.; Geha, R.S. 2008: Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency. Journal of Allergy and Clinical Immunology 122(6): 1113-1118.E1
Stelljes, M.; Krug, U.; Beelen, D.W.; Braess, J.; Sauerland, M.C.; Heinecke, A.; Ligges, S.; Sauer, T.; Tschanter, P.; Thoennissen, G.B.; Berning, B.ör.; Kolb, H.J.; Reichle, A.; Holler, E.; Schwerdtfeger, R.; Arnold, R.; Scheid, C.; Müller-Tidow, C.; Woermann, B.J.; Hiddemann, W.; Berdel, W.E.; Büchner, T. 2014: Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 32(4): 288-296
Armand, P.; Kim, H.T.; Ho, V.T.; Cutler, C.S.; Koreth, J.; Antin, J.H.; LaCasce, A.S.; Jacobsen, E.D.; Fisher, D.C.; Brown, J.R.; Canellos, G.P.; Freedman, A.S.; Soiffer, R.J.; Alyea, E.P. 2008: Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 14(4): 418-425
Li, X.; Xu, F.; Karoopongse, E.; Marcondes, A.M.; Lee, K.; Kowdley, K.V.; Miao, C.H.; Trobridge, G.D.; Campbell, J.S.; Deeg, H.J. 2013: Allogeneic transplantation, Fas signaling, and dysregulation of hepcidin. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 19(8): 1210-1219
Bensinger, W.I. 2012: Allogeneic transplantation: peripheral blood vs. bone marrow. Current Opinion in Oncology 24(2): 191-196
Shaw, B.E.; Nolan, A. 2013: Allogeneic transplantation: when is a mismatch better than a match?. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 19(1): 1-2
Hari, P.; Carreras, J.; Zhang, M.-J.; Gale, R.P.; Bolwell, B.J.; Bredeson, C.N.; Burns, L.J.; Cairo, M.S.; Freytes, C.és.O.; Goldstein, S.C.; Hale, G.A.; Inwards, D.J.; Lemaistre, C.F.; Maharaj, D.; Marks, D.I.; Schouten, H.C.; Slavin, S.; Vose, J.M.; Lazarus, H.M.; van Besien, K. 2008: Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 14(2): 236-245
Srivatsan, S.; Patel, J.M.; Bozeman, E.N.; Imasuen, I.E.; He, S.; Daniels, D.; Selvaraj, P. 2014: Allogeneic tumor cell vaccines: the promise and limitations in clinical trials. Human Vaccines and Immunotherapeutics 10(1): 52-63
Dubsky, P.; Hayden, H.; Sachet, M.; Bachleitner-Hofmann, T.; Hassler, M.; Pfragner, R.; Gnant, M.; Stift, A.; Friedl, J. 2008: Allogeneic tumor lysate can serve as both antigen source and protein supplementation for dendritic cell culture. Cancer Immunology Immunotherapy: Cii 57(6): 859-870
Podack, E.R.; Raez, L.E. 2007: Allogeneic tumor-cell-based vaccines secreting endoplasmic reticulum chaperone gp96. Expert Opinion on Biological Therapy 7(11): 1679-1688
Bianchi, M.; Giannantonio, C.; Spartano, S.; Fioretti, M.; Landini, A.; Molisso, A.; Tesfagabir, G.M.; Tornesello, A.; Barbagallo, O.; Valentini, C.G.; Vento, G.; Zini, G.; Romagnoli, C.; Papacci, P.; Teofili, L. 2015: Allogeneic umbilical cord blood red cell concentrates: an innovative blood product for transfusion therapy of preterm infants. Neonatology 107(2): 81-86
Garcia, J. 2010: Allogeneic unrelated cord blood banking worldwide: an update. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 42(3): 257-263
Tryphonopoulos, P.; Tzakis, A.G.; Tekin, A.; Johannesson, L.; Rivas, K.; Morales, P.R.; Wagner, J.; Mölne, J.; Enskog, A.; Diaz-Garcia, C.; Dahm-Kähler, P.; Berho, M.; Zimberg, S.; Falcone, T.; Ruiz, P.; Olausson, M.; Brännström, M. 2014: Allogeneic uterus transplantation in baboons: surgical technique and challenges to long-term graft survival. Transplantation 98(5): E51-E56
Chalfin, H.J.; Frank, S.M.; Feng, Z.; Trock, B.J.; Drake, C.G.; Partin, A.W.; Humphreys, E.; Ness, P.M.; Jeong, B.C.; Lee, S.B.; Han, M. 2014: Allogeneic versus autologous blood transfusion and survival after radical prostatectomy. Transfusion 54(9): 2168-2174
Mahalingam, V.D.; Behbahani-Nejad, N.; Horine, S.V.; Olsen, T.J.; Smietana, M.J.; Wojtys, E.M.; Wellik, D.M.; Arruda, E.M.; Larkin, L.M. 2015: Allogeneic versus autologous derived cell sources for use in engineered bone-ligament-bone grafts in sheep anterior cruciate ligament repair. Tissue Engineering. Part a 21(5-6): 1047-1054
Melenhorst, J.J.; Leen, A.M.; Bollard, C.M.; Quigley, M.ái.F.; Price, D.A.; Rooney, C.M.; Brenner, M.K.; Barrett, A.J.; Heslop, H.E. 2010: Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects. Blood 116(22): 4700-4702
Long, D.; Wu, W.-Q.; Lu, J.; Feng, L.; Li, Y.-P.; Li, S.-F. 2013: Allogenic BMSCs reverse chimerism inducing the tolerance of xeno-skin graft in mouse model. Sichuan da Xue Xue Bao. Yi Xue Ban 44(2): 165-169
Murphree, R.W. 2009: Allogenic acellular dermal matrix in the management of an enterocutaneous fistula: WOC nurse challenges. Journal of Wound Ostomy and Continence Nursing: Official Publication of Wound Ostomy and Continence Nurses Society 36(6): 674-678
Saleh, A.; Small, T.; Chandran Pillai, A.L.P.; Schiltz, N.K.; Klika, A.K.; Barsoum, W.K. 2014: Allogenic blood transfusion following total hip arthroplasty: results from the nationwide inpatient sample, 2000 to 2009. Journal of Bone and Joint Surgery. American Volume 96(18): E155
Yamamoto, M.; Kuroda, J.; Uchiyama, H.; Kobayashi, T.; Tsutsumi, Y.; Ohshiro, M.; Sasaki, N.; Shimura, Y.; Mizutani, S.; Matsumoto, Y.; Shimazaki, C.; Horiike, S.; Taniwaki, M.; Shimazaki, C. 2010: Allogenic bone marrow transplantation with fludarabine/busulfan16 conditioning regimen and dasatinib maintenance therapy for elderly Philadelphia-positive acute/advanced leukemia patients. Leukemia Research 34(4): E111-E112
Zhang, H.; Zeng, X.; Sun, L. 2010: Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus. Expert Opinion on Biological Therapy 10(5): 701-709
Kursova, L.V.; Konoplyannikov, A.G.; Kal'sina, S.Sh.; Baboyan, S.B. 2014: Allogenic cardiomyoblasts raised from human mesenchymal stem cells in the therapy of radiation cardiomyopathy and pericarditis: case report. Bulletin of Experimental Biology and Medicine 157(1): 143-145
Tsuda, H.; Yamahara, K.; Ishikane, S.; Otani, K.; Nakamura, A.; Sawai, K.; Ichimaru, N.; Sada, M.; Taguchi, A.; Hosoda, H.; Tsuji, M.; Kawachi, H.; Horio, M.; Isaka, Y.; Kangawa, K.; Takahara, S.; Ikeda, T. 2010: Allogenic fetal membrane-derived mesenchymal stem cells contribute to renal repair in experimental glomerulonephritis. American Journal of Physiology. Renal Physiology 299(5): F1004-F1013
Wardhana; Datau, E.A.; Rotty, L.W.A.; Haroen, H. 2011: Allogenic hematopoietic stem cell as curative treatment in myelofibrosis. Acta Medica Indonesiana 43(4): 252-259
Vanikar, A.V.; Trivedi, H.L.; Patel, R.D.; Kanodia, K.V.; Modi, P.R.; Shah, V.R. 2012: Allogenic hematopoietic stem cell transplantation in pemphigus vulgaris: a single-center experience. Indian Journal of Dermatology 57(1): 9-11
Barriga, F.; Wietstruck, Aélica.; Rojas, Nás.; Bertin, P.; Pizarro, I.; Carmona, A.; Guilof, A.; Rojas, Ián.; Oyarzún, E. 2013: Allogenic hematopoietic stem cell transplantation with unrelated cord blood: report of three cases from the Chilean cord blood bank. Revista Medica de Chile 141(8): 1064-1067
Shimoni, A.; Hardan, I.; Ayuk, F.; Schilling, G.; Atanackovic, D.; Zeller, W.; Yerushalmi, R.; Zander, A.R.; Kroger, N.; Nagler, A. 2010: Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-up. Cancer 116(15): 3621-3630
Moharib, M.N.; Waldemar; Olszewski, L.; Mikhail, N.E.; Nossier, M.M.F.; Atta, S.A.H.; Saber, M.A. 2014: Allogenic hepatocyte transplantation in immunomodulated Lewis rats with acute liver insufficiency following hepatectomy. Journal of the Egyptian Society of Parasitology 44(1): 221-228
Chaib, E.; Papalois, A.; Brons, I.G.M.; Calne, R.Y. 2006: Allogenic islet transplantation on the rat liver after allogenic nonparenchymal cells injection in the thymus. Arquivos de Gastroenterologia 43(4): 321-327
Tey, M.; Erquicia, J.I.; Pelfort, X.; Miquel, J.; Gelber, P.E.; Ribas, M. 2011: Allogenic labral transplantation in hip instability following arthroscopic labrectomy. Hip International: the Journal of Clinical and Experimental Research on Hip Pathology and Therapy 21(2): 260-262
Eberwein, P.; Böhringer, D.; Schwartzkopff, J.; Birnbaum, F.; Reinhard, T. 2012: Allogenic limbo-keratoplasty with conjunctivoplasty, mitomycin C, and amniotic membrane for bilateral limbal stem cell deficiency. Ophthalmology 119(5): 930-937
Ma, X.; Che, N.; Gu, Z.; Huang, J.; Wang, D.; Liang, J.; Hou, Y.; Gilkeson, G.; Lu, L.; Sun, L. 2013: Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation. Cell Transplantation 22(12): 2279-2290
Broeckx, S.; Suls, M.; Beerts, C.; Vandenberghe, A.él.; Seys, B.; Wuertz-Kozak, K.; Duchateau, L.; Spaas, J.H. 2014: Allogenic mesenchymal stem cells as a treatment for equine degenerative joint disease: a pilot study. Current Stem Cell Research and Therapy 9(6): 497-503
Liang, J.; Zhang, H.; Hua, B.; Wang, H.; Lu, L.; Shi, S.; Hou, Y.; Zeng, X.; Gilkeson, G.S.; Sun, L. 2010: Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Annals of the Rheumatic Diseases 69(8): 1423-1429
Takeuchi, E.; Takeuchi, Y. 2007: Allogenic mixed chimerism induced by nonlymphoablative regimen including donor BMT with low-dose TBi and anti-CD40L cured proliferative glomerulonephritis in lupus mice. Annals of the new York Academy of Sciences 1110: 362-367
Craig, J.B.; Lane, F.L.; Nistor, G.; Motakef, S.; Pham, Q-Anh.; Keirstead, H. 2010: Allogenic myoblast transplantation in the rat anal sphincter. Female Pelvic Medicine and Reconstructive Surgery 16(4): 205-208
Scevola, S.; Nicoletti, G.; Brenta, F.; Isernia, P.; Maestri, M.; Faga, A. 2010: Allogenic platelet gel in the treatment of pressure sores: a pilot study. International Wound Journal 7(3): 184-190
Imanishi, Y.; Miyagawa, S.; Saito, A.; Kitagawa-Sakakida, S.; Sawa, Y. 2011: Allogenic skeletal myoblast transplantation in acute myocardial infarction model rats. Transplantation 91(4): 425-431
Umar, S.; de Visser, Y.P.; Steendijk, P.; Schutte, C.I.; Laghmani, E.H.; Wagenaar, G.T.M.; Bax, W.H.; Mantikou, E.; Pijnappels, D.A.; Atsma, D.E.; Schalij, M.J.; van der Wall, E.E.; van der Laarse, A. 2009: Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension. American Journal of Physiology. Heart and Circulatory Physiology 297(5): H1606-H1616
Schattenberg, A.V.M.B.; Schouten, H.C.; Verdonck, L.F.; Willemze, R.; van der Lelie, J.; Huijgens, P.C.; van Imhoff, G.W.; van Biezen, A.; Brand, R.; Hagenbeek, A.; de Witte, T.; Cornelissen, J.J. 2009: Allogenic stem cell transplantation in the Netherlands. Nederlands Tijdschrift Voor Geneeskunde 153(9): 380-385
Jantunen, E.; Jyrkkiö, S.; Kuittinen, O.; Lehtinen, T.; Janes, R.; Elonen, E.; Volin, L. 2010: Allogenic stem cell transplantations in lymphoma patients. Duodecim; Laaketieteellinen Aikakauskirja 126(2): 167-173
Stella, F.; Dell'Amore, A.; Dolci, G.; Cassanelli, N.; Caroli, G.; Zamagni, C.; Bini, A. 2012: Allogenic sternal transplant after sternectomy for metastasis of ovarian carcinoma. Annals of Thoracic Surgery 93(3): E71-E72
Saito, K.; Nakatomi, M.; Kenmotsu, S.; Ohshima, H. 2014: Allogenic tooth transplantation inhibits the maintenance of dental pulp stem/progenitor cells in mice. Cell and Tissue Research 356(2): 357-367
Min, K.; Song, J.; Lee, J.Hyun.; Kang, M.Seo.; Jang, S.Jin.; Kim, S.Heum.; Kim, M. 2013: Allogenic umbilical cord blood therapy combined with erythropoietin for patients with severe traumatic brain injury: three case reports. Restorative Neurology and Neuroscience 31(4): 397-410
Putzier, M.; Strube, P.; Funk, J.F.; Gross, C.; Mönig, H.-J.; Perka, C.; Pruss, A. 2009: Allogenic versus autologous cancellous bone in lumbar segmental spondylodesis: a randomized prospective study. European Spine Journal: Official Publication of the European Spine Society the European Spinal Deformity Society and the European Section of the Cervical Spine Research Society 18(5): 687-695
Apostolou, T.; Fotiadis, E.; Samoladas, E.; Christodoulou, A.; Akritopoulos, P.; Notaras, I. 2007: Allogenic versus autologous transfusions: comparison of results following primary total knee replacement. Orthopedics 30(3): 196-200
Charron, D. 2013: Allogenicity and immunogenicity in regenerative stem cell therapy. Indian Journal of Medical Research 138(5): 749-754
Lauden, L.; Boukouaci, W.; Borlado, L.R.; López, I.Palacios.; Sepúlveda, P.; Tamouza, R.; Charron, D.; Al-Daccak, R. 2013: Allogenicity of human cardiac stem/progenitor cells orchestrated by programmed death ligand 1. Circulation Research 112(3): 451-464
Schleicher, I.; Lips, K.S.; Sommer, U.; Schappat, I.; Martin, A.P.; Szalay, G.; Schnettler, R. 2013: Allogenous bone with collagen for repair of deep osteochondral defects. Journal of Surgical Research 185(2): 667-675
Tosun, Z.; Karabekmez, F.E.; Keskin, M.; Duymaz, A.; Savaci, N. 2008: Allogenous cartilage graft versus autogenous cartilage graft in augmentation rhinoplasty: a decade of clinical experience. Aesthetic Plastic Surgery 32(2): 252-260; Discussion 261
Kazemi-Darabadi, S.; Sarrafzadeh-Rezaei, F.; Farshid, A.-A.; Dalir-Naghadeh, B. 2014: Allogenous skin fibroblast transplantation enhances excisional wound healing following alloxan diabetes in sheep, a randomized controlled trial. International Journal of Surgery 12(8): 751-756
Shen, W.; Chen, J.; Yin, Z.; Chen, X.; Liu, H.; Heng, B.C.; Chen, W.; Ouyang, H.-W. 2012: Allogenous tendon stem/progenitor cells in silk scaffold for functional shoulder repair. Cell Transplantation 21(5): 943-958
Maitin, N.; Maitin, S.; Rastogi, K.; Bhushan, R. 2013: Allogenous tooth fragment reattachment. BMJ Case Reports
Nedved, K.; Suchý, T.; Hálová, J.; Malický, M.ír.; Gorun, P.; Vitvar, P. 2012: Allogenous vein graft as vascular access for hemodialysis--lost battle?. Journal of Vascular Access 13(3): 366-373
Tkach, V.V.; Greiman, S.E.; Steffes, K.R. 2013: Alloglossidium demshini sp. nov. (Digenea: Macroderoididae) from leeches in Minnesota. Acta Parasitologica 58(4): 434-440
Kasl, E.L.; Fayton, T.J.; Font, W.F.; Criscione, C.D. 2014: Alloglossidium floridense n. sp. (Digenea: Macroderoididae) from a spring run in North Central Florida. Journal of Parasitology 100(1): 121-126
Tan, M.; Bassiri-Tehrani, M.; Woo, P. 2011: Allograft (Alloderm) and autograft (temporalis fascia) implantation for glottic insufficiency: a novel approach. Journal of Voice: Official Journal of the Voice Foundation 25(5): 619-625
Amirlak, B.; Gerdes, J.; Puri, V.; Fitzgibbons, R.J. 2014: Allograft AlloDerm(®) tissue for laparoscopic transabdominal preperitoneal groin hernia repair: A case report. International Journal of Surgery Case Reports 5(6): 294-297
Kim, D.H.; Berkowitz, M.J. 2014: Allograft Dermal Matrix Interpositional Arthroplasty in the Treatment of Failed Revision Arthrodesis at the Talonavicular Joint. Foot and Ankle International 35(6): 619-622
Kaeding, C.C.; Aros, B.; Pedroza, A.; Pifel, E.; Amendola, A.; Andrish, J.T.; Dunn, W.R.; Marx, R.G.; McCarty, E.C.; Parker, R.D.; Wright, R.W.; Spindler, K.P. 2011: Allograft Versus Autograft Anterior Cruciate Ligament Reconstruction: Predictors of Failure from a MOON Prospective Longitudinal Cohort. Sports Health 3(1): 73-81
Sato, M.; Liu, M.; Anraku, M.; Ogura, T.; D'Cruz, G.; Alman, B.A.; Waddell, T.K.; Kim, E.; Zhang, L.; Keshavjee, S. 2008: Allograft airway fibrosis in the pulmonary milieu: a disorder of tissue remodeling. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 8(3): 517-528
Hart, R.; Komzák, M.; Okál, Fšek.; Náhlík, D.; Jajtner, P.; Puskeiler, Mš. 2014: Allograft alone versus allograft with bone marrow concentrate for the healing of the instrumented posterolateral lumbar fusion. Spine Journal: Official Journal of the North American Spine Society 14(7): 1318-1324
Goodman, S.B. 2010: Allograft alternatives: bone substitutes and beyond. Orthopedics 33(9): 661
Blokhuis, T.J.; Lindner, T. 2008: Allograft and bone morphogenetic proteins: an overview. Injury 39(Suppl 2): S33-S36
Christenson, L.J.; Cherikh, W.S.; Otley, C.C.; Salasche, S.J.; Kauffman, H.M. 2011: Allograft and overall survival of patients with posttransplant skin cancer. Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery 37(2): 183-191
Sreejith, P.; Jha, V.; Kohli, H.S.; Rathi, M.; Gupta, K.L.; Sakhuja, V. 2010: Allograft and prostatic involvement in a renal transplant recipient with disseminated tuberculosis. Indian Journal of Nephrology 20(1): 40-42
O'Brien, D.F.; Kraeutler, M.J.; Koyonos, L.; Flato, R.R.; Ciccotti, M.G.; Cohen, S.B. 2014: Allograft anterior cruciate ligament reconstruction in patients younger than 30 years: a matched-pair comparison of bone-patellar tendon-bone and tibialis anterior. American Journal of Orthopedics 43(3): 132-136
Barrett, G.R.; Luber, K.; Replogle, W.H.; Manley, J.L. 2010: Allograft anterior cruciate ligament reconstruction in the young, active patient: Tegner activity level and failure rate. Arthroscopy: the Journal of Arthroscopic and Related Surgery: Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association 26(12): 1593-1601
Vyas, D.; Rabuck, S.J.; Harner, C.D. 2012: Allograft anterior cruciate ligament reconstruction: indications, techniques, and outcomes. Journal of Orthopaedic and Sports Physical Therapy 42(3): 196-207
Lopes, S.ér.; Calvinho, P.; de Oliveira, F.ão.; Antunes, M. 2007: Allograft aortic root replacement in complex prosthetic endocarditis. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 32(1): 126-130; Discussion: 131-132
Lv, C.; Tu, C.; Min, L.; Duan, H. 2012: Allograft arthrodesis of the knee for giant cell tumors. Orthopedics 35(3): E397-E402
Stillman, I.E.; Pavlakis, M. 2009: Allograft biopsies: studying them for all they're worth. Journal of the American Society of Nephrology: Jasn 20(11): 2282-2284
Ali, A.A.; Al-Mudhaffer, A.J.M.; Al-Taee, Q.; Al-Windawi, S. 2013: Allograft biopsy in kidney transplant recipients in the medical city of Baghdad. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 24(5): 1039-1043
Robinson, C.W.; Arnaoutakis, G.J.; Allen, J.G.; George, T.J.; Conte, J.V. 2011: Allograft cardiectomy and biventricular assist device placement as a salvage maneuver in a heart transplant recipient. Journal of Cardiac Surgery 26(1): 114-116
Evans, B.J.; Westaby, S. 2007: Allograft carotid artery as a systemic-to-pulmonary conduit. Journal of Thoracic and Cardiovascular Surgery 133(5): 1367-1368
Hollawell, S.M. 2012: Allograft cellular bone matrix as an alternative to autograft in hindfoot and ankle fusion procedures. Journal of Foot and Ankle Surgery: Official Publication of the American College of Foot and Ankle Surgeons 51(2): 222-225
Tohmeh, A.G.; Watson, B.; Tohmeh, M.; Zielinski, X.J. 2012: Allograft cellular bone matrix in extreme lateral interbody fusion: preliminary radiographic and clinical outcomes. Thescientificworldjournal 2012: 263637
Greenberg, D.D.; Robertson, M.; Vallurupalli, S.; White, R.A.; Allen, W.C. 2010: Allograft compared with autograft infection rates in primary anterior cruciate ligament reconstruction. Journal of Bone and Joint Surgery. American Volume 92(14): 2402-2408
Torres, S.A.; Cheema, O.; Shah, D.J.; Torre-Amione, G.; Estep, J.D. 2012: Allograft coronary artery thrombosis: a case report of early cardiac allograft left ventricular myocardial infarction. Methodist Debakey Cardiovascular Journal 8(1): 46-48
Tank, J.C.; Vignos, M.F.; Wetzel, R.J.; Weiner, S.D. 2014: Allograft cortical strut for reconstruction of space-occupying bone lesions. Orthopedics 37(1): E66-E70
Bell, R.C.W.; Fearon, J.; Freeman, K.D. 2013: Allograft dermal matrix hiatoplasty during laparoscopic primary fundoplication, paraesophageal hernia repair, and reoperation for failed hiatal hernia repair. Surgical Endoscopy 27(6): 1997-2004
Waterman, B.R.; Langston, J.; Slade, D.L. 2013: Allograft distal biceps reconstruction after closed intramuscular transection with delayed presentation. Journal of Shoulder and Elbow Surgery 22(5): E10-E13
Shelley, O.; Farroha, A. 2013: Allograft dressing for a free muscle flap in foot burns. Journal of Burn Care and Research: Official Publication of the American Burn Association 34(2): E116-E117
Salehian, M.-T.; Salehian, A.; Mossaffa, N.; Hadian, M.; Eghtesadi-Araghi, P. 2008: Allograft en bloc vagino-utero-ovarian avascular transplant versus autograft implantation in rats. Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation 6(4): 307-311
Angelo, J.R.; Bell, C.S.; Braun, M.C. 2011: Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 57(2): 291-299
Mannon, R.B.; Fairchild, R. 2010: Allograft fibrosis--unmasking the players at the dance. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 10(2): 201-202
Guerrero, J.S.; Al-Jandan, B.A. 2012: Allograft for maxillary sinus floor augmentation: a retrospective study of 90 cases. Implant Dentistry 21(2): 136-140
Honsová, E.; Gottfriedová, H.; Oliverius, M.; Trunecka, P. 2009: Allograft hepatitis after liver transplantation for epithelioid haemangioendothelioma. Prague Medical Report 110(3): 214-221
Lorente-Cebrián, S.; Decaunes, P.; Dungner, E.; Bouloumié, A.; Arner, P.; Dahlman, I. 2013: Allograft inflammatory factor 1 (AIF-1) is a new human adipokine involved in adipose inflammation in obese women. Bmc Endocrine Disorders 13: 54
Chen, Q.-R.; Guan, F.; Song, S.-M.; Jin, J.-K.; Lei, D.-S.; Chen, C.-M.; Lei, J.-H.; Chen, Z.-W.; Niu, A.-O. 2014: Allograft inflammatory factor-1 alleviates liver disease of BALB/c mice infected with Schistosoma japonicum. Parasitology Research 113(7): 2629-2639
Pawlik, A.; Kurzawski, M.; Dziedziejko, V.; Safranow, K.; Paczkowska, E.; Maslinski, W.; Drozdzik, M.; Gawronska-Szklarz, B. 2012: Allograft inflammatory factor-1 gene polymorphisms in patients with rheumatoid arthritis. Genetic Testing and Molecular Biomarkers 16(5): 341-345
Ye, Y.; Miao, S.; Lu, R.; Xia, X.; Chen, Y.; Zhang, J.; Wu, X.; He, S.; Qiang, F.; Zhou, J. 2014: Allograft inflammatory factor-1 is an independent prognostic indicator that regulates β-catenin in gastric cancer. Oncology Reports 31(2): 828-834
Yamamoto, A.; Ashihara, E.; Nakagawa, Y.; Obayashi, H.; Ohta, M.; Hara, H.; Adachi, T.; Seno, T.; Kadoya, M.; Hamaguchi, M.; Ishino, H.; Kohno, M.; Maekawa, T.; Kawahito, Y. 2011: Allograft inflammatory factor-1 is overexpressed and induces fibroblast chemotaxis in the skin of sclerodermatous GVHD in a murine model. Immunology Letters 135(1-2): 144-150
Jiang, W.; Kong, L.; Wu, X.; Pu, L.; Wang, X. 2011: Allograft inflammatory factor-1 is up-regulated in warm and cold ischemia-reperfusion injury in rat liver and may be inhibited by FK506. Journal of Surgical Research 165(1): 158-164
Kadoya, M.; Yamamoto, A.; Hamaguchi, M.; Obayashi, H.; Mizushima, K.; Ohta, M.; Seno, T.; Oda, R.; Fujiwara, H.; Kohno, M.; Kawahito, Y. 2014: Allograft inflammatory factor-1 stimulates chemokine production and induces chemotaxis in human peripheral blood mononuclear cells. Biochemical and Biophysical Research Communications 448(3): 287-291
Broglio, L.; Erne, B.; Tolnay, M.; Schaeren-Wiemers, N.; Fuhr, P.; Steck, A.J.; Renaud, S. 2008: Allograft inflammatory factor-1: a pathogenetic factor for vasculitic neuropathy. Muscle and Nerve 38(4): 1272-1279
Izadi, M.; Taheri, S. 2011: Allograft involvement by lymphoproliferative disorders after lung transplantation: report from the PTLD. Int survey. Progress in Transplantation 21(4): 353-359
Endean, T. 2007: Allograft irradiation. Orthopedics 30(4): 257; Author Reply 257
Yan, D.; Song, Y.; Pei, F. 2014: Allograft ligament transplantation in anterior cruciate ligament reconstruction patients with meniscal tears. Archives of Orthopaedic and Trauma Surgery 134(4): 521-527
Ulusal, B.G.; Ulusal, A.E.; Wei, F.C.; Lin, C.-Y. 2010: Allograft mass as a possible contributing factor to the skin transplant outcome. Journal of Surgical Research 161(2): 321-327
Solomon, M.P.; Komlo, C.; Defrain, M. 2013: Allograft materials in phalloplasty: a comparative analysis. Annals of Plastic Surgery 71(3): 297-299
Folia, M.; Disant, F.ço.; Faure, F. 2010: Allograft maxillary composite face transplantation. Plastic and Reconstructive Surgery 125(1): 417-418
Lee, A.S.; Kang, R.W.; Kroin, E.; Verma, N.N.; Cole, B.J. 2012: Allograft meniscus transplantation. Sports Medicine and Arthroscopy Review 20(2): 106-114
Mastrobuoni, S.; Dell'aquila, A.M.; Arraiza, M.; Bastarrika, G.; Azcarate, P.M.; Pueyo, J.; Rabago, G.; Herreros, J. 2011: Allograft morphology and function in heart transplant recipients surviving more than 15 years by magnetic resonance imaging and dual-source computed tomography. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 40(1): E62-E66
Park, W.; Jang, M.; Hwang, E.; Han, S.; Park, S.; Kim, H.; Choe, M. 2014: Allograft mucormycosis due to Rhizopus microsporus in a kidney transplant recipient. Transplantation Proceedings 46(2): 623-625
Schaefer, H.M.; Helderman, J.H. 2010: Allograft nephrectomy after transplant failure: should it be performed in all patients returning to dialysis?. Journal of the American Society of Nephrology: Jasn 21(2): 207-208
Guo, Z.; Wang, Z.; Wang, Z.; Zhang, Y. 2008: Allograft of clavicle for reconstruction of bone defect after tumor resection. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 22(1): 102-105
Bourdenx, M. 2013: Allograft of stem cell-derived dopaminergic neurons for Parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society 28(6): 736
Scully, W.F.; Parada, S.A.; Arrington, E.D. 2011: Allograft osteochondral transplantation in the knee in the active duty population. Military Medicine 176(10): 1196-1201
Fu, W.; Luo, D.; Ye, J.; Chen, Y.; Li, Q.; Li, J. 2009: Allograft osteochondral transplantation with arthroscopic assistance for repair of osteochondritis dissecans. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 23(3): 278-281
Zhang, M.; Tavora, F.; Huebner, T.; Heath, J.; Burke, A. 2012: Allograft pathology in patients transplanted for idiopathic dilated cardiomyopathy. American Journal of Surgical Pathology 36(3): 389-395
Muscolo, D.Luis.; Ayerza, M.A.; Aponte-Tinao, L.; Farfalli, G. 2008: Allograft reconstruction after sarcoma resection in children younger than 10 years old. Clinical Orthopaedics and Related Research 466(8): 1856-1862
Taras, J.S.; Amin, N.; Patel, N.; McCabe, L.A. 2013: Allograft reconstruction for digital nerve loss. Journal of Hand Surgery 38(10): 1965-1971
Sayegh, E.T.; Mascarenhas, R.; Chalmers, P.N.; Cole, B.J.; Verma, N.N.; Romeo, A.A. 2014: Allograft reconstruction for glenoid bone loss in glenohumeral instability: a systematic review. Arthroscopy: the Journal of Arthroscopic and Related Surgery: Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association 30(12): 1642-1649